-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E3s+loIJDpmLIonvhw5iIWgp6wbPzV2w2Tqc2/DjsoXr5tqhYdOdjAFxn9izOlog Lz6RwkUlW3uzE9v9sEOGcg== 0001047469-10-006788.txt : 20100730 0001047469-10-006788.hdr.sgml : 20100730 20100730113927 ACCESSION NUMBER: 0001047469-10-006788 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20100630 FILED AS OF DATE: 20100730 DATE AS OF CHANGE: 20100730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAGELLAN HEALTH SERVICES INC CENTRAL INDEX KEY: 0000019411 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 581076937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-06639 FILM NUMBER: 10980117 BUSINESS ADDRESS: STREET 1: 6950 COLUMBIA GATEWAY STREET 2: STE 400 CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 4109531000 FORMER COMPANY: FORMER CONFORMED NAME: CHARTER MEDICAL CORP DATE OF NAME CHANGE: 19920703 10-Q 1 a2199476z10-q.htm 10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q


(Mark One)
ý		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended June 30, 2010
Or
o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

Commission File No. 1-6639

MAGELLAN HEALTH SERVICES, INC.
(Exact name of registrant as specified in its charter)


Delaware (State or other jurisdiction of incorporation or organization)		58-1076937 (IRS Employer Identification No.)
55 Nod Road, Avon, Connecticut (Address of principal executive offices)		06001 (Zip code)

(860) 507-1900
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer ý		Accelerated filer o		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No ý

The number of shares of the registrant's Ordinary Common Stock outstanding as of June 30, 2010 was 33,381,346.

Table of Contents

FORM 10-Q

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

INDEX

		Page No.

PART I—Financial Information:
Item 1:	Financial Statements	3
	Consolidated Balance Sheets—December 31, 2009 and June 30, 2010	3
	Consolidated Statements of Income—For the Three and Six Months Ended June 30, 2009 and 2010	4
	Consolidated Statements of Cash Flows—For the Six Months Ended June 30, 2009 and 2010	5
	Notes to Consolidated Financial Statements	6
Item 2:	Management's Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3:	Quantitative and Qualitative Disclosures About Market Risk	41
Item 4:	Controls and Procedures	41
PART II—Other Information:
Item 1:	Legal Proceedings	42
Item 1A:	Risk Factors	42
Item 2:	Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3:	Defaults Upon Senior Securities	43
Item 4:	Submission of Matters to a Vote of Security Holders	43
Item 5:	Other Information	43
Item 6:	Exhibits	43
Signatures		44

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

	December 31, 2009			June 30, 2010 (unaudited)

ASSETS
Current Assets:
Cash and cash equivalents	$	196,507		$	230,088
Restricted cash		159,659			123,703
Accounts receivable, less allowance for doubtful accounts of $1,358 and $1,667 at December 31, 2009 and June 30, 2010, respectively		114,434			116,879
Short-term investments (restricted investments of $102,922 and $120,676 at December 31, 2009 and June 30, 2010, respectively)		162,922			195,416
Deferred income taxes		57,329			57,329
Other current assets (restricted deposits of $15,467 and $20,838 at December 31, 2009 and June 30, 2010, respectively)		62,737			57,035

Total Current Assets		753,588			780,450
Property and equipment, net		108,219			109,323
Long-term investments (restricted investments of $60,230 and $41,814 at December 31, 2009 and June 30, 2010, respectively)		67,523			41,814
Deferred income taxes		17,725			2,757
Other long-term assets		2,703			2,372
Goodwill		426,471			426,471
Other intangible assets, net		64,812			59,405

Total Assets	$	1,441,041		$	1,422,592

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable	$	27,086		$	24,655
Accrued liabilities		93,760			71,141
Medical claims payable		143,669			153,976
Other medical liabilities		104,649			86,704
Current maturities of long-term capital lease obligation		—			533

Total Current Liabilities		369,164			337,009
Long-term capital lease obligation		—			559
Tax Contingencies		118,859			121,762
Deferred credits and other long-term liabilities		2,526			2,631

Total Liabilities		490,549			461,961

Preferred stock, par value $.01 per share Authorized—10,000 shares—Issued and outstanding—none		—			—
Ordinary common stock, par value $.01 per share Authorized—100,000 shares at December 31, 2009 and June 30, 2010—Issued and outstanding—41,044 shares and 34,535 shares at December 31, 2009, respectively, and 41,602 and 33,381 shares at June 30, 2010, respectively		410			416
Multi-Vote common stock, par value $.01 per share Authorized—40,000 shares—Issued and outstanding—none		—			—
Other Stockholders' Equity:
Additional paid-in capital		614,483			638,367
Retained earnings		555,923			616,870
Warrants outstanding		5,382			5,370
Accumulated other comprehensive income (loss)		114			(145	)
Ordinary common stock in treasury, at cost, 6,509 shares and 8,221 shares at December 31, 2009 and June 30, 2010, respectively		(225,820	)		(300,247	)

Total Stockholders' Equity		950,492			960,631

Total Liabilities and Stockholders' Equity	$	1,441,041		$	1,422,592

See accompanying notes to consolidated financial statements.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share amounts)

		Three Months Ended June 30,						Six Months Ended June 30,

		2009			2010			2009			2010
Net revenue		$	635,801		$	741,658		$	1,255,316		$	1,469,711

Cost and expenses:
	Cost of care		443,048			472,478			874,766			949,157
	Cost of goods sold		49,286			54,771			101,358			111,067
	Direct service costs and other operating expenses(1)		102,934			139,617			205,998			277,871
	Depreciation and amortization		10,516			14,235			21,559			27,657
	Interest expense		657			584			1,084			1,269
	Interest income		(1,734	)		(803	)		(4,045	)		(1,620	)

			604,707			680,882			1,200,720			1,365,401

Income from continuing operations before income taxes			31,094			60,776			54,596			104,310
Provision for income taxes			12,695			25,348			22,637			43,363

Net income			18,399			35,428			31,959			60,947
Other comprehensive income (loss)			66			(285	)		(220	)		(259	)

Comprehensive income		$	18,465		$	35,143		$	31,739		$	60,688

Weighted average number of common shares outstanding—basic (See Note B)			34,955			33,323			35,578			33,849

Weighted average number of common shares outstanding—diluted (See Note B)			34,992			33,800			35,686			34,434

Net income per common share—basic:		$	0.53		$	1.06		$	0.90		$	1.80

Net income per common share—diluted:		$	0.53		$	1.05		$	0.90		$	1.77

(1): Includes stock compensation expense of $6,168 and $3,706 for the three months ended June 30, 2009 and 2010, and $12,600 and $8,234 for the six months ended June 30, 2009 and 2010, respectively.

See accompanying notes to consolidated financial statements.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30,

(Unaudited)

(In thousands)

	2009			2010

Cash flows from operating activities:
Net income	$	31,959		$	60,947
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		21,559			27,657
Non-cash interest expense		456			361
Non-cash stock compensation expense		12,600			8,234
Non-cash income tax expense		13,343			18,039
Cash flows from changes in assets and liabilities, net of effects from acquisitions of businesses:
Restricted cash		40,956			35,956
Accounts receivable, net		(19,880	)		(2,445	)
Other assets		(23,604	)		5,674
Accounts payable and accrued liabilities		(23,960	)		(25,050	)
Medical claims payable and other medical liabilities		(14,259	)		(7,638	)
Other		973			4,454

Net cash provided by operating activities		40,143			126,189

Cash flows from investing activities:
Capital expenditures		(12,457	)		(21,681	)
Purchase of investments		(144,370	)		(96,515	)
Maturity of investments		161,449			84,959

Net cash provided by (used in) investing activities		4,622			(33,237	)

Cash flows from financing activities:
Payments on long-term debt and capital lease obligations		(3	)		(588	)
Payments to acquire treasury stock		(64,019	)		(74,427	)
Proceeds from exercise of stock options and warrants		1,101			17,148
Other		2,531			(1,504	)

Net cash used in financing activities		(60,390	)		(59,371	)

Net (decrease) increase in cash and cash equivalents		(15,625	)		33,581
Cash and cash equivalents at beginning of period		211,825			196,507

Cash and cash equivalents at end of period	$	196,200		$	230,088

See accompanying notes to consolidated financial statements.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2010

(Unaudited)

NOTE A—General

Basis of Presentation

The accompanying unaudited consolidated financial statements of Magellan Health Services, Inc., a Delaware corporation ("Magellan"), include the accounts of Magellan, its majority owned subsidiaries, and the variable interest entity ("VIE") for which Magellan is the primary beneficiary (together with Magellan, the "Company"). The financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the Securities and Exchange Commission's (the "SEC") instructions to Form 10-Q. Accordingly, the financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included. The results of operations for the six months ended June 30, 2010 are not necessarily indicative of the results to be expected for the full year. All significant intercompany accounts and transactions have been eliminated in consolidation.

The Company evaluated all events or transactions that occurred after June 30, 2010 and through the date we issued these financial statements. The Company did not have any material recognizable subsequent events during this period.

These unaudited consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements for the year ended December 31, 2009 and the notes thereto, which are included in the Company's Annual Report on Form 10-K filed with the SEC on February 26, 2010.

Business Overview

The Company is engaged in the specialty managed healthcare business. Through 2005, the Company predominantly operated in the managed behavioral healthcare business. During 2006, the Company expanded into radiology benefits management and specialty pharmaceutical management as a result of certain acquisitions. During 2009, the Company expanded into Medicaid administration. The Company provides services to health plans, insurance companies, employers, labor unions and various governmental agencies. The Company's business is divided into the following six segments, based on the services it provides and/or the customers that it serves, as described below.

Managed Behavioral Healthcare

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

except as related to the Company's contract to provide managed behavioral healthcare services to Medicaid recipients and other beneficiaries of the Maricopa County Regional Behavioral Health Authority (the "Maricopa Contract"). Under the Maricopa Contract, effective August 31, 2007 the Company was required to assume the operations of twenty-four behavioral health direct care facilities for a transitional period and to divest itself of these facilities over a two year period. During March 2009, the Company began the operation of two additional behavioral health direct care facilities. In 2008 and 2009, the Company entered into agreements to transition all behavioral health direct care facilities over various dates. All of the direct care facilities were transitioned as of December 31, 2009.

The Company provides its management services primarily through: (i) risk-based products, where the Company assumes all or a substantial portion of the responsibility for the cost of providing treatment services in exchange for a fixed per member per month fee, (ii) administrative services only ("ASO") products, where the Company provides services such as utilization review, claims administration and/or provider network management, but does not assume responsibility for the cost of the treatment services, and (iii) employee assistance programs ("EAPs") where the Company provides short-term outpatient behavioral counseling services.

The managed behavioral healthcare business is managed based on the services provided and/or the customers served, through the following two segments:

Radiology Benefits Management

The Radiology Benefits Management segment ("Radiology Benefits Management") generally reflects the management of the delivery of diagnostic imaging services to ensure that such services are clinically appropriate and cost effective. The Company's radiology benefits management services currently are provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members. The Company also contracts with state and local governmental agencies for the provision of such services to Medicaid recipients. The Company offers its radiology benefits management services through ASO contracts, where the Company provides services such as utilization review and claims administration, but does not assume responsibility for the cost of the imaging services, and through risk-based contracts, where the Company assumes all or a substantial portion of the responsibility for the cost of providing diagnostic imaging services.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

Specialty Pharmaceutical Management

The Specialty Pharmaceutical Management segment ("Specialty Pharmaceutical Management") generally reflects the management of specialty drugs used in the treatment of cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis and other diseases. Specialty pharmaceutical drugs represent high-cost injectible, infused, oral, or inhaled drugs often with sensitive handling or storage needs. Patients receiving these drugs require greater amounts of clinical and financial support than those taking more traditional agents. The Company's specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, and governmental agencies for some or all of their commercial, Medicare and Medicaid members. The Company's specialty pharmaceutical services include (i) contracting and formulary optimization on behalf of health plans and pharmaceutical manufacturers; (ii) dispensing specialty pharmaceutical drugs on behalf of health plans; (iii) providing strategic consulting services to health plans and pharmaceutical manufacturers; and (iv) providing oncology management services to health plans and state Medicaid programs.

Medicaid Administration

The Medicaid Administration segment ("Medicaid Administration") generally reflects integrated clinical management services provided to the public sector to manage Medicaid, pharmacy, mental health and long-term care programs. The primary focus of the Company's Medicaid Administration involves providing pharmacy benefits administration ("PBA") services under contracts with states to Medicaid and other state sponsored program recipients. Medicaid Administration's contracts encompass Fee-For-Service ("FFS") arrangements.

Corporate and Other

This segment of the Company is comprised primarily of operational support functions such as sales and marketing and information technology, as well as corporate support functions such as executive, finance, human resources and legal.

Summary of Significant Accounting Policies

Recent Accounting Pronouncements

In June 2009, the Financial Accounting Standards Board ("FASB") established the FASB Accounting Standards Codification ("ASC") as the source of authoritative accounting principles recognized by the FASB to be applied in the preparation of financial statements in conformity with generally accepted accounting principles ("GAAP"). This statement has been incorporated into ASC 105. This guidance explicitly recognizes rules and interpretive releases of the SEC under federal securities laws as authoritative GAAP for SEC registrants. Such guidance was effective for financial statements issued for interim and annual reporting periods ending after September 15, 2009 (the quarter ending September 30, 2009 for the Company) and did not have an impact on the Company's results of operations or financial condition, but changed the referencing system for accounting

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

standards. All public filings of the Company now reference the ASC as the sole source of authoritative literature.

In June 2009, the FASB issued Statement of Financial Accounting Standards ("SFAS") No. 167, "Amendments to FASB Interpretation No. 46R". This statement has been incorporated into ASC 810 "Consolidation" ("ASC 810") and amends FASB Interpretation No. 46 (revised December 2003), "Consolidation of Variable Interest Entities" to require an analysis to determine whether a variable interest gives the entity a controlling financial interest in a variable interest entity. This statement requires an ongoing reassessment and eliminates the quantitative approach previously required for determining whether an entity is the primary beneficiary. This statement was effective for fiscal years beginning after November 15, 2009. Accordingly, the Company adopted ASC 810 on January 1, 2010. The adoption of this standard did not have a material impact on the consolidated financial statements.

In January 2010, the FASB issued Accounting Standards Update, ("ASU"), No. 2010-06, "Improving Disclosures about Fair Value Measurements", ("ASU 2010-06"). ASU 2010-06 amends ASC Topic 820, "Fair Value Measurements and Disclosures", to require a number of additional disclosures regarding fair value measurements. Effective January 1, 2010, ASU 2010-06 requires disclosure of the amounts of significant transfers between Level I and Level II and the reasons for such transfers, the reasons for any transfers in or out of Level III, and disclosure of the policy for determining when transfers between levels are recognized. ASU 2010-06 also clarified that disclosures should be provided for each class of assets and liabilities and clarified the requirement to disclose information about the valuation techniques and inputs used in estimating Level II and Level III measurements. Beginning January 1, 2011, ASU 2010-06 also requires that information in the reconciliation of recurring Level III measurements about purchases, sales, issuances and settlements be provided on a gross basis. The adoption of ASU 2010-06 only required additional disclosures and did not have an impact on the consolidated financial statements. As the Company does not have significant transfers between Levels, or any Level III measurements, no additional disclosures were necessary.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates of the Company include, among other things, accounts receivable realization, valuation allowances for deferred tax assets, valuation of goodwill and intangible assets, medical claims payable, other medical liabilities, stock compensation assumptions, tax contingencies and legal liabilities. Actual results could differ from those estimates.

Managed Care Revenue

Managed care revenue, inclusive of revenue from the Company's risk, EAP and ASO contracts, is recognized over the applicable coverage period on a per member basis for covered members. The Company is paid a per member fee for all enrolled members, and this fee is recorded as revenue in the

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

month in which members are entitled to service. The Company adjusts its revenue for retroactive membership terminations, additions and other changes, when such adjustments are identified, with the exception of retroactivity that can be reasonably estimated. Any fees paid prior to the month of service are recorded as deferred revenue. Managed care revenues approximated $573.9 million and $1,128.1 million for the three and six months ended June 30, 2009, respectively, and $591.2 million and $1,174.6 million for the three and six months ended June 30, 2010, respectively.

Fee-For-Service and Cost-Plus Contracts

The Company has certain fee-for-service ("FFS") contracts, including cost-plus contracts, with customers under which the Company recognizes revenue as services are performed and as costs are incurred. Revenues from fee-for-service and cost-plus contracts approximated $9.7 million and $19.2 million for the three and six months ended June 30, 2009, respectively, and $48.9 million and $98.3 million for the three and six months ended June 30, 2010, respectively. FFS revenue for 2010 includes the activity from the Medicaid Administration segment.

Block Grant Revenues

The Maricopa Contract is partially funded by federal, state and county block grant money, which represents annual appropriations. The Company recognizes revenue from block grant activity ratably over the period to which the block grant funding applies. Block grant revenues were approximately $29.3 million and $54.7 million for the three and six months ended June 30, 2009, respectively, and $30.7 million and $56.8 million for the three and six months ended June 30, 2010, respectively.

Dispensing Revenue

The Company recognizes dispensing revenue, which includes the co-payments received from members of the health plans the Company serves, when the specialty pharmaceutical drugs are shipped. At the time of shipment, the earnings process is complete; the obligation of the Company's customer to pay for the specialty pharmaceutical drugs is fixed, and, due to the nature of the product, the member may neither return the specialty pharmaceutical drugs nor receive a refund. Revenues from the dispensing of specialty pharmaceutical drugs on behalf of health plans were $53.6 million and $110.2 million for the three and six months ended June 30, 2009, respectively, and $58.7 million and $119.7 million for the three and six months ended June 30, 2010, respectively.

Performance-Based Revenue

The Company has the ability to earn performance-based revenue under certain risk and non-risk contracts. Performance-based revenue generally is based on either the ability of the Company to manage care for its clients below specified targets, or on other operating metrics. For each such contract, the Company estimates and records performance-based revenue after considering the relevant contractual terms and the data available for the performance-based revenue calculation. Pro-rata performance-based revenue is recognized on an interim basis pursuant to the rights and obligations of each party upon termination of the contracts. Performance-based revenues were $2.0 million and

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

$3.3 million for the three and six months ended June 30, 2009, respectively, and $4.8 million and $5.8 million for the three and six months ended June 30, 2010, respectively.

Significant Customers

Consolidated Company

The Maricopa Contract generated net revenues that exceeded, in the aggregate, ten percent of net revenues for the consolidated Company for the six months ended June 30, 2009 and 2010. The Company also has a significant concentration of business from contracts with subsidiaries of WellPoint, Inc. ("WellPoint") and with various counties in the State of Pennsylvania (the "Pennsylvania Counties") which are part of the Pennsylvania Medicaid program.

Pursuant to the Maricopa Contract, the Company provides behavioral healthcare management and other related services to approximately 727,000 members in Maricopa County, Arizona. Under the Maricopa Contract, the Company is responsible for providing covered behavioral health services to persons eligible under Title XIX (Medicaid) and Title XXI (State Children's Health Insurance Program) of the Social Security Act, non-Title XIX and non-Title XIX eligible children and adults with a serious mental illness, and to certain non-Title XIX and non-Title XXI adults with behavioral health or substance abuse disorders. The Maricopa Contract began on September 1, 2007 and extends through June 30, 2012 unless sooner terminated by the parties. The State of Arizona has the right to terminate the Maricopa Contract for cause, as defined, upon ten days' notice with an opportunity to cure, and without cause immediately upon notice from the State. The Maricopa Contract generated net revenues of $351.9 million and $400.9 million for the six months ended June 30, 2009 and 2010, respectively.

Total net revenues from the Company's contracts with WellPoint were $88.5 million and $87.1 million during the six months ended June 30, 2009 and 2010, respectively, including radiology benefits management revenue of $81.6 million and $79.3 million, respectively.

In July 2007, WellPoint acquired a radiology benefits management company, and expressed its intent to in-source all of its radiology benefits management contracts when such contracts expire. The Company has a radiology benefits management contract with WellPoint that converted from an ASO arrangement to a risk arrangement effective July 1, 2007. Such risk contract has a term through December 31, 2010, and cannot be terminated early, except for cause, as defined in the agreement; the Company has received notice from WellPoint that it will allow this contract to expire as of December 31, 2010.

Net revenues from the Pennsylvania Counties in the aggregate totaled $153.7 million and $169.9 million for the six months ended June 30, 2009 and 2010, respectively.

By Segment

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

2014, terminable without cause upon 180 days' notice after June 30, 2012, and generated net revenues of $42.2 million and $36.8 million for the six months ended June 30, 2009 and 2010, respectively.

In addition to the Maricopa Contract, one other customer generated net revenues greater than ten percent of the net revenues for the Public Sector segment for the six months ended June 30, 2009 and 2010. This customer has a contract that extends through June 30, 2012, with options for the customer to extend the term of the contract for three one year terms, and generated net revenues of $72.4 million and $72.6 million for the six months ended June 30, 2009 and 2010, respectively.

In addition to WellPoint, one other customer generated greater than ten percent of the net revenues for the Radiology Benefits Management segment for the six months ended June 30, 2009 and three customers generated greater than ten percent of the net revenues for the Radiology Benefits Management segment for the six months ended June 30, 2010. The first customer has a contract that extends through May 31, 2011 and generated net revenues of $42.5 million and $34.4 million for the six months ended June 30, 2009 and 2010, respectively. For the six months ended June 30, 2010, the remaining two of three such customers generated $53.4 million and $25.9 million of the net revenues for this segment.

For the six months ended June 30, 2009, four customers each exceeded ten percent of the net revenues for the Specialty Pharmaceutical Management segment. Such customers generated $42.4 million, $26.8 million, $19.3 million, and $15.2 million of net revenues during the six months ended June 30, 2009. For the six months ended June 30, 2010, four customers each exceeded ten percent of the net revenues for this segment. Such customers generated $43.3 million, $30.4 million, $18.3 million, and $17.1 million of net revenues during the six months ended June 30, 2010.

For the six months ended June 30, 2010, five customers each exceeded ten percent of the net revenues for the Medicaid Administration segment. Three of such customers generated $11.5 million, $10.9 million, and $7.9 million of net revenues for this segment. One additional customer generated revenue of $15.8 million during the six months ended June 30, 2010, and this contract is scheduled to terminate on September 29, 2012, unless terminated earlier by the customer. Pursuant to a competitive bid process, the customer is expected to award this contract to a vendor other than the Company, with such transition scheduled to take place on June 30, 2011. Although the Company anticipates that its contract with the customer will terminate and the contract will transition to a new vendor on June 30, 2011, until formally terminated, the Company is obligated under the contract until September 29, 2012, and up to 18 months thereafter upon mutual consent. The remaining customer generated revenue of $9.5 million during this period, and this contract terminated June 30, 2010.

Fair Value Measurements

The Company currently does not have non-financial assets and non-financial liabilities that are required to be measured at fair value on a recurring basis. Financial assets and liabilities are to be measured using inputs from the three levels of the fair value hierarchy, which are as follows:

Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

Level 2—Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).

Level 3—Unobservable inputs that reflect the Company's assumptions about the assumptions that market participants would use in pricing the asset or liability. The Company develops these inputs based on the best information available, including the Company's data.

In accordance with the fair value hierarchy described above, the following table shows the fair value of the Company's financial assets and liabilities that are required to be measured at fair value as of June 30, 2010 (in thousands):

	Fair Value Measurements at June 30, 2010

	Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents(1)	$	—	$	66,249	$	—	$	66,249
Restricted Cash(2)		—		87,416		—		87,416
Investments:
U.S. Government and agency securities		2,185		—		—		2,185
Obligations of government-sponsored enterprises(3)		—		6,980		—		6,980
Corporate debt securities		—		215,589		—		215,589
Certificates of deposit		—		9,750		—		9,750
Taxable municipal bonds		—		2,726				2,726

	$	2,185	$	388,710	$	—	$	390,895

(1): Excludes $163.8 million of cash held in bank accounts by the Company.
(2): Excludes $36.3 million of restricted cash held in bank accounts by the Company.
(3): Includes investments in notes issued by the Federal Home Loan Mortgage Corporation, and the Federal Home Loan Bank.

All of the Company's investments are classified as "available-for-sale" and are carried at fair value, based on quoted market prices. The Company's policy is to classify all investments with contractual maturities within one year as current. Investment income is recognized when earned and reported net of investment expenses. Net unrealized holding gains or losses are excluded from earnings and are reported, net of tax, as "accumulated other comprehensive income (loss)" in the accompanying consolidated balance sheets and consolidated statements of income until realized, unless the losses are deemed to be other-than-temporary. Realized gains or losses, including any provision for other-than-temporary declines in value, are included in the consolidated statements of income.

ASC 320-10-65 applies to debt securities only and provides guidance on the recognition and presentation of other-than-temporary impairments. In addition, additional disclosures are required

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

related to other-than-temporary impairments. Under this revised guidance, if a debt security is in an unrealized loss position and the Company has the intent to sell the debt security, or it is more likely than not that the Company will have to sell the debt security before recovery of its amortized cost basis, the decline in value is deemed to be other-than-temporary and is recorded to other-than-temporary impairment losses recognized in income in the consolidated statements of income. For impaired debt securities that the Company does not intend to sell or it is more likely than not that the Company will not have to sell such securities, but the Company expects that it will not fully recover the amortized cost basis, the credit component of the other-than-temporary impairment is recognized in other-than-temporary impairment losses recognized in income in the consolidated statements of income and the non-credit component of the other-than-temporary impairment is recognized in other comprehensive income.

The credit component of an other-than-temporary impairment is determined by comparing the net present value of projected future cash flows with the amortized cost basis of the debt security. The net present value is calculated by discounting the best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings, and estimates regarding timing and amount of recoveries associated with a default. Furthermore, unrealized losses entirely caused by non-credit related factors related to debt securities for which the Company expects to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive income.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

As of December 31, 2009 and June 30, 2010, there were no unrealized losses that the Company believed to be other-than-temporary. No realized gains or losses were recorded for either the six months ended June 30, 2009 or June 30, 2010. The following is a summary of short-term and long-term investments at December 31, 2009 and June 30, 2010 (in thousands):

	December 31, 2009

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
U.S. Government and agency securities	$	378	$	1	$	—		$	379
Obligations of government-sponsored enterprises(1)		11,297		39		(8	)		11,328
Corporate debt securities		208,832		458		(302	)		208,988
Certificates of deposit		9,750		—		—			9,750

Total investments at December 31, 2009	$	230,257	$	498	$	(310	)	$	230,445

	June 30, 2010

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
U.S. Government and agency securities	$	2,184	$	1	$	—		$	2,185
Obligations of government-sponsored enterprises(1)		6,961		19		—			6,980
Corporate debt securities		215,834		128		(373	)		215,589
Certificates of deposit		9,750		—		—			9,750
Taxable municipal bonds		2,740		—		(14	)		2,726

Total investments at June 30, 2010	$	237,469	$	148	$	(387	)	$	237,230

(1): Includes investments in notes issued by the Federal Home Loan Mortgage Corporation, and the Federal Home Loan Bank.

The maturity dates of the Company's investments as of June 30, 2010 are summarized below (in thousands):

	Amortized Cost		Estimated Fair Value

2010	$	112,837	$	112,805
2011		122,468		122,257
2012		2,164		2,168

Total investments at June 30, 2010	$	237,469	$	237,230

The carrying value for the Company's current assets (other than short-term investments) and current liabilities approximate their fair value due to their short maturities.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

Income Taxes

The Company's effective income tax rates were 41.5 percent and 41.6 percent for the six months ended June 30, 2009 and 2010, respectively. These rates differ from the federal statutory income tax rate primarily due to state income taxes and permanent differences between book and tax income. The Company also accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes.

Stock Compensation

At December 31, 2009 and June 30, 2010, the Company had equity-based employee incentive plans, which are described more fully in Note 6 in the Company's Annual Report on Form 10-K for the year ended December 31, 2009. The Company recorded stock compensation expense of $6.2 million and $12.6 million for the three and six months ended June 30, 2009, respectively, and $3.7 million and $8.2 million for the three and six months ended June 30, 2010, respectively. Stock compensation expense recognized in the consolidated statements of income for the three and six months ended June 30, 2009 and 2010 has been reduced for estimated forfeitures, estimated at five percent for each period.

The weighted average grant date fair value of all stock options granted during the six months ended June 30, 2010 was $11.78 as estimated using the Black-Scholes-Merton option pricing model, which also assumed an expected volatility of 31.7 percent based on the historical volatility of the Company's stock price.

The benefits of tax deductions in excess of recognized stock compensation expense are reported as a financing cash flow, rather than as an operating cash flow. In the six months ended June 30, 2009 and 2010, approximately $3.0 million and $0 million of benefits of such tax deductions related to stock compensation expense were realized and as such were reported as financing cash flows, respectively.

Summarized information related to the Company's stock options for the six months ended June 30, 2010 is as follows:

			Weighted Average Exercise Price

Outstanding, beginning of period	5,185,091		$	38.19
Granted	850,255			42.72
Forfeited	(182,355	)		43.28
Exercised	(475,403	)		35.99

Outstanding, end of period	5,377,588			38.93

Vested and expected to vest at end of period	5,240,347			38.94

Exercisable, end of period	3,169,066		$	39.28

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

All of the Company's options granted during the six months ended June 30, 2010 vest ratably on each anniversary date over the three years subsequent to grant, and all have a ten year life.

Summarized information related to the Company's nonvested restricted stock awards for the six months ended June 30, 2010 is as follows:

			Weighted Average Grant Date Fair Value

Outstanding, beginning of period	28,910		$	30.27
Awarded	22,309			39.23
Vested	(28,910	)		30.27
Forfeited	—			—

Outstanding, ending of period	22,309		$	39.23

Restricted stock awards granted during the six months ended June 30, 2010 generally vest ratably on each anniversary date over a period of one year subsquent to grant.

Summarized information related to the Company's nonvested restricted stock units for the six months ended June 30, 2010 is as follows:

			Weighted Average Grant Date Fair Value

Outstanding, beginning of period	184,454		$	34.99
Awarded	101,812			42.75
Vested	(84,533	)		36.19
Forfeited	(1,680	)		37.37

Outstanding, ending of period	200,053		$	38.42

Restricted stock units granted during the six months ended June 30, 2010 generally vest ratably on each anniversary date over the three years subsequent to grant.

Long Term Debt and Capital Lease Obligations

On April 30, 2008, the Company entered into a credit facility with Deutsche Bank AG and Citigroup Global Markets Inc. that provided for a $100.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2008 Credit Facility").

On April 29, 2009, the Company entered into an amendment to the 2008 Credit Facility with Deutsche Bank AG, Citibank, N.A., and Bank of America, N.A. that provided for an $80.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2009 Credit Facility"). Borrowings under the 2009 Credit Facility matured on April 28, 2010. The 2009 Credit Facility was guaranteed by

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE A—General (Continued)

substantially all of the subsidiaries of the Company and was secured by substantially all of the assets of the Company and the subsidiary guarantors.

Under the 2009 Credit Facility, the annual interest rate on Revolving Loan borrowings was equal to (i) in the case of U.S. dollar denominated loans, the sum of a borrowing margin of 2.25 percent plus the higher of the prime rate or one-half of one percent in excess of the overnight "federal funds" rate, or (ii) in the case of Eurodollar denominated loans, the sum of a borrowing margin of 3.25 percent plus the Eurodollar rate for the selected interest period. The Company had the option to borrow in U.S. dollar denominated loans or Eurodollar denominated loans at its discretion. Letters of Credit issued under the Revolving Loan Commitment bore interest at the rate of 3.375 percent. The commitment commission on the 2009 Credit Facility was 0.625 percent of the unused Revolving Loan Commitment.

On April 28, 2010, the Company entered into an amendment to the 2009 Credit Facility with Deutsche Bank AG, Citibank, N.A., and Bank of America, N.A. that provided for an $80.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2010 Credit Facility"). Borrowings under the 2010 Credit Facility mature on April 28, 2013. The 2010 Credit Facility is guaranteed by substantially all of the subsidiaries of the Company and is secured by substantially all of the assets of the Company and the subsidiary guarantors.

Under the 2010 Credit Facility, the annual interest rate on Revolving Loan borrowings is equal to (i) in the case of U.S. dollar denominated loans, the sum of a borrowing margin of 1.75 percent plus the higher of the prime rate or one-half of one percent in excess of the overnight "federal funds" rate, or (ii) in the case of Eurodollar denominated loans, the sum of a borrowing margin of 2.75 percent plus the Eurodollar rate for the selected interest period. The Company has the option to borrow in U.S. dollar denominated loans or Eurodollar denominated loans at its discretion. Letters of Credit issued under the Revolving Loan Commitment bear interest at the rate of 2.875 percent. The commitment commission on the 2010 Credit Facility is 0.50 percent of the unused Revolving Loan Commitment.

There were $1.1 million of capital lease obligations and no Revolving Loan borrowings at June 30, 2010.

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE B—Net Income per Common Share

The following tables reconcile income (numerator) and shares (denominator) used in the computations of net income per common share (in thousands, except per share data):

		Three Months Ended June 30,				Six Months Ended June 30,

		2009		2010		2009		2010
Numerator:
Net income		$	18,399	$	35,428	$	31,959	$	60,947

Denominator:
Weighted average number of common shares outstanding—basic			34,955		33,323		35,578		33,849
	Common stock equivalents—stock options		11		261		49		345
	Common stock equivalents—warrants		26		142		57		146
	Common stock equivalents—restricted stock		—		13		2		17
	Common stock equivalents—restricted stock units		—		60		—		76
	Common stock equivalents—employee stock purchase plan		—		1		—		1

Weighted average number of common shares outstanding—diluted			34,992		33,800		35,686		34,434

Net income per common share—basic		$	0.53	$	1.06	$	0.90	$	1.80

Net income per common share—diluted		$	0.53	$	1.05	$	0.90	$	1.77

The weighted average number of common shares outstanding for the three and six months ended June 30, 2009 and 2010 were calculated using outstanding shares of the Company's Ordinary Common Stock. Common stock equivalents included in the calculation of diluted weighted average common shares outstanding for the three and six months ended June 30, 2009 and 2010 represent stock options to purchase shares of the Company's Ordinary Common Stock, restricted stock awards and restricted stock units, stock to be purchased under the Employee Stock Purchase Plan and shares of Ordinary Common Stock related to certain warrants issued on January 5, 2004.

For the three months and six months ended June 30, 2010, the Company had additional potential dilutive securities outstanding representing 3.0 million and 1.9 million options, respectively, that were not included in the computation of dilutive securities because they were anti-dilutive for such periods. Had these shares not been anti-dilutive, all of these shares would not have been included in the net income per common share calculation as the Company uses the treasury stock method of calculating diluted shares.

NOTE C—Business Segment Information

The accounting policies of the Company's segments are the same as those described in Note A—"General." The Company evaluates performance of its segments based on profit or loss from continuing operations before stock compensation expense, depreciation and amortization, interest

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE C—Business Segment Information (Continued)

expense, interest income, gain on sale of assets, special charges or benefits, and income taxes ("Segment Profit"). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Intersegment sales and transfers are not significant.

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

Three Months Ended June 30, 2009	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Corporate and Other			Consolidated

Net revenue	$	160,190		$	343,181		$	70,565		$	61,865		$	—		$	635,801
Cost of care		(88,851	)		(309,770	)		(44,427	)		—			—			(443,048	)
Cost of goods sold		—			—			—			(49,286	)		—			(49,286	)
Direct service costs		(38,008	)		(16,910	)		(12,469	)		(6,870	)		—			(74,257	)
Other operating expenses		—			—			—			—			(28,677	)		(28,677	)
Stock compensation expense(1)		188			209			424			2,136			3,211			6,168

Segment profit (loss)	$	33,519		$	16,710		$	14,093		$	7,845		$	(25,466	)	$	46,701

Three Months Ended June 30, 2010	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Medicaid Administration			Corporate and Other			Consolidated

Net revenue	$	160,982		$	368,011		$	105,263		$	67,993		$	39,409		$	—		$	741,658
Cost of care		(90,583	)		(311,609	)		(70,286	)		—			—			—			(472,478	)
Cost of goods sold		—			—			—			(54,771	)		—			—			(54,771	)
Direct service costs		(37,716	)		(15,458	)		(15,401	)		(5,922	)		(34,039	)		—			(108,536	)
Other operating expenses		—			—			—			—			—			(31,081	)		(31,081	)
Stock compensation expense(1)		194			172			368			114			22			2,836			3,706

Segment profit (loss)	$	32,877		$	41,116		$	19,944		$	7,414		$	5,392		$	(28,245	)	$	78,498

Six Months Ended June 30, 2009	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Corporate and Other			Consolidated

Net revenue	$	318,943		$	665,041		$	144,124		$	127,208		$	—		$	1,255,316
Cost of care		(178,637	)		(601,916	)		(94,213	)		—			—			(874,766	)
Cost of goods sold		—			—			—			(101,358	)		—			(101,358	)
Direct service costs		(76,533	)		(34,206	)		(25,507	)		(13,264	)		—			(149,510	)
Other operating expenses		—			—			—			—			(56,488	)		(56,488	)
Stock compensation expense(1)		520			444			794			4,218			6,624			12,600

Segment profit (loss)	$	64,293		$	29,363		$	25,198		$	16,804		$	(49,864	)	$	85,794

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE C—Business Segment Information (Continued)

Six Months Ended June 30, 2010	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Medicaid Administration			Corporate and Other			Consolidated

Net revenue	$	322,684		$	717,479		$	214,720		$	136,131		$	78,697		$	—		$	1,469,711
Cost of care		(181,255	)		(620,671	)		(147,231	)		—			—			—			(949,157	)
Cost of goods sold		—			—			—			(111,067	)		—			—			(111,067	)
Direct service costs		(75,184	)		(33,005	)		(30,239	)		(11,473	)		(66,627	)		—			(216,528	)
Other operating expenses		—			—			—			—			—			(61,343	)		(61,343	)
Stock compensation expense(1)		432			373			761			257			40			6,371			8,234

Segment profit (loss)	$	66,677		$	64,176		$	38,011		$	13,848		$	12,110		$	(54,972	)	$	139,850

(1): Stock compensation expense is included in direct service costs and other operating expenses, however this amount is excluded from the computation of Segment Profit since it is managed on a consolidated basis.

The following table reconciles Segment Profit to consolidated income from continuing operations before income taxes (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,

	2009			2010			2009			2010
Segment profit	$	46,701		$	78,498		$	85,794		$	139,850
Stock compensation expense		(6,168	)		(3,706	)		(12,600	)		(8,234	)
Depreciation and amortization		(10,516	)		(14,235	)		(21,559	)		(27,657	)
Interest expense		(657	)		(584	)		(1,084	)		(1,269	)
Interest income		1,734			803			4,045			1,620

Income from continuing operations before income taxes	$	31,094		$	60,776		$	54,596		$	104,310

NOTE D—Commitments and Contingencies

Legal

The management and administration of the delivery of specialty managed healthcare entails significant risks of liability. From time to time, the Company is subject to various actions and claims arising from the acts or omissions of its employees, network providers or other parties. In the normal course of business, the Company receives reports relating to deaths and other serious incidents involving patients whose care is being managed by the Company. Such incidents occasionally give rise to malpractice, professional negligence and other related actions and claims against the Company or its network providers. Many of these actions and claims received by the Company seek substantial damages and therefore require the Company to incur significant fees and costs related to their defense. The Company is also subject to or party to certain class actions, litigation and claims relating to its operations and business practices. In the opinion of management, the Company has recorded reserves that are adequate to cover litigation, claims or assessments that have been or may be asserted against the Company, and for which the outcome is probable and reasonably estimable. Management believes that the resolution of such litigation and claims will not have a material adverse effect on the

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE D—Commitments and Contingencies (Continued)

Company's financial condition or results of operations; however, there can be no assurance in this regard.

Stock Repurchases

On July 30, 2008 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $200 million of its outstanding common stock through January 31, 2010. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 3,866,505 shares of the Company's common stock at an aggregate cost of $136.0 million (excluding broker commissions) during the year ended December 31, 2008 and made open market purchases of 1,859,959 shares of the Company's common stock at an average share price of $34.39 per share for an aggregate cost of $64.0 million (excluding broker commissions) during the period January 1, 2009 through April 7, 2009, which was the date that the repurchase program was completed, the $200 million authorization having been exhausted.

On July 28, 2009 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $100 million of its outstanding common stock through July 28, 2011. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 782,400 shares of the Company's common stock at an average price of $32.75 per share for an aggregate cost of $25.6 million (excluding broker commissions) during the period from August 17, 2009 through December 31, 2009. Pursuant to this program, the Company made open market purchases of 1,711,881 shares of the Company's common stock at an average price of $43.46 per share for an aggregate cost of $74.4 million (excluding broker commissions) during the period January 1, 2010 through April 1, 2010, which was the date that the repurchase program was completed, the $100 million authorization having been exhausted.

Acquisition of First Health Services

Pursuant to the June 4, 2009 Purchase Agreement (the "Purchase Agreement") with Coventry, on July 31, 2009 the Company acquired (the "Acquisition") all of the outstanding equity interests of Coventry's direct and indirect subsidiaries First Health Services Corporation ("FHS"), FHC, Inc. ("FHC") and Provider Synergies, LLC (together with FHS and FHC, "First Health Services") and certain assets of Coventry which are related to the operation of the business conducted by First Health Services. First Health Services provides pharmacy benefits management and other services to Medicaid programs. As consideration for the Acquisition, the Company paid $115.4 million in cash, excluding

Table of Contents

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

June 30, 2010

(Unaudited)

NOTE D—Commitments and Contingencies (Continued)

cash acquired and including a payment of $7.4 million for excess working capital with such amount being subject to final adjustments as provided in the Purchase Agreement. The Company funded the Acquisition with cash on hand.

As of June 30, 2010, settlement of the working capital receivable and certain contractual liabilities remain open and therefore subject to further estimation. In addition, the amount recognized for deferred tax liabilities may be impacted by the determination of these items. The Company will make appropriate adjustments to the purchase price allocation prior to the completion of the measurement period as required.

The Company reports the results of operations of First Health Services within Medicaid Administration.

Effective July 1, 2010 the Company discontinued the use of the name First Health Services Corporation and officially changed such name to "Magellan Medicaid Administration, Inc."

NOTE E—Subsequent Event

Stock Repurchase

On July 27, 2010 the Company's board of directors approved a stock repurchase plan which authorizes the Company to purchase up to $350 million of its outstanding common stock through July 27, 2012. Stock repurchases under the program may be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions from time to time and in such amounts and via such methods as management deems appropriate. The stock repurchase program may be limited or terminated at any time without prior notice.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of the financial condition and results of operations of Magellan Health Services, Inc. ("Magellan"), and its majority-owned subsidiaries and all variable interest entities ("VIEs") for which Magellan is the primary beneficiary (together with Magellan, the "Company") should be read together with the Consolidated Financial Statements and the notes to the Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q and the Company's Annual Report on Form 10-K for the year ended December 31, 2009, which was filed with the Securities and Exchange Commission ("SEC") on February 26, 2010.

Forward-Looking Statements

This Form 10-Q includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Although the Company believes that its plans, intentions and expectations as reflected in such forward-looking statements are reasonable, it can give no assurance that such plans, intentions or expectations will be achieved. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include:

•: the Company's inability to renegotiate or extend expiring customer contracts, or the termination of customer contracts;
•: the Company's inability to integrate acquisitions in a timely and effective manner;
•: changes in business practices of the industry, including the possibility that certain of the Company's managed care customers could seek to provide managed healthcare services directly to their subscribers, instead of contracting with the Company for such services, particularly as a result of further consolidation in the managed care industry and especially regarding managed healthcare customers that have already done so with a portion of their membership;
•: the impact of changes in the contracting model for Medicaid contracts, including certain changes in the contracting model used by states for managed healthcare services contracts relating to Medicaid lives;
•: the Company's ability to accurately predict and control healthcare costs, and to properly price the Company's services;
•: the Company's dependence on government spending for managed healthcare, including changes in federal, state and local healthcare policies;
•: restrictive covenants in the Company's debt instruments;
•: present or future state regulations and contractual requirements that the Company provide financial assurance of its ability to meet its obligations;
•: the impact of the competitive environment in the managed healthcare services industry which may limit the Company's ability to maintain or obtain contracts, as well as to its ability to maintain or increase its rates;
•: the impact of healthcare reform legislation;
•: government regulation;
•: the possible impact of additional regulatory scrutiny and liability associated with the Company's Specialty Pharmaceutical Management segment;

Table of Contents

•: the inability to realize the value of goodwill and intangible assets;
•: pending or future actions or claims for professional liability;
•: claims brought against the Company that either exceed the scope of the Company's liability coverage or result in denial of coverage;
•: class action suits and other legal proceedings;
•: the impact of governmental investigations;
•: the impact of varying economic and market conditions on the Company's investment portfolio;
•: the state of the national economy and adverse changes in economic conditions; and
•: the Mental and Substance Abuse Benefit Parity Law and Regulations.

Further discussion of factors currently known to management that could cause actual results to differ materially from those in forward-looking statements is set forth under the heading "Risk Factors" in Item 1A of Magellan's Annual Report on Form 10-K for the year ended December 31, 2009. When used in this Quarterly Report on Form 10-Q, the words "estimate," "anticipate," "expect," "believe," "should," and similar expressions are intended to be forward-looking statements. Magellan undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

Business Overview

Managed Behavioral Healthcare

Two of the Company's segments are in the managed behavioral healthcare business. This line of business generally reflects the Company's coordination and management of the delivery of behavioral healthcare treatment services that are provided through its contracted network of third-party treatment providers, which includes psychiatrists, psychologists, other behavioral health professionals, psychiatric hospitals, general medical facilities with psychiatric beds, residential treatment centers and other treatment facilities. The treatment services provided through the Company's provider network include outpatient programs (such as counseling or therapy), intermediate care programs (such as intensive outpatient programs and partial hospitalization services), inpatient treatment and crisis intervention services. The Company generally does not directly provide, or own any provider of, treatment services except as related to the Company's contract to provide managed behavioral healthcare services to Medicaid recipients and other beneficiaries of the Maricopa County Regional Behavioral Health Authority (the "Maricopa Contract"). Under the Maricopa Contract, effective August 31, 2007 the Company was required to assume the operations of twenty-four behavioral health direct care facilities for a transitional period and to divest itself of these facilities over a two year period. During March 2009, the Company began the operation of two additional behavioral health direct care facilities. In 2008 and 2009, the Company entered into agreements to transition all behavioral health direct care facilities over various dates. All of the direct care facilities were transitioned as of December 31, 2009.

Table of Contents

The managed behavioral healthcare business is managed based on the services provided and/or the customers served, through the following two segments:

Commercial. The Managed Behavioral Healthcare Commercial segment ("Commercial") generally reflects managed behavioral healthcare services and EAP services provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members, as well as with employers, including corporations and governmental agencies, and labor unions. Commercial's contracts encompass risk-based, ASO and EAP arrangements. As of June 30, 2010, Commercial's covered lives were 3.9 million, 12.3 million and 20.3 million for risk-based, EAP and ASO products, respectively. For the six months ended June 30, 2010, Commercial's revenue was $214.0 million, $46.3 million and $62.4 million for risk-based, EAP and ASO products, respectively.

Public Sector. The Managed Behavioral Healthcare Public Sector segment ("Public Sector") generally reflects services provided to Medicaid recipients under contracts with state and local governmental agencies. Public Sector contracts encompass either risk-based or ASO arrangements. As of June 30, 2010, Public Sector's covered lives were 1.6 million and 0.3 million for risk-based and ASO products, respectively. For the six months ended June 30, 2010, Public Sector's revenue was $714.7 million and $2.8 million for risk-based and ASO products, respectively.

Radiology Benefits Management

Specialty Pharmaceutical Management

Table of Contents

Company's specialty pharmaceutical services include (i) contracting and formulary optimization on behalf of health plans and pharmaceutical manufacturers; (ii) dispensing specialty pharmaceutical drugs on behalf of health plans; (iii) providing strategic consulting services to health plans and pharmaceutical manufacturers; and (iv) providing oncology management services to health plans and state Medicaid programs. The Company's Specialty Pharmaceutical Management segment had contracts with 40 health plans as of June 30, 2010.

Medicaid Administration

Corporate and Other

Significant Customers

Consolidated Company

Table of Contents

Company has received notice from WellPoint that it will allow this contract to expire as of December 31, 2010.

Net revenues from the Pennsylvania Counties in the aggregate totaled $153.7 million and $169.9 million for the six months ended June 30, 2009 and 2010, respectively.

By Segment

Two customers generated greater than ten percent of Commercial net revenues for the six months ended June 30, 2009 and 2010. The first customer has a contract that extends through December 31, 2012 and generated net revenues of $116.8 million and $126.9 million for the six months ended June 30, 2009 and 2010, respectively. The second customer has a contract that extends through June 30, 2014, terminable without cause upon 180 days' notice after June 30, 2012, and generated net revenues of $42.2 million and $36.8 million for the six months ended June 30, 2009 and 2010, respectively.

Table of Contents

Critical Accounting Policies and Estimates

Income Taxes

The Company files a consolidated federal income tax return for the Company and its eighty-percent or more owned subsidiaries, and the Company and its subsidiaries file income tax returns in various states and local jurisdictions.

With few exceptions, the Company is no longer subject to state or local income tax assessments by tax authorities for years ended prior to December 31, 2006. Further, the statute of limitations regarding the assessment of the federal and most state and local income taxes for the year ended December 31, 2006 will expire during 2010.

Results of Operations

The Company evaluates performance of its segments based on profit or loss from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes ("Segment Profit"). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Intersegment sales and transfers are not significant. The Company's segments are defined above.

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

Three Months Ended June 30, 2009	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Corporate and Other			Consolidated

Net revenue	$	160,190		$	343,181		$	70,565		$	61,865		$	—		$	635,801
Cost of care		(88,851	)		(309,770	)		(44,427	)		—			—			(443,048	)
Cost of goods sold		—			—			—			(49,286	)		—			(49,286	)
Direct service costs		(38,008	)		(16,910	)		(12,469	)		(6,870	)		—			(74,257	)
Other operating expenses		—			—			—			—			(28,677	)		(28,677	)
Stock compensation expense(1)		188			209			424			2,136			3,211			6,168

Segment profit (loss)	$	33,519		$	16,710		$	14,093		$	7,845		$	(25,466	)	$	46,701

Table of Contents

Three Months Ended June 30, 2010	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Medicaid Administration			Corporate and Other			Consolidated

Net revenue	$	160,982		$	368,011		$	105,263		$	67,993		$	39,409		$	—		$	741,658
Cost of care		(90,583	)		(311,609	)		(70,286	)		—			—			—			(472,478	)
Cost of goods sold		—			—			—			(54,771	)		—			—			(54,771	)
Direct service costs		(37,716	)		(15,458	)		(15,401	)		(5,922	)		(34,039	)		—			(108,536	)
Other operating expenses		—			—			—			—			—			(31,081	)		(31,081	)
Stock compensation expense(1)		194			172			368			114			22			2,836			3,706

Segment profit (loss)	$	32,877		$	41,116		$	19,944		$	7,414		$	5,392		$	(28,245	)	$	78,498

Six Months Ended June 30, 2009	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Corporate and Other			Consolidated

Net revenue	$	318,943		$	665,041		$	144,124		$	127,208		$	—		$	1,255,316
Cost of care		(178,637	)		(601,916	)		(94,213	)		—			—			(874,766	)
Cost of goods sold		—			—			—			(101,358	)		—			(101,358	)
Direct service costs		(76,533	)		(34,206	)		(25,507	)		(13,264	)		—			(149,510	)
Other operating expenses		—			—			—			—			(56,488	)		(56,488	)
Stock compensation expense(1)		520			444			794			4,218			6,624			12,600

Segment profit (loss)	$	64,293		$	29,363		$	25,198		$	16,804		$	(49,864	)	$	85,794

Six Months Ended June 30, 2010	Commercial			Public Sector			Radiology Benefits Management			Specialty Pharmaceutical Management			Medicaid Administration			Corporate and Other			Consolidated

Net revenue	$	322,684		$	717,479		$	214,720		$	136,131		$	78,697		$	—		$	1,469,711
Cost of care		(181,255	)		(620,671	)		(147,231	)		—			—			—			(949,157	)
Cost of goods sold		—			—			—			(111,067	)		—			—			(111,067	)
Direct service costs		(75,184	)		(33,005	)		(30,239	)		(11,473	)		(66,627	)		—			(216,528	)
Other operating expenses		—			—			—			—			—			(61,343	)		(61,343	)
Stock compensation expense(1)		432			373			761			257			40			6,371			8,234

Segment profit (loss)	$	66,677		$	64,176		$	38,011		$	13,848		$	12,110		$	(54,972	)	$	139,850

(1): Stock compensation expense is included in direct service costs and other operating expenses, however this amount is excluded from the computation of Segment Profit since it is managed on a consolidated basis.

The following table reconciles Segment Profit to consolidated income from continuing operations before income taxes (in thousands):

		Three Months Ended June 30,						Six Months Ended June 30,

		2009			2010			2009			2010
Segment profit		$	46,701		$	78,498		$	85,794		$	139,850
Stock compensation expense			(6,168	)		(3,706	)		(12,600	)		(8,234	)
Depreciation and amortization			(10,516	)		(14,235	)		(21,559	)		(27,657	)
Interest expense			(657	)		(584	)		(1,084	)		(1,269	)
Interest income			1,734			803			4,045			1,620

	Income from continuing operations before income taxes	$	31,094		$	60,776		$	54,596		$	104,310

Table of Contents

Quarter ended June 30, 2010 ("Current Year Quarter"), compared to the quarter ended June 30, 2009 ("Prior Year Quarter")

Commercial

Net Revenue

Net revenue related to Commercial increased by 0.5 percent or $0.8 million from the Prior Year Quarter to the Current Year Quarter. The increase in revenue is mainly due to favorable rates changes of $6.5 million, net incentive revenue recorded in the Current Year Quarter of $1.5 million, revenue from new contracts implemented after the Prior Year Quarter of $1.3 million, and other net increases of $2.2 million, which increases were partially offset by terminated contracts of $7.3 million, decreased membership from existing customers of $2.4 million, and net favorable retroactive membership and rate adjustments of $1.0 million recorded in the Prior Year Quarter.

Cost of Care

Cost of care increased by 1.9 percent or $1.7 million from the Prior Year Quarter to the Current Year Quarter. The increase in cost of care is primarily due to the impact of favorable contractual settlements in the Prior Year Quarter of $2.7 million, favorable prior period medical claims development recorded in the Prior Year Quarter of $0.5 million, and care trends and other net unfavorable variances of $7.3 million, which increases were partially offset by terminated contracts of $3.0 million, favorable medical claims development for the Prior Year Quarter which was recorded after the Prior Year Quarter of $2.8 million, favorable prior period medical claims development recorded in the Current Year Quarter of $1.8 million, and decreased membership from existing customers of $1.2 million. Cost of care decreased as a percentage of risk revenue (excluding EAP business) from 79.4 percent in the Prior Year Quarter to 78.5 percent in the Current Year Quarter, mainly due to favorable out of period care development, and changes in business mix.

Direct Service Costs

Direct service costs decreased by 0.8 percent or $0.3 million from the Prior Year Quarter to the Current Year Quarter. The decrease in direct service costs is mainly attributable to terminated contracts. Direct service costs decreased as a percentage of revenue from 23.7 percent in the Prior Year Quarter to 23.4 percent in the Current Year Quarter mainly due to rate increases and changes in business mix.

Public Sector

Net Revenue

Net revenue related to Public Sector increased by 7.2 percent or $24.8 million from the Prior Year Quarter to the Current Year Quarter. This increase is primarily due to the net impact of increased membership from existing customers offset by terminated contracts of $25.7 million, net rate and other contract funding changes of $9.5 million, the recognition in the Current Year Quarter of $5.6 million of previously deferred revenue on the Maricopa Contract, and other net favorable variances of $0.4 million, which increases were partially offset by the revenue impact for favorable prior period medical claims development recorded in the Current Year Quarter of $6.3 million, the revenue impact for out of period care development pertaining to the Prior Year Quarter of $4.1 million and the recognition in the Prior Year Quarter of $6.0 million of deferred revenue on the Maricopa Contract.

Cost of Care

Cost of care increased by 0.6 percent or $1.8 million from the Prior Year Quarter to the Current Year Quarter. This increase is primarily due to the net impact of care associated with increased

Table of Contents

membership from existing customers offset by terminated contracts of $20.9 million and care trends and other net unfavorable variances of $1.8 million, which increases were partially offset by favorable prior period medical claims development recorded in the Current Year Quarter of $11.8 million, favorable medical claims development for the Prior Year Quarter which was recorded after the Prior Year Quarter of $5.6 million and unfavorable prior period medical claims development recorded in the Prior Year Quarter of $3.5 million. Cost of care decreased as a percentage of risk revenue from 90.7 percent in the Prior Year Quarter to 85.0 percent in the Current Year Quarter mainly due to favorable out of period care development and changes in business mix.

Direct Service Costs

Direct service costs decreased by 8.6 percent or $1.5 million from the Prior Year Quarter to the Current Year Quarter. The decrease in direct service costs is mainly attributable to terminated contracts. Direct service costs decreased as a percentage of revenue from 4.9 percent for the Prior Year Quarter to 4.2 percent in the Current Year Quarter mainly due to changes in business mix.

Radiology Benefits Management

Net Revenue

Net revenue related to Radiology Benefits Management increased by 49.2 percent or $34.7 million from the Prior Year Quarter to the Current Year Quarter. This increase is primarily due to revenue from new contracts implemented after the Prior Year Quarter of $41.8 million and favorable rate changes of $6.9 million, which increases were partially offset by decreased membership from existing customers of $7.8 million, favorable retroactive membership and rate adjustments recorded in the Prior Year Quarter of $1.8 million, profit share impact of $3.2 million related to favorable prior period medical claims development in the Current Year Quarter, and other net decreases of $1.2 million.

Cost of Care

Cost of care increased by 58.2 percent or $25.9 million from the Prior Year Quarter to the Current Year Quarter. This increase is primarily attributed to new contracts implemented after the Prior Year Quarter of $36.6 million and favorable contractual settlements of $5.2 million recorded in the Prior Year Quarter, which increases were partially offset by favorable prior period medical claims development recorded in the Current Year Quarter of $8.7 million, decreased membership from existing customers of $6.0 million, and care trends and other net favorable variances of $1.2 million. Cost of care decreased as a percentage of risk revenue from 76.6 percent in the Prior Year Quarter to 75.1 percent in the Current Year Quarter mainly due to favorable rate changes, care development and business mix.

Direct Service Costs

Direct service costs increased by 23.5 percent or $2.9 million from the Prior Year Quarter to the Current Year Quarter. The increase in direct service costs is mainly attributable to costs associated with new business. As a percentage of revenue, direct service costs decreased from 17.7 percent in the Prior Year Quarter to 14.6 percent in the Current Year Quarter, mainly due to favorable rate changes and business mix.

Table of Contents

Specialty Pharmaceutical Management

Net Revenue

Net revenue related to Specialty Pharmaceutical Management increased by 9.9 percent or $6.1 million from the Prior Year Quarter to the Current Year Quarter. This increase is primarily due to net increased dispensing activity of $5.6 million and other net increases of $0.5 million.

Cost of Goods Sold

Cost of goods sold increased by 11.1 percent or $5.5 million from the Prior Year Quarter to the Current Year Quarter. This increase is primarily due to net increased dispensing activity. As a percentage of the portion of net revenue that relates to dispensing activity, cost of goods sold increased from 92.0 percent in the Prior Year Quarter to 93.3 percent in the Current Year Quarter, mainly due to business mix.

Direct Service Costs

Direct service costs decreased by 13.8 percent or $0.9 million from the Prior Year Quarter to the Current Year Quarter. This decrease is primarily due to a reduction in stock compensation expense, partially offset by an increase in expenses to support the development of new products. As a percentage of revenue, direct service costs decreased from 11.1 percent in the Prior Year Quarter to 8.7 percent in the Current Year Quarter, mainly due to a decrease in stock compensation expense.

Medicaid Administration

Net Revenue

Net revenue related to Medicaid Administration was $39.4 million for the Current Year Quarter. The acquisition of First Health Services closed on July 31, 2009 and the Prior Year Quarter does not include any operating results for this segment of the Company.

Direct Service Costs

Direct service costs were $34.0 million for the Current Year Quarter. As a percentage of revenue, direct service costs were 86.4 percent in the Current Year Quarter.

Corporate and Other

Other Operating Expenses

Other operating expenses related to the Corporate and Other Segment increased by 8.4 percent or $2.4 million from the Prior Year Quarter to the Current Year Quarter. The increase results primarily from net one-time unfavorable adjustments recorded in the Current Year Quarter of $0.6 million, increased discretionary benefit costs of $0.5 million, net favorable one-time adjustments recorded in the Prior Year Quarter of $0.4 million, and other net increased expenses of $0.9 million required to support the Company's growth. As a percentage of total net revenue, other operating expenses decreased from 4.5 percent for the Prior Year Quarter to 4.2 percent for the Current Year Quarter, primarily due to changes in business mix.

Depreciation and Amortization

Depreciation and amortization expense increased by 35.4 percent or $3.7 million from the Prior Year Quarter to the Current Year Quarter, primarily due to asset additions after the Prior Year Quarter (inclusive of assets related to the acquisition of First Health Services).

Table of Contents

Interest Expense

Interest expense was $0.6 million for the Current Year Quarter, which is consistent with the Prior Year Quarter.

Interest Income

Interest income decreased by $0.9 million from the Prior Year Quarter to the Current Year Quarter, mainly due to lower yields.

Income Taxes

The Company's effective income tax rate was 40.8 percent in the Prior Year Quarter and 41.7 percent in the Current Year Quarter. The increase in the effective rate is mainly due to higher income taxes in the Current Year Quarter. The Prior Year Quarter and Current Year Quarter effective income tax rates differ from the federal statutory income tax rate primarily due to state income taxes and permanent differences between book and tax income. The Company also accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes.

Six Months ended June 30, 2010 ("Current Year Period"), compared to the six months ended June 30, 2009 ("Prior Year Period")

Commercial

Net Revenue

Net revenue related to Commercial increased by 1.2 percent or $3.7 million from the Prior Year Period to the Current Year Period. The increase in revenue is mainly due to favorable rates changes of $16.4 million, revenue from new contracts implemented after the Prior Year Period of $2.7 million, favorable retroactive membership adjustments of $1.7 million recorded in the Current Year Period, and net incentive revenue recorded in the Current Year Period of $1.5 million, which increases were partially offset by terminated contracts of $15.3 million, decreased membership from existing customers of $1.5 million, and other net unfavorable variances of $1.8 million.

Cost of Care

Cost of care increased by 1.5 percent or $2.6 million from the Prior Year Period to the Current Year Period. The increase in cost of care is primarily due to the impact of favorable contractual settlements in the Prior Year Period of $2.7 million, favorable prior period medical claims development recorded in the Prior Year Period of $0.5 million, and care trends and other net unfavorable variances of $9.3 million, which increases were partially offset by terminated contracts of $6.2 million, favorable medical claims development for the Prior Year Period which was recorded after the Prior Year Period of $2.9 million, and favorable prior period medical claims development recorded in the Current Year Period of $0.8 million. Cost of care decreased as a percentage of risk revenue (excluding EAP business) from 80.4 percent in the Prior Year Period to 78.2 percent in the Current Year Period, mainly due to rate increases in excess of care trends.

Direct Service Costs

Direct service costs decreased by 1.8 percent or $1.3 million from the Prior Year Period to the Current Year Period. The decrease in direct service costs is mainly attributable to terminated contracts. Direct service costs decreased as a percentage of revenue from 24.0 percent in the Prior Year Period to 23.3 percent in the Current Year Period mainly due to rate changes and changes in business mix.

Table of Contents

Public Sector

Net Revenue

Net revenue related to Public Sector increased by 7.9 percent or $52.4 million from the Prior Year Period to the Current Year Period. This increase is primarily due to the net impact of increased membership from existing customers offset by terminated contracts of $63.0 million, the recognition in the Current Year Period of $5.6 million of previously deferred revenue on the Maricopa Contract, and other net favorable variances of $5.9 million, which increases were partially offset by unfavorable rate changes of $16.1 million and the recognition in the Prior Year Period of $6.0 million of deferred revenue on the Maricopa Contract.

Cost of Care

Cost of care increased by 3.1 percent or $18.8 million from the Prior Year Period to the Current Year Period. This increase is primarily due to the net impact of care associated with increased membership from existing customers offset by terminated contracts of $53.5 million, which increase was partially offset by lower care associated with rate changes for contracts with minimum care requirements recorded in the Current Year Period of $13.9 million, favorable medical claims development for the Prior Year Period which was recorded after the Prior Year Period of $7.2 million, favorable prior period medical claims development recorded in the Current Year Period of $6.5 million, unfavorable prior period medical claims development recorded in the Prior Year Period of $1.3 million, and care trends and other net favorable variances of $5.8 million. Cost of care decreased as a percentage of risk revenue from 90.9 percent in the Prior Year Period to 86.8 percent in the Current Year Period mainly due to business mix and net favorable care development.

Direct Service Costs

Direct service costs decreased by 3.5 percent or $1.2 million from the Prior Year Period to the Current Year Period mainly due to terminated contracts. Direct service costs decreased as a percentage of revenue from 5.1 percent for the Prior Year Period to 4.6 percent in the Current Year Period mainly due to business mix.

Radiology Benefits Management

Net Revenue

Net revenue related to Radiology Benefits Management increased by 49.0 percent or $70.6 million from the Prior Year Period to the Current Year Period. This increase is primarily due to revenue from new contracts implemented after the Prior Year Period of $81.9 million and favorable rate changes of $9.5 million, which increases were partially offset by decreased membership from existing customers of $15.6 million, favorable retroactive membership and rate adjustments recorded in the Prior Year Period of $3.2 million, terminated contracts of $1.0 million, and other net decreases of $1.0 million.

Cost of Care

Cost of care increased by 56.3 percent or $53.0 million from the Prior Year Period to the Current Year Period. This increase is primarily attributed to new contracts implemented after the Prior Year Period of $65.1 million and favorable contractual settlements of $4.7 million recorded in the Prior Year Period, which increases were partially offset by decreased membership from existing customers of $12.4 million, favorable prior period medical claims development recorded in the Current Year Period of $2.1 million, and care trends and other net favorable variances of $2.3 million. Cost of care decreased as a percentage of risk revenue from 79.9 percent in the Prior Year Period to 77.4 percent in the Current Year Period mainly due to rate increases and business mix.

Table of Contents

Direct Service Costs

Direct service costs increased by 18.6 percent or $4.7 million from the Prior Year Period to the Current Year Period. The increase in direct service costs is mainly attributable to costs associated with new business. As a percentage of revenue, direct service costs decreased from 17.7 percent in the Prior Year Period to 14.1 percent in the Current Year Period, mainly due to business mix.

Specialty Pharmaceutical Management

Net Revenue

Net revenue related to Specialty Pharmaceutical Management increased by 7.0 percent or $8.9 million from the Prior Year Period to the Current Year Period. This increase is primarily due to net increased dispensing activity of $10.3 million, which increase was partially offset by other net decreases of $1.4 million.

Cost of Goods Sold

Cost of goods sold increased by 9.6 percent or $9.7 million from the Prior Year Period to the Current Year Period. This increase is primarily due to net increased dispensing activity. As a percentage of the portion of net revenue that relates to dispensing activity, cost of goods sold increased from 92.0 percent in the Prior Year Period to 92.8 percent in the Current Year Period, mainly due to business mix.

Direct Service Costs

Direct service costs decreased by 13.5 percent or $1.8 million from the Prior Year Period to the Current Year Period. This decrease is primarily due to a reduction in stock compensation expense, partially offset by an increase in expenses to support the development of new products. As a percentage of revenue, direct service costs decreased from 10.4 percent in the Prior Year Period to 8.4 percent in the Current Year Period, mainly due to a decrease in stock compensation expense.

Medicaid Administration

Net Revenue

Net revenue related to Medicaid Administration was $78.7 million for the Current Year Period. The acquisition of First Health Services closed on July 31, 2009 and the Prior Year Period does not include any operating results for this segment of the Company.

Direct Service Costs

Direct service costs were $66.6 million for the Current Year Period. As a percentage of revenue, direct service costs were 84.7 percent in the Current Year Period.

Corporate and Other

Other Operating Expenses

Other operating expenses related to the Corporate and Other Segment increased by 8.6 percent or $4.9 million from the Prior Year Period to the Current Year Period. The increase results primarily from increased discretionary benefit costs of $1.9 million and other net increased expenses of $3.0 million required to support the Company's growth. As a percentage of total net revenue, other operating expenses decreased from 4.5 percent for the Prior Year Period to 4.2 percent for the Current Year Period, primarily due to changes in business mix.

Depreciation and Amortization

Depreciation and amortization expense increased by 28.3 percent or $6.1 million from the Prior Year Period to the Current Year Period, primarily due to asset additions after the Prior Year Period (inclusive of assets related to the acquisition of First Health Services).

Table of Contents

Interest Expense

Interest expense increased by $0.2 million from the Prior Year Period to the Current Year Period, mainly due to increased letter of credit fees in the Current Year Period.

Interest Income

Interest income decreased by $2.4 million from the Prior Year Period to the Current Year Period, mainly due to lower yields.

Income Taxes

The Company's effective income tax rate was 41.5 percent in the Prior Year Period and 41.6 percent in the Current Year Period. The Prior Year Period and Current Year Period effective income tax rates differ from the federal statutory income tax rate primarily due to state income taxes and permanent differences between book and tax income. The Company also accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes.

Outlook—Results of Operations

The Company's Segment Profit and net income are subject to significant fluctuations from period to period. These fluctuations may result from a variety of factors such as those set forth under Item 2—"Forward-Looking Statements" as well as a variety of other factors including: (i) changes in utilization levels by enrolled members of the Company's risk-based contracts, including seasonal utilization patterns; (ii) contractual adjustments and settlements; (iii) retrospective membership adjustments; (iv) timing of implementation of new contracts, enrollment changes and contract terminations; (v) pricing adjustments upon contract renewals (and price competition in general); and (vi) changes in estimates regarding medical costs and incurred but not yet reported medical claims.

Care Trends. The Company expects that the Commercial care trend factor for 2010 will be 7 to 9 percent, the Public Sector care trend factor will be flat year-over-year and the Radiology Benefits Management care trend for 2010 will be 4 to 6 percent.

Interest Rate Risk. Changes in interest rates affect interest income earned on the Company's cash equivalents and investments, as well as interest expense on variable interest rate borrowings under the Company's 2010 Credit Facility (as defined below). Based on the amount of cash equivalents and investments and the borrowing levels under the 2010 Credit Facility as of June 30, 2010, a hypothetical 10 percent increase or decrease in the interest rate associated with these instruments, with all other variables held constant, would not materially affect the Company's future earnings and cash outflows.

Historical—Liquidity and Capital Resources

Operating Activities. The Company reported net cash provided by operating activities of $40.1 million and $126.2 million for the Prior Year Period and Current Year Period, respectively. The $86.1 million increase in operating cash flows from the Prior Year Period to the Current Year Period is primarily attributable to the increase in segment profit of $54.1 million from the Prior Year Period and other net favorable variances of $32.0 million primarily associated with working capital changes. The working capital changes are primarily due to the build-up of medical claims payable for Radiology Benefits Management attributable to new risk radiology contracts and reductions in inventory for Specialty Pharmaceutical Management, partially offset by higher year-over-year cash tax payments.

During the Current Year Period, the Company's restricted cash decreased $36.0 million. The decrease is attributable to a reduction in restricted cash of $37.3 million associated with the Company's regulated entities, partially offset by the shift of restricted investments of $0.7 million to restricted cash and other net increases of $0.6 million. In regards to the decrease in restricted cash for the Company's

Table of Contents

regulated entities, $47.8 million is offset by changes in other assets and liabilities, primarily accounts receivable, accrued liabilities, medical claims payable and other medical liabilities, thus having no impact on operating cash flows. Partially offsetting these net reductions is the net funding of $10.5 million in additional restricted cash associated with the Company's regulated entities.

Investing Activities. The Company utilized $12.5 million and $21.7 million during the Prior Year Period and Current Year Period, respectively, for capital expenditures. The majority of the increase in capital expenditures of $9.2 million is attributable to management information systems and related equipment.

During the Prior Year Period, the Company received net cash of $17.1 million for the net maturity of "available for sale" investments. During the Current Year Period, the Company used net cash of $11.6 million from the net purchase of "available-for-sale" investments.

Financing Activities. During the Prior Year Period, the Company paid $64.0 million for repurchase of treasury stock under the Company's share repurchase program. In addition, the Company received $1.1 million from the exercise of stock options and warrants and had other net favorable items of $2.5 million.

During the Current Year Period, the Company paid $74.4 million for repurchase of treasury stock under the Company's share repurchase program. In addition, the Company received $17.1 million from the exercise of stock options and warrants, made capital lease payments of $0.6 million and had other net unfavorable items of $1.5 million.

Outlook—Liquidity and Capital Resources

Liquidity. During the remainder of 2010, the Company expects to fund its additional estimated capital expenditures of $20 to $30 million with cash from operations. The Company does not anticipate that it will need to draw on amounts available under the 2010 Credit Facility (as defined below) for its operations, capital needs or debt service in 2010. The Company also currently expects to have adequate liquidity to satisfy its existing financial commitments over the periods in which they will become due. The Company maintains its current investment strategy of investing in a diversified, high quality, liquid portfolio of investments and continues to closely monitor the situation in the financial and credit markets. The Company estimates that it has no risk of any material permanent loss on its investment portfolio; however, there can be no assurance that the Company will not experience any such losses in the future.

Stock Repurchases. On July 30, 2008 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $200 million of its outstanding common stock through January 31, 2010. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 3,866,505 shares of the Company's common stock at an aggregate cost of $136.0 million (excluding broker commissions) during the year ended December 31, 2008 and made open market purchases of 1,859,959 shares of the Company's common stock at an average share price of $34.39 per share for an aggregate cost of $64.0 million (excluding broker commissions) during the period January 1, 2009 through April 7, 2009, which was the date that the repurchase program was completed, the $200 million authorization having been exhausted.

On July 28, 2009 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $100 million of its outstanding common stock through

Table of Contents

July 28, 2011. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 782,400 shares of the Company's common stock at an average price of $32.75 per share for an aggregate cost of $25.6 million (excluding broker commissions) during the period from August 17, 2009 through December 31, 2009. Pursuant to this program, the Company made open market purchases of 1,711,881 shares of the Company's common stock at an average price of $43.46 per share for an aggregate cost of $74.4 million (excluding broker commissions) during the period from January 1, 2010 through April 1, 2010, which was the date that the repurchase program was completed, the $100 million authorization having been exhausted.

Off-Balance Sheet Arrangements. As of June 30, 2010, the Company has no material off-balance sheet arrangements.

Credit Facility. On April 30, 2008, the Company entered into a credit facility with Deutsche Bank AG and Citigroup Global Markets Inc. that provided for a $100.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2008 Credit Facility").

Table of Contents

There were $1.1 million of capital lease obligations and no Revolving Loan borrowings at June 30, 2010.

Restrictive Covenants in Debt Agreements. The 2010 Credit Facility contains covenants that limit management's discretion in operating the Company's business by restricting or limiting the Company's ability, among other things, to:

•: incur or guarantee additional indebtedness or issue preferred or redeemable stock;
•: pay dividends and make other distributions;
•: repurchase equity interests;
•: make certain advances, investments and loans;
•: enter into sale and leaseback transactions;
•: create liens;
•: sell and otherwise dispose of assets;
•: acquire or merge or consolidate with another company; and
•: enter into some types of transactions with affiliates.

These restrictions could adversely affect the Company's ability to finance future operations or capital needs or engage in other business activities that may be in the Company's interest.

The 2010 Credit Facility also requires the Company to comply with specified financial ratios and tests. Failure to do so, unless waived by the lenders under the 2010 Credit Facility pursuant to its terms, would result in an event of default under the 2010 Credit Facility.

Net Operating Loss Carryforwards. The Company estimates that it had reportable federal net operating loss carryforwards ("NOLs") as of December 31, 2009 of approximately $54.9 million available to reduce future federal taxable income. These estimated NOLs expire in 2011 through 2020 and are subject to examination and adjustment by the Internal Revenue Service.

As of December 31, 2009, the Company's valuation allowances against deferred tax assets were $7.3 million, mostly relating to uncertainties regarding the eventual realization of certain state NOLs. Determination of the amount of deferred tax assets considered realizable required significant judgment and estimation. Changes in these estimates in the future could materially affect the Company's financial condition and results of operations.

Recent Accounting Pronouncements

Table of Contents

105. This guidance explicitly recognizes rules and interpretive releases of the SEC under federal securities laws as authoritative GAAP for SEC registrants. Such guidance was effective for financial statements issued for interim and annual reporting periods ending after September 15, 2009 (the quarter ending September 30, 2009 for the Company) and did not have an impact on the Company's results of operations or financial condition, but changed the referencing system for accounting standards. All public filings of the Company now reference the ASC as the sole source of authoritative literature.

In June 2009, the FASB issued Statement of Financial Accounting Standards ("SFAS") No. 167, "Amendments to FASB Interpretation No. 46R". This statement has been incorporated into ASC 810 "Consolidation" ("ASC 810") and amends FASB Interpretation ("FIN") No. 46 (revised December 2003), "Consolidation of Variable Interest Entities" ("FIN 46R") to require an analysis to determine whether a variable interest gives the entity a controlling financial interest in a variable interest entity. This statement requires an ongoing reassessment and eliminates the quantitative approach previously required for determining whether an entity is the primary beneficiary. This statement was effective for fiscal years beginning after November 15, 2009. Accordingly, the Company adopted ASC 810 on January 1, 2010. The adoption of this standard did not have a material impact on the consolidated financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Changes in interest rates affect interest income earned on the Company's cash equivalents and restricted cash and investments, as well as interest expense on variable interest rate borrowings under the 2010 Credit Facility. Based on the Company's investment balances, and the borrowing levels under the 2010 Credit Facility as of June 30, 2010, a hypothetical 10 percent increase or decrease in the interest rate associated with these instruments, with all other variables held constant, would not materially affect the Company's future earnings and cash outflows.

Item 4. Controls and Procedures.

a) The Company's management evaluated, with the participation of the Company's principal executive and principal financial officers, the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) under the Exchange Act), as of June 30, 2010. Based on their evaluation, the Company's principal executive and principal financial officers concluded that the Company's disclosure controls and procedures were effective as of June 30, 2010.

b) Under the supervision and with the participation of management, including the Company's principal executive and principal financial officers, the Company has determined that there has been no change in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the Company's quarter ended June 30, 2010 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

The management and administration of the delivery of specialty managed healthcare entails significant risks of liability. From time to time, the Company is subject to various actions and claims arising from the acts or omissions of its employees, network providers or other parties. In the normal course of business, the Company receives reports relating to deaths and other serious incidents involving patients whose care is being managed by the Company. Such incidents occasionally give rise to malpractice, professional negligence and other related actions and claims against the Company or its network providers. Many of these actions and claims received by the Company seek substantial damages and therefore require the Company to incur significant fees and costs related to their defense. The Company is also subject to or party to certain class actions, litigation and claims relating to its operations or business practices. In the opinion of management, the Company has recorded reserves that are adequate to cover litigation, claims or assessments that have been or may be asserted against the Company, and for which the outcome is probable and reasonably estimable. Management believes that the resolution of such litigation and claims will not have a material adverse effect on the Company's financial condition or results of operations; however, there can be no assurance in this regard.

Item 1A. Risk Factors.

None.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Table of Contents

commissions) during the period from January 1, 2010 through April 1, 2010, which was the date the repurchase program was completed, the $100 million authorization having been exhausted.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Submission of Matters to a Vote of Security Holders.

None.

Item 5. Other Information.

Stock Repurchase

Bonus Award

On July 26, 2010 the Company's Compensation Committee awarded a discretionary performance bonus of $100,000 to Tina Blasi, Chief Executive Officer of the Company's Radiology Benefits Management segment.

Item 6. Exhibits.

Exhibit No.			Description

	31.1		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
	31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	32.1		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished).
	32.2		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished).
	101		The following financial statements from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, formatted in Extensive Business Reporting Language ("XBRL"): (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of cash flows, and (iv) the notes to the consolidated financial statements.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date: July 30, 2010	MAGELLAN HEALTH SERVICES, INC. (Registrant)
	By:	/s/ JONATHAN N. RUBIN Jonathan N. Rubin Executive Vice President and Chief Financial Officer (Principal Financial Officer and Duly Authorized Officer)

EX-31.1 2 a2199476zex-31_1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATIONS

I, Rene Lerer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Magellan Health Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ RENE LERER
	Rene´ Lerer
Date: July 30, 2010	Chief Executive Officer

EX-31.2 3 a2199476zex-31_2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATIONS

I, Jonathan N. Rubin, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Magellan Health Services, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ JONATHAN N. RUBIN
	Jonathan N. Rubin
Date: July 30, 2010	Chief Financial Officer

EX-32.1 4 a2199476zex-32_1.htm EXHIBIT 32.1

Exhibit 32.1

Certification Required by Rule 13a-14(b) and 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)

I, Rene Lerer, as Chief Executive Officer of Magellan Health Services, Inc (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:

(1) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2010 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ RENE LERER
	Rene´ Lerer
Date: July 30, 2010	Chief Executive Officer

EX-32.2 5 a2199476zex-32_2.htm EXHIBIT 32.2

Exhibit 32.2

Certification Required by Rule 13a-14(b) and 18 U.S.C. Section 1350

(as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)

I, Jonathan N. Rubin, as Chief Financial Officer of Magellan Health Services, Inc (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ JONATHAN N. RUBIN
	Jonathan N. Rubin
Date: July 30, 2010	Chief Financial Officer

EX-101.INS 6 mgln-20100630.xml EX-101.INS 0000019411 2009-04-01 2009-06-30 0000019411 2008-12-31 0000019411 2009-12-31 0000019411 mgln:MultiVoteCommonStockMember 2009-12-31 0000019411 mgln:MultiVoteCommonStockMember 2010-06-30 0000019411 mgln:OrdinaryCommonStockMember 2009-12-31 0000019411 mgln:OrdinaryCommonStockMember 2010-06-30 0000019411 2010-06-30 0000019411 2010-04-01 2010-06-30 0000019411 2009-06-30 0000019411 2010-01-01 2010-06-30 0000019411 2009-01-01 2009-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

635801000

443048000

49286000

102934000

10516000

657000

1734000

604707000

31094000

12695000

18399000

66000

18465000

34955000

34992000

0.53

0.90

35143000

60688000

1255316000

874766000

101358000

205998000

21559000

1084000

4045000

1200720000

54596000

22637000

31959000

-220000

31739000

35578000

35686000

6168000

3706000

12600000

8234000

456000

13343000

-40956000

19880000

23604000

-23960000

-14259000

-973000

40143000

12457000

144370000

161449000

4622000

3000

64019000

1101000

2531000

-60390000

-15625000

33581000

211825000

196200000

230088000

196507000

159659000

114434000

162922000

57329000

62737000

753588000

108219000

67523000

17725000

2703000

426471000

64812000

1441041000

27086000

93760000

143669000 104649000

369164000

118859000

2526000

490549000

614483000

555923000

5382000

114000

225820000

950492000

1441041000

410000

416000

1422592000

1358000

102922000

15467000

60230000

0.01

10000000

0.01

100000000

41044000

34535000

41602000

33381000

0.01

40000000

533000

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE AGeneral Basis of Presentation         The accompanying unaudited consolidated financial statements of Magellan Health Services, Inc., a Delaware corporation ("Magellan"), include the accounts of Magellan, its majority owned subsidiaries, and the variable interest entity ("VIE") for which Magellan is the primary beneficiary (together with Magellan, the "Company"). The financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the Securities and Exchange Commission's (the "SEC") instructions to Form 10-Q. Accordingly, the financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments con sidered necessary for a fair presentation, have been included. The results of operations for the six months ended June 30, 2010 are not necessarily indicative of the results to be expected for the full year. All significant intercompany accounts and transactions have been eliminated in consolidation.         The Company evaluated all events or transactions that occurred after June 30, 2010 and through the date we issued these financial statements. The Company did not have any material recognizable subsequent events during this period.         These unaudited consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements for the year ended December 31, 2009 and the notes thereto, which are included in the Company's Annual Report on Form 10-K filed with the SEC on February 26, 2010. Business Overview         The Company is engaged in the specialty managed healthcare business. Through 2005, the Company predominantly operated in the managed behavioral healthcare business. During 2006, the Company expanded into radiology benefits management and specialty pharmaceutical management as a result of certain acquisitions. During 2009, the Company expanded into Medicaid administration. The Company provides services to health plans, insurance companies, employers, labor unions and various governmental agencies. The Company's business is divided into the following six segments, based on the services it provides and/or the customers that it serves, as described below. Managed Behavioral Healthcare         Two of the Company's segments are in the managed behavioral healthcare business. This line of business generally reflects the Company's coordination and management of the delivery of behavioral healthcare treatment services that are provided through its contracted network of third-party treatment providers, which includes psychiatrists, psychologists, other behavioral health professionals, psychiatric hospitals, general medical facilities with psychiatric beds, residential treatment centers and other treatment facilities. The treatment services provided through the Company's provider network include outpatient programs (such as counseling or therapy), intermediate care programs (such as intensive outpatient programs and partial hospitalization services), inpatient treatment and crisis intervention services. The Company generally does not directly provide, or own any provide r of, treatment services except as related to the Company's contract to provide managed behavioral healthcare services to Medicaid recipients and other beneficiaries of the Maricopa County Regional Behavioral Health Authority (the "Maricopa Contract"). Under the Maricopa Contract, effective August 31, 2007 the Company was required to assume the operations of twenty-four behavioral health direct care facilities for a transitional period and to divest itself of these facilities over a two year period. During March 2009, the Company began the operation of two additional behavioral health direct care facilities. In 2008 and 2009, the Company entered into agreements to transition all behavioral health direct care facilities over various dates. All of the direct care facilities were transitioned as of December 31, 2009.         The Company provides its management services primarily through: (i) risk-based products, where the Company assumes all or a substantial portion of the responsibility for the cost of providing treatment services in exchange for a fixed per member per month fee, (ii) administrative services only ("ASO") products, where the Company provides services such as utilization review, claims administration and/or provider network management, but does not assume responsibility for the cost of the treatment services, and (iii) employee assistance programs ("EAPs") where the Company provides short-term outpatient behavioral counseling services.         The managed behavioral healthcare business is managed based on the services provided and/or the customers served, through the following two segments:         Commercial.    The Managed Behavioral Healthcare Commercial segment ("Commercial") generally reflects managed behavioral healthcare services and EAP services provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members, as well as with employers, including corporations and governmental agencies, and labor unions. Commercial's contracts encompass risk-based, ASO and EAP arrangements.         Public Sector.    The Managed Behavioral Healthcare Public Sector segment ("Public Sector") generally reflects services provided to Medicaid recipients under contracts with state and local governmental agencies. Public Sector contracts encompass either risk-based or ASO arrangements. Radiology Benefits Management         The Radiology Benefits Management segment ("Radiology Benefits Management") generally reflects the management of the delivery of diagnostic imaging services to ensure that such services are clinically appropriate and cost effective. The Company's radiology benefits management services currently are provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members. The Company also contracts with state and local governmental agencies for the provision of such services to Medicaid recipients. The Company offers its radiology benefits management services through ASO contracts, where the Company provides services such as utilization review and claims administration, but does not assume responsibility for the cost of the imaging services, and through risk-based contracts, where the Company assumes all or a subst antial portion of the responsibility for the cost of providing diagnostic imaging services. Specialty Pharmaceutical Management         The Specialty Pharmaceutical Management segment ("Specialty Pharmaceutical Management") generally reflects the management of specialty drugs used in the treatment of cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis and other diseases. Specialty pharmaceutical drugs represent high-cost injectible, infused, oral, or inhaled drugs often with sensitive handling or storage needs. Patients receiving these drugs require greater amounts of clinical and financial support than those taking more traditional agents. The Company's specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, and governmental agencies for some or all of their commercial, Medicare and Medicaid members. The Company's specialty pharmaceutical services include (i) contracting and formulary optimi zation on behalf of health plans and pharmaceutical manufacturers; (ii) dispensing specialty pharmaceutical drugs on behalf of health plans; (iii) providing strategic consulting services to health plans and pharmaceutical manufacturers; and (iv) providing oncology management services to health plans and state Medicaid programs. Medicaid Administration         The Medicaid Administration segment ("Medicaid Administration") generally reflects integrated clinical management services provided to the public sector to manage Medicaid, pharmacy, mental health and long-term care programs. The primary focus of the Company's Medicaid Administration involves providing pharmacy benefits administration ("PBA") services under contracts with states to Medicaid and other state sponsored program recipients. Medicaid Administration's contracts encompass Fee-For-Service ("FFS") arrangements. Corporate and Other         This segment of the Company is comprised primarily of operational support functions such as sales and marketing and information technology, as well as corporate support functions such as executive, finance, human resources and legal. Summary of Significant Accounting Policies Recent Accounting Pronouncements         In June 2009, the Financial Accounting Standards Board ("FASB") established the FASB Accounting Standards Codification ("ASC") as the source of authoritative accounting principles recognized by the FASB to be applied in the preparation of financial statements in conformity with generally accepted accounting principles ("GAAP"). This statement has been incorporated into ASC 105. This guidance explicitly recognizes rules and interpretive releases of the SEC under federal securities laws as authoritative GAAP for SEC registrants. Such guidance was effective for financial statements issued for interim and annual reporting periods ending after September 15, 2009 (the quarter ending September 30, 2009 for the Company) and did not have an impact on the Company's results of operations or financial condition, but changed the referencing system for accounting standa rds. All public filings of the Company now reference the ASC as the sole source of authoritative literature.         In June 2009, the FASB issued Statement of Financial Accounting Standards ("SFAS") No. 167, "Amendments to FASB Interpretation No. 46R". This statement has been incorporated into ASC 810 "Consolidation" ("ASC 810") and amends FASB Interpretation No. 46 (revised December 2003), "Consolidation of Variable Interest Entities" to require an analysis to determine whether a variable interest gives the entity a controlling financial interest in a variable interest entity. This statement requires an ongoing reassessment and eliminates the quantitative approach previously required for determining whether an entity is the primary beneficiary. This statement was effective for fiscal years beginning after November 15, 2009. Accordingly, the Company adopted ASC 810 on January 1, 2010. The adoption of this standard did not have a material impac t on the consolidated financial statements.         In January 2010, the FASB issued Accounting Standards Update, ("ASU"), No. 2010-06, "Improving Disclosures about Fair Value Measurements", ("ASU 2010-06"). ASU 2010-06 amends ASC Topic 820, "Fair Value Measurements and Disclosures", to require a number of additional disclosures regarding fair value measurements. Effective January 1, 2010, ASU 2010-06 requires disclosure of the amounts of significant transfers between Level I and Level II and the reasons for such transfers, the reasons for any transfers in or out of Level III, and disclosure of the policy for determining when transfers between levels are recognized. ASU 2010-06 also clarified that disclosures should be provided for each class of assets and liabilities and clarified the requirement to disclose information about the valuation techniques and inputs used in estimating Level II and Level III measurements. Beginning January 1, 2011, ASU 2010-06 also requires that information in the reconciliation of recurring Level III measurements about purchases, sales, issuances and settlements be provided on a gross basis. The adoption of ASU 2010-06 only required additional disclosures and did not have an impact on the consolidated financial statements. As the Company does not have significant transfers between Levels, or any Level III measurements, no additional disclosures were necessary. Use of Estimates         The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates of the Company include, among other things, accounts receivable realization, valuation allowances for deferred tax assets, valuation of goodwill and intangible assets, medical claims payable, other medical liabilities, stock compensation assumptions, tax contingencies and legal liabilities. Actual results could differ from those estimates. Managed Care Revenue         Managed care revenue, inclusive of revenue from the Company's risk, EAP and ASO contracts, is recognized over the applicable coverage period on a per member basis for covered members. The Company is paid a per member fee for all enrolled members, and this fee is recorded as revenue in the month in which members are entitled to service. The Company adjusts its revenue for retroactive membership terminations, additions and other changes, when such adjustments are identified, with the exception of retroactivity that can be reasonably estimated. Any fees paid prior to the month of service are recorded as deferred revenue. Managed care revenues approximated $573.9 million and $1,128.1 million for the three and six months ended June 30, 2009, respectively, and $591.2 million and $1,174.6 million for the three and six months ended June& amp;nbsp;30, 2010, respectively. Fee-For-Service and Cost-Plus Contracts         The Company has certain fee-for-service ("FFS") contracts, including cost-plus contracts, with customers under which the Company recognizes revenue as services are performed and as costs are incurred. Revenues from fee-for-service and cost-plus contracts approximated $9.7 million and $19.2 million for the three and six months ended June 30, 2009, respectively, and $48.9 million and $98.3 million for the three and six months ended June 30, 2010, respectively. FFS revenue for 2010 includes the activity from the Medicaid Administration segment. Block Grant Revenues         The Maricopa Contract is partially funded by federal, state and county block grant money, which represents annual appropriations. The Company recognizes revenue from block grant activity ratably over the period to which the block grant funding applies. Block grant revenues were approximately $29.3 million and $54.7 million for the three and six months ended June 30, 2009, respectively, and $30.7 million and $56.8 million for the three and six months ended June 30, 2010, respectively. Dispensing Revenue         The Company recognizes dispensing revenue, which includes the co-payments received from members of the health plans the Company serves, when the specialty pharmaceutical drugs are shipped. At the time of shipment, the earnings process is complete; the obligation of the Company's customer to pay for the specialty pharmaceutical drugs is fixed, and, due to the nature of the product, the member may neither return the specialty pharmaceutical drugs nor receive a refund. Revenues from the dispensing of specialty pharmaceutical drugs on behalf of health plans were $53.6 million and $110.2 million for the three and six months ended June 30, 2009, respectively, and $58.7 million and $119.7 million for the three and six months ended June 30, 2010, respectively. Performance-Based Revenue         The Company has the ability to earn performance-based revenue under certain risk and non-risk contracts. Performance-based revenue generally is based on either the ability of the Company to manage care for its clients below specified targets, or on other operating metrics. For each such contract, the Company estimates and records performance-based revenue after considering the relevant contractual terms and the data available for the performance-based revenue calculation. Pro-rata performance-based revenue is recognized on an interim basis pursuant to the rights and obligations of each party upon termination of the contracts. Performance-based revenues were $2.0 million and $3.3 million for the three and six months ended June 30, 2009, respectively, and $4.8 million and $5.8 million for the three and six months ended June&nbs p;30, 2010, respectively. Significant Customers <ul> <li style="list-style: none"> Consolidated Company </li></ul>         The Maricopa Contract generated net revenues that exceeded, in the aggregate, ten percent of net revenues for the consolidated Company for the six months ended June 30, 2009 and 2010. The Company also has a significant concentration of business from contracts with subsidiaries of WellPoint, Inc. ("WellPoint") and with various counties in the State of Pennsylvania (the "Pennsylvania Counties") which are part of the Pennsylvania Medicaid program.         Pursuant to the Maricopa Contract, the Company provides behavioral healthcare management and other related services to approximately 727,000 members in Maricopa County, Arizona. Under the Maricopa Contract, the Company is responsible for providing covered behavioral health services to persons eligible under Title XIX (Medicaid) and Title XXI (State Children's Health Insurance Program) of the Social Security Act, non-Title XIX and non-Title XIX eligible children and adults with a serious mental illness, and to certain non-Title XIX and non-Title XXI adults with behavioral health or substance abuse disorders. The Maricopa Contract began on September 1, 2007 and extends through June 30, 2012 unless sooner terminated by the parties. The State of Arizona has the right to terminate the Maricopa Contract for cause, as defined, upon ten days' notice with an opport unity to cure, and without cause immediately upon notice from the State. The Maricopa Contract generated net revenues of $351.9 million and $400.9 million for the six months ended June 30, 2009 and 2010, respectively.         Total net revenues from the Company's contracts with WellPoint were $88.5 million and $87.1 million during the six months ended June 30, 2009 and 2010, respectively, including radiology benefits management revenue of $81.6 million and $79.3 million, respectively.         In July 2007, WellPoint acquired a radiology benefits management company, and expressed its intent to in-source all of its radiology benefits management contracts when such contracts expire. The Company has a radiology benefits management contract with WellPoint that converted from an ASO arrangement to a risk arrangement effective July 1, 2007. Such risk contract has a term through December 31, 2010, and cannot be terminated early, except for cause, as defined in the agreement; the Company has received notice from WellPoint that it will allow this contract to expire as of December 31, 2010.         Net revenues from the Pennsylvania Counties in the aggregate totaled $153.7 million and $169.9 million for the six months ended June 30, 2009 and 2010, respectively. <ul> <li style="list-style: none"> By Segment </li></ul>         Two customers generated greater than ten percent of Commercial net revenues for the six months ended June 30, 2009 and 2010. The first customer has a contract that extends through December 31, 2012 and generated net revenues of $116.8 million and $126.9 million for the six months ended June 30, 2009 and 2010, respectively. The second customer has a contract that extends through June 30, 2014, terminable without cause upon 180 days' notice after June 30, 2012, and generated net revenues of $42.2 million and $36.8 million for the six months ended June 30, 2009 and 2010, respectively.         In addition to the Maricopa Contract, one other customer generated net revenues greater than ten percent of the net revenues for the Public Sector segment for the six months ended June 30, 2009 and 2010. This customer has a contract that extends through June 30, 2012, with options for the customer to extend the term of the contract for three one year terms, and generated net revenues of $72.4 million and $72.6 million for the six months ended June 30, 2009 and 2010, respectively.         In addition to WellPoint, one other customer generated greater than ten percent of the net revenues for the Radiology Benefits Management segment for the six months ended June 30, 2009 and three customers generated greater than ten percent of the net revenues for the Radiology Benefits Management segment for the six months ended June 30, 2010. The first customer has a contract that extends through May 31, 2011 and generated net revenues of $42.5 million and $34.4 million for the six months ended June 30, 2009 and 2010, respectively. For the six months ended June 30, 2010, the remaining two of three such customers generated $53.4 million and $25.9 million of the net revenues for this segment.         For the six months ended June 30, 2009, four customers each exceeded ten percent of the net revenues for the Specialty Pharmaceutical Management segment. Such customers generated $42.4 million, $26.8 million, $19.3 million, and $15.2 million of net revenues during the six months ended June 30, 2009. For the six months ended June 30, 2010, four customers each exceeded ten percent of the net revenues for this segment. Such customers generated $43.3 million, $30.4 million, $18.3 million, and $17.1 million of net revenues during the six months ended June 30, 2010.         For the six months ended June 30, 2010, five customers each exceeded ten percent of the net revenues for the Medicaid Administration segment. Three of such customers generated $11.5 million, $10.9 million, and $7.9 million of net revenues for this segment. One additional customer generated revenue of $15.8 million during the six months ended June 30, 2010, and this contract is scheduled to terminate on September 29, 2012, unless terminated earlier by the customer. Pursuant to a competitive bid process, the customer is expected to award this contract to a vendor other than the Company, with such transition scheduled to take place on June 30, 2011. Although the Company anticipates that its contract with the customer will terminate and the contract will transition to a new vendor on June 30, 2011, until formally terminated, the Company is obligated under the contract until September 29, 2012, and up to 18 months thereafter upon mutual consent. The remaining customer generated revenue of $9.5 million during this period, and this contract terminated June 30, 2010. Fair Value Measurements         The Company currently does not have non-financial assets and non-financial liabilities that are required to be measured at fair value on a recurring basis. Financial assets and liabilities are to be measured using inputs from the three levels of the fair value hierarchy, which are as follows:         Level 1Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.         Level 2Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).         Level 3Unobservable inputs that reflect the Company's assumptions about the assumptions that market participants would use in pricing the asset or liability. The Company develops these inputs based on the best information available, including the Company's data.         In accordance with the fair value hierarchy described above, the following table shows the fair value of the Company's financial assets and liabilities that are required to be measured at fair value as of June 30, 2010 (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="39"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="36"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="11">Fair Value Measurements at June 30, 2010</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Level 1 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Level 2 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Level 3 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Total </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Cash and Cash Equivalents(1)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">66,249</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">66,249</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Restricted Cash(2)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">87,416</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">87,416</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Investments:</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> U.S. Government and agency securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Obligations of government-sponsored enterprises(3)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,980</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,980</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Corporate debt securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,589</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,589</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Certificates of deposit</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Taxable municipal bonds</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,726</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,726</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom">  </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">388,710</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">390,895</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div> <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt; POSITION: relative; TEXT-ALIGN: left"> <hr style="COLOR: #000000" align="left" width="26%" noshade="noshade" size="1" /> <dl compact="compact"> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(1)</dt> <dd style="FONT-FAMILY: times">Excludes $163.8 million of cash held in bank accounts by the Company. </dd> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(2)</dt> <dd style="FONT-FAMILY: times">Excludes $36.3 million of restricted cash held in bank accounts by the Company. </dd> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(3)</dt> <dd style="FONT-FAMILY: times">Includes investments in notes issued by the Federal Home Loan Mortgage Corporation, and the Federal Home Loan Bank.</dd></dl></div>         All of the Company's investments are classified as "available-for-sale" and are carried at fair value, based on quoted market prices. The Company's policy is to classify all investments with contractual maturities within one year as current. Investment income is recognized when earned and reported net of investment expenses. Net unrealized holding gains or losses are excluded from earnings and are reported, net of tax, as "accumulated other comprehensive income (loss)" in the accompanying consolidated balance sheets and consolidated statements of income until realized, unless the losses are deemed to be other-than-temporary. Realized gains or losses, including any provision for other-than-temporary declines in value, are included in the consolidated statements of income.         ASC 320-10-65 applies to debt securities only and provides guidance on the recognition and presentation of other-than-temporary impairments. In addition, additional disclosures are required related to other-than-temporary impairments. Under this revised guidance, if a debt security is in an unrealized loss position and the Company has the intent to sell the debt security, or it is more likely than not that the Company will have to sell the debt security before recovery of its amortized cost basis, the decline in value is deemed to be other-than-temporary and is recorded to other-than-temporary impairment losses recognized in income in the consolidated statements of income. For impaired debt securities that the Company does not intend to sell or it is more likely than not that the Company will not have to sell such securities, but the Company expects that it will not fully r ecover the amortized cost basis, the credit component of the other-than-temporary impairment is recognized in other-than-temporary impairment losses recognized in income in the consolidated statements of income and the non-credit component of the other-than-temporary impairment is recognized in other comprehensive income.         The credit component of an other-than-temporary impairment is determined by comparing the net present value of projected future cash flows with the amortized cost basis of the debt security. The net present value is calculated by discounting the best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings, and estimates regarding timing and amount of recoveries associated with a default. Furthermore, unrealized losses entirely caused by non-credit related factors related to debt securities for which the Company expects to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive income.         As of December 31, 2009 and June 30, 2010, there were no unrealized losses that the Company believed to be other-than-temporary. No realized gains or losses were recorded for either the six months ended June 30, 2009 or June 30, 2010. The following is a summary of short-term and long-term investments at December 31, 2009 and June 30, 2010 (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="11">December 31, 2009 </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Amortized Cost </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Gains </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Losses </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Estimated Fair Value </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> U.S. Government and agency securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">378</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">1</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">379</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Obligations of government-sponsored enterprises(1)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">11,297</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(8</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">11,328</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Corporate debt securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">208,832</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">458</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(302</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">208,988</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Certificates of deposit</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Total investments at December 31, 2009</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">230,257</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">498</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(310</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">230,445</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="11">June 30, 2010 </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Amortized Cost </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Gains </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Losses </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Estimated Fair Value </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> U.S. Government and agency securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,184</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">1</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Obligations of government-sponsored enterprises(1)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,961</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">19</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,980</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Corporate debt securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,834</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">128</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(373</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,589</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Certificates of deposit</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Taxable municipal bonds</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,740</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(14</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,726</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Total investments at June 30, 2010</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,469</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">148</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(387</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,230</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div> <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt; POSITION: relative; TEXT-ALIGN: left"> <hr style="COLOR: #000000" align="left" width="26%" noshade="noshade" size="1" /> <dl compact="compact"> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(1)</dt> <dd style="FONT-FAMILY: times">Includes investments in notes issued by the Federal Home Loan Mortgage Corporation, and the Federal Home Loan Bank.</dd></dl></div>         The maturity dates of the Company's investments as of June 30, 2010 are summarized below (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Amortized Cost </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Estimated Fair Value </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> 2010</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">112,837</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">112,805</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> 2011</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">122,468</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">122,257</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> 2012</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,164</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,168</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Total investments at June 30, 2010</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,469</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,230</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         The carrying value for the Company's current assets (other than short-term investments) and current liabilities approximate their fair value due to their short maturities. Income Taxes         The Company's effective income tax rates were 41.5 percent and 41.6 percent for the six months ended June 30, 2009 and 2010, respectively. These rates differ from the federal statutory income tax rate primarily due to state income taxes and permanent differences between book and tax income. The Company also accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. Stock Compensation         At December 31, 2009 and June 30, 2010, the Company had equity-based employee incentive plans, which are described more fully in Note 6 in the Company's Annual Report on Form 10-K for the year ended December 31, 2009. The Company recorded stock compensation expense of $6.2 million and $12.6 million for the three and six months ended June 30, 2009, respectively, and $3.7 million and $8.2 million for the three and six months ended June 30, 2010, respectively. Stock compensation expense recognized in the consolidated statements of income for the three and six months ended June 30, 2009 and 2010 has been reduced for estimated forfeitures, estimated at five percent for each period.         The weighted average grant date fair value of all stock options granted during the six months ended June 30, 2010 was $11.78 as estimated using the Black-Scholes-Merton option pricing model, which also assumed an expected volatility of 31.7 percent based on the historical volatility of the Company's stock price.         The benefits of tax deductions in excess of recognized stock compensation expense are reported as a financing cash flow, rather than as an operating cash flow. In the six months ended June 30, 2009 and 2010, approximately $3.0 million and $0 million of benefits of such tax deductions related to stock compensation expense were realized and as such were reported as financing cash flows, respectively.         Summarized information related to the Company's stock options for the six months ended June 30, 2010 is as follows: <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="55"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="44"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Options </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Weighted Average Exercise Price</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, beginning of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">5,185,091</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.19</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Granted</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">850,255</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">42.72</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Forfeited</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(182,355</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">43.28</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Exercised</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(475,403</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">35.99</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, end of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">5,377,588</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.93</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Vested and expected to vest at end of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">5,240,347</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.94</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Exercisable, end of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">3,169,066</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39.28</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         All of the Company's options granted during the six months ended June 30, 2010 vest ratably on each anniversary date over the three years subsequent to grant, and all have a ten year life.         Summarized information related to the Company's nonvested restricted stock awards for the six months ended June 30, 2010 is as follows: <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="44"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="54"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Shares </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Weighted Average Grant Date Fair Value</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, beginning of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">28,910</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">30.27</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Awarded</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">22,309</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39.23</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Vested</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(28,910</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">30.27</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Forfeited</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, ending of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">22,309</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39.23</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         Restricted stock awards granted during the six months ended June 30, 2010 generally vest ratably on each anniversary date over a period of one year subsquent to grant.         Summarized information related to the Company's nonvested restricted stock units for the six months ended June 30, 2010 is as follows: <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="45"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="54"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Shares </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Weighted Average Grant Date Fair Value</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, beginning of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">184,454</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">34.99</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Awarded</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">101,812</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">42.75</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Vested</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(84,533</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">36.19</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Forfeited</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(1,680</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">37.37</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, ending of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">200,053</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.42</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         Restricted stock units granted during the six months ended June 30, 2010 generally vest ratably on each anniversary date over the three years subsequent to grant. Long Term Debt and Capital Lease Obligations         On April 30, 2008, the Company entered into a credit facility with Deutsche Bank AG and Citigroup Global Markets Inc. that provided for a $100.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2008 Credit Facility").         On April 29, 2009, the Company entered into an amendment to the 2008 Credit Facility with Deutsche Bank AG, Citibank, N.A., and Bank of America, N.A. that provided for an $80.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2009 Credit Facility"). Borrowings under the 2009 Credit Facility matured on April 28, 2010. The 2009 Credit Facility was guaranteed by substantially all of the subsidiaries of the Company and was secured by substantially all of the assets of the Company and the subsidiary guarantors.         Under the 2009 Credit Facility, the annual interest rate on Revolving Loan borrowings was equal to (i) in the case of U.S. dollar denominated loans, the sum of a borrowing margin of 2.25 percent plus the higher of the prime rate or one-half of one percent in excess of the overnight "federal funds" rate, or (ii) in the case of Eurodollar denominated loans, the sum of a borrowing margin of 3.25 percent plus the Eurodollar rate for the selected interest period. The Company had the option to borrow in U.S. dollar denominated loans or Eurodollar denominated loans at its discretion. Letters of Credit issued under the Revolving Loan Commitment bore interest at the rate of 3.375 percent. The commitment commission on the 2009 Credit Facility was 0.625 percent of the unused Revolving Loan Commitment.         On April 28, 2010, the Company entered into an amendment to the 2009 Credit Facility with Deutsche Bank AG, Citibank, N.A., and Bank of America, N.A. that provided for an $80.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2010 Credit Facility"). Borrowings under the 2010 Credit Facility mature on April 28, 2013. The 2010 Credit Facility is guaranteed by substantially all of the subsidiaries of the Company and is secured by substantially all of the assets of the Company and the subsidiary guarantors.         Under the 2010 Credit Facility, the annual interest rate on Revolving Loan borrowings is equal to (i) in the case of U.S. dollar denominated loans, the sum of a borrowing margin of 1.75 percent plus the higher of the prime rate or one-half of one percent in excess of the overnight "federal funds" rate, or (ii) in the case of Eurodollar denominated loans, the sum of a borrowing margin of 2.75 percent plus the Eurodollar rate for the selected interest period. The Company has the option to borrow in U.S. dollar denominated loans or Eurodollar denominated loans at its discretion. Letters of Credit issued under the Revolving Loan Commitment bear interest at the rate of 2.875 percent. The commitment commission on the 2010 Credit Facility is 0.50 percent of the unused Revolving Loan Commitment.         There were $1.1 million of capital lease obligations and no Revolving Loan borrowings at June 30, 2010.</td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE BNet Income per Common Share         The following tables reconcile income (numerator) and shares (denominator) used in the computations of net income per common share (in thousands, except per share data): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left" width="10"></td> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="45"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="45"></td> <td style="FONT-FAMILY: times" width="24"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="45"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="45"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left" colspan="2">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="5">Three Months Ended June 30, </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="5">Six Months Ended June 30, </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left" colspan="2">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2009 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2010 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2009 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2010 </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" colspan="2"> Numerator:</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times" colspan="2"> Net income</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">18,399</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">35,428</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">31,959</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">60,947</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" colspan="2"> Denominator:</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times" colspan="2"> Weighted average number of common shares outstandingbasic</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">34,955</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">33,323</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">35,578</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">33,849</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> Common stock equivalentsstock options</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">11</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">261</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">49</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">345</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> Common stock equivalentswarrants</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">26</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">142</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">57</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">146</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> Common stock equivalentsrestricted stock</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">13</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">2</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">17</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> Common stock equivalentsrestricted stock units</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">60</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">76</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> Common stock equivalentsemployee stock purchase plan</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">1</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">1</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times" colspan="2"> Weighted average number of common shares outstandingdiluted</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">34,992</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">33,800</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">35,686</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">34,434</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" colspan="2"> Net income per common sharebasic</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">0.53</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1.06</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">0.90</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1.80</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times" colspan="2"> Net income per common sharediluted</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">0.53</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1.05</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">0.90</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1.77</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         The weighted average number of common shares outstanding for the three and six months ended June 30, 2009 and 2010 were calculated using outstanding shares of the Company's Ordinary Common Stock. Common stock equivalents included in the calculation of diluted weighted average common shares outstanding for the three and six months ended June 30, 2009 and 2010 represent stock options to purchase shares of the Company's Ordinary Common Stock, restricted stock awards and restricted stock units, stock to be purchased under the Employee Stock Purchase Plan and shares of Ordinary Common Stock related to certain warrants issued on January 5, 2004.         For the three months and six months ended June 30, 2010, the Company had additional potential dilutive securities outstanding representing 3.0 million and 1.9 million options, respectively, that were not included in the computation of dilutive securities because they were anti-dilutive for such periods. Had these shares not been anti-dilutive, all of these shares would not have been included in the net income per common share calculation as the Company uses the treasury stock method of calculating diluted shares.</td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE CBusiness Segment Information         The accounting policies of the Company's segments are the same as those described in Note A"General." The Company evaluates performance of its segments based on profit or loss from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes ("Segment Profit"). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Intersegment sales and transfers are not significant.         The following tables summarize, for the periods indicated, operating results by business segment (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 123pt; BORDER-BOTTOM: #000000 1pt solid">Three Months Ended June 30, 2009 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">160,190</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">343,181</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">70,565</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">61,865</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">635,801</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(88,851</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(309,770</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(44,427</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(443,048</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(49,286</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(49,286</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(38,008</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(16,910</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(12,469</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(6,870</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(74,257</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(28,677</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(28,677</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">188</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">209</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">424</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">2,136</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">3,211</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">6,168</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">33,519</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">16,710</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">14,093</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">7,845</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(25,466</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">46,701</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="70"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 75pt; BORDER-BOTTOM: #000000 1pt solid">Three Months Ended June 30, 2010 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Medicaid Administration </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">160,982</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">368,011</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">105,263</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">67,993</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">39,409</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">741,658</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(90,583</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(311,609</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(70,286</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(472,478</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(54,771</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(54,771</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(37,716</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(15,458</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(15,401</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(5,922</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(34,039</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(108,536</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(31,081</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(31,081</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">194</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">172</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">368</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">114</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">22</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">2,836</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">3,706</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">32,877</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">41,116</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">19,944</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">7,414</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">5,392</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(28,245</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">78,498</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 114pt; BORDER-BOTTOM: #000000 1pt solid">Six Months Ended June 30, 2009 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">318,943</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">665,041</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">144,124</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">127,208</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1,255,316</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(178,637</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(601,916</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(94,213</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(874,766</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(101,358</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(101,358</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(76,533</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(34,206</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(25,507</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(13,264</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(149,510</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(56,488</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(56,488</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">520</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">444</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">794</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">4,218</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">6,624</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">12,600</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">64,293</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">29,363</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">25,198</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">16,804</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(49,864</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">85,794</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="70"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 66pt; BORDER-BOTTOM: #000000 1pt solid">Six Months Ended June 30, 2010 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Medicaid Administration </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">322,684</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">717,479</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">214,720</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">136,131</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">78,697</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1,469,711</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(181,255</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(620,671</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(147,231</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(949,157</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(111,067</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(111,067</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(75,184</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(33,005</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(30,239</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(11,473</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(66,627</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(216,528</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(61,343</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(61,343</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">432</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">373</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">761</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">257</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">40</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">6,371</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">8,234</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">66,677</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">64,176</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">38,011</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">13,848</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">12,110</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(54,972</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">139,850</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div> <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt; POSITION: relative; TEXT-ALIGN: left"> <hr style="COLOR: #000000" align="left" width="26%" noshade="noshade" size="1" /> <dl compact="compact"> <dt style="MARGIN-BOTTOM: -9pt; FONT-FAMILY: times">(1)</dt> <dd style="FONT-FAMILY: times">Stock compensation expense is included in direct service costs and other operating expenses, however this amount is excluded from the computation of Segment Profit since it is managed on a consolidated basis. </dd></dl></div>         The following table reconciles Segment Profit to consolidated income from continuing operations before income taxes (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="18"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="5">Three Months Ended June 30, </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="5">Six Months Ended June 30, </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2009 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2010 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2009 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2010 </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">46,701</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">78,498</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">85,794</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">139,850</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(6,168</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(3,706</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(12,600</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(8,234</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Depreciation and amortization</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(10,516</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(14,235</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(21,559</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(27,657</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Interest expense</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(657</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(584</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(1,084</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(1,269</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Interest income</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">1,734</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">803</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">4,045</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">1,620</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Income from continuing operations before income taxes</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">31,094</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">60,776</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">54,596</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">104,310</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div></td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE DCommitments and Contingencies Legal         The management and administration of the delivery of specialty managed healthcare entails significant risks of liability. From time to time, the Company is subject to various actions and claims arising from the acts or omissions of its employees, network providers or other parties. In the normal course of business, the Company receives reports relating to deaths and other serious incidents involving patients whose care is being managed by the Company. Such incidents occasionally give rise to malpractice, professional negligence and other related actions and claims against the Company or its network providers. Many of these actions and claims received by the Company seek substantial damages and therefore require the Company to incur significant fees and costs related to their defense. The Company is also subject to or party to certain class actions, litigation and claims rel ating to its operations and business practices. In the opinion of management, the Company has recorded reserves that are adequate to cover litigation, claims or assessments that have been or may be asserted against the Company, and for which the outcome is probable and reasonably estimable. Management believes that the resolution of such litigation and claims will not have a material adverse effect on the Company's financial condition or results of operations; however, there can be no assurance in this regard. Stock Repurchases         On July 30, 2008 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $200 million of its outstanding common stock through January 31, 2010. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 3,866,505 shares of the Company's common stock at an aggregate cost of $136.0 million (excluding broker commissions) durin g the year ended December 31, 2008 and made open market purchases of 1,859,959 shares of the Company's common stock at an average share price of $34.39 per share for an aggregate cost of $64.0 million (excluding broker commissions) during the period January 1, 2009 through April 7, 2009, which was the date that the repurchase program was completed, the $200 million authorization having been exhausted.         On July 28, 2009 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $100 million of its outstanding common stock through July 28, 2011. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 782,400 shares of the Company's common stock at an average price of $32.75 per share for an aggregate cost of $25.6 million ( excluding broker commissions) during the period from August 17, 2009 through December 31, 2009. Pursuant to this program, the Company made open market purchases of 1,711,881 shares of the Company's common stock at an average price of $43.46 per share for an aggregate cost of $74.4 million (excluding broker commissions) during the period January 1, 2010 through April 1, 2010, which was the date that the repurchase program was completed, the $100 million authorization having been exhausted. Acquisition of First Health Services         Pursuant to the June 4, 2009 Purchase Agreement (the "Purchase Agreement") with Coventry, on July 31, 2009 the Company acquired (the "Acquisition") all of the outstanding equity interests of Coventry's direct and indirect subsidiaries First Health Services Corporation ("FHS"), FHC, Inc. ("FHC") and Provider Synergies, LLC (together with FHS and FHC, "First Health Services") and certain assets of Coventry which are related to the operation of the business conducted by First Health Services. First Health Services provides pharmacy benefits management and other services to Medicaid programs. As consideration for the Acquisition, the Company paid $115.4 million in cash, excluding cash acquired and including a payment of $7.4 million for excess working capital with such amount being subject to final adjustments as provided in the Purchase Agreement. The Company funded the Acquisition with cash on hand.         As of June 30, 2010, settlement of the working capital receivable and certain contractual liabilities remain open and therefore subject to further estimation. In addition, the amount recognized for deferred tax liabilities may be impacted by the determination of these items. The Company will make appropriate adjustments to the purchase price allocation prior to the completion of the measurement period as required.         The Company reports the results of operations of First Health Services within Medicaid Administration.         Effective July 1, 2010 the Company discontinued the use of the name First Health Services Corporation and officially changed such name to "Magellan Medicaid Administration, Inc."</td></tr></table>

MAGELLAN HEALTH SERVICES INC 0000019411 10-Q 2010-06-30 false --12-31 Yes Large Accelerated Filer 2010 Q2 33381346 139617000 277871000

6509000

8221000

123703000

116879000

195416000

57329000

57035000

780450000

109323000

41814000

2757000

2372000

426471000

59405000

24655000

71141000

153976000 86704000

337009000

121762000

2631000

461961000

300247000

960631000

5370000

-145000

638367000

616870000

1667000

120676000

20838000

41814000

741658000

472478000

54771000

14235000

584000

803000

680882000

60776000

25348000

35428000

-285000

33323000

33800000

1.06

1.05

1469711000

949157000

111067000

27657000

1269000

1620000

1365401000

104310000

43363000

60947000

-259000

33849000

34434000

1.80

1.77

361000

18039000

-35956000

2445000

-5674000

-25050000

-7638000

-4454000

126189000

21681000

96515000

84959000

-33237000

74427000

17148000

-1504000

-59371000

588000

559000

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE ESubsequent Event Stock Repurchase         On July 27, 2010 the Company's board of directors approved a stock repurchase plan which authorizes the Company to purchase up to $350 million of its outstanding common stock through July 27, 2012. Stock repurchases under the program may be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions from time to time and in such amounts and via such methods as management deems appropriate. The stock repurchase program may be limited or terminated at any time without prior notice.</td></tr></table>

Includes stock compensation expense of $6,168 and $3,706 for the three months ended June 30, 2009 and 2010, and $12,600 and $8,234 for the six months ended June 30, 2009 and 2010, respectively. EX-101.SCH 7 mgln-20100630.xsd EX-101.SCH 0010 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0020 - Statement - CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 8000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 9999 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 8110 - Disclosure - Schedule II Valuation And Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 1010 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 8010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 8020 - Disclosure - Acquisitions and Joint Ventures link:presentationLink link:calculationLink link:definitionLink 8030 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 8040 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 8050 - Disclosure - Long-Term Debt and Capital Lease Obligations link:presentationLink link:calculationLink link:definitionLink 8060 - Disclosure - Stockholders Equity link:presentationLink link:calculationLink link:definitionLink 8070 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 8080 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 1040 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 8090 - Disclosure - Certain Relationships and Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 1030 - Disclosure - Business Segment Information link:presentationLink link:calculationLink link:definitionLink 8100 - Disclosure - Selected Quarterly Financial Data link:presentationLink link:calculationLink link:definitionLink 1020 - Disclosure - Net Income per Common Share link:presentationLink link:calculationLink link:definitionLink 0025 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1050 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 mgln-20100630_cal.xml EX-101.CAL EX-101.LAB 9 mgln-20100630_lab.xml EX-101.LAB Accounts Receivable, Net, Current Accounts receivable, less allowance for doubtful accounts of $1,358 and $1,667 at December 31, 2009 and June 30, 2010, respectively Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income (loss) Payments to Acquire Businesses, Net of Cash Acquired Acquisitions and investments in businesses, net of cash acquired Additional Paid in Capital Additional paid-in capital Allowance for Doubtful Accounts Receivable, Current Allowance for doubtful accounts (in dollars) CONSOLIDATED BALANCE SHEETS Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities Increase (Decrease) in Accounts Receivable Accounts receivable, net Cash flows from changes in assets and liabilities, net of effects from acquisitions of businesses: Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock, Shares Authorized Common stock, Authorized shares Common Stock, Shares, Outstanding Common stock, outstanding shares Balance Balance Common Stock, Value, Issued Common stock Comprehensive Income, Net of Tax, Attributable to Parent Comprehensive income Cost of Goods Sold Cost of goods sold Current Liabilities: Liabilities, Current Total Current Liabilities Long-term Debt and Capital Lease Obligations, Current Current maturities of long-term capital lease obligation Long-term Debt and Capital Lease Obligations Long-term capital lease obligation Debt Disclosure [Text Block] Long-Term Debt and Capital Lease Obligations Depreciation and amortization Business Combination Disclosure [Text Block] Acquisitions and Joint Ventures Earnings Per Share, Diluted Net income per common share-diluted: (in dollars per share) Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Discontinued Operations Income (Loss) from Equity Method Investments Equity in earnings of unconsolidated subsidiaries Share-based Compensation Non-cash stock compensation expense Stock compensation expense Gain (Loss) on Disposition of Assets Gain on sale of assets CONSOLIDATED STATEMENTS OF INCOME Income Tax Disclosure [Text Block] Income Taxes Increase (Decrease) in Other Operating Assets Other assets Intangible Assets, Net (Excluding Goodwill) Other intangible assets, net Interest Expense Interest expense LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Stockholders' Equity. Total Liabilities and Stockholders' Equity Liabilities Total Liabilities Stockholders' Equity Attributable to Noncontrolling Interest Minority interest Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities Cash flows from investing activities: Net Cash Provided by (used in) Investing Activities Net cash provided by (used in) investing activities Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities Net cash provided by operating activities Net Income (Loss) Attributable to Parent Net income Net income Cash and Cash Equivalents, Period Increase (Decrease) Net (decrease) increase in cash and cash equivalents Revenues Net revenue Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] General Increase (Decrease) in Other Operating Assets and Liabilities, Net Other Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss) Other comprehensive income-other Other Assets, Current Other current assets (restricted deposits of $15,467 and $20,838 at December 31, 2009 and June 30, 2010, respectively) Proceeds from (Payments for) Other Financing Activities Other Other Restricted Assets, Current Restricted deposits (in dollars) Pension and Other Postretirement Benefits Disclosure [Text Block] Benefit Plans Preferred Stock, Shares Authorized Preferred stock, Authorized shares Preferred Stock, Shares Issued Preferred stock, Issued shares Proceeds from Issuance or Sale of Equity Proceeds from exercise of stock options and warrants Proceeds from Sale of Productive Assets Proceeds from sale of assets Property, Plant and Equipment, Net Property and equipment, net Payments to Acquire Investments Purchase of investments Payments to Acquire Property, Plant, and Equipment Capital expenditures Related Party Transactions Disclosure [Text Block] Certain Relationships and Related Party Transactions Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities Payments on long-term debt and capital lease obligations Payments for Repurchase of Common Stock Payments to acquire treasury stock Restricted Cash and Cash Equivalents, Current Restricted cash Restricted Investments, Current Short-term restricted investments (in dollars) Retained Earnings (Accumulated Deficit) Retained earnings Benefit Plans Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS Segment Reporting Disclosure [Text Block] Business Segment Information Short-term Investments Short-term investments (restricted investments of $102,922 and $120,676 at December 31, 2009 and June 30, 2010, respectively) Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies CONSOLIDATED STATEMENTS OF CASH FLOWS CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Stockholders' Equity Current Assets: Assets, Current Total Current Assets Common Stock In Treasury Repurchase of stock (in shares) Warrants and Rights Outstanding Warrants outstanding Weighted Average Number of Shares Outstanding, Diluted Weighted average number of common shares outstanding-diluted (See Note B) (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares outstanding-basic (See Note B) (in shares) Common Stock Warrants Outstanding Assets. Total Assets Investment Income, Interest Interest income Deferred Tax Assets, Net, Noncurrent Deferred income taxes Deferred Tax Assets, Net, Current Deferred income taxes Scenario, Unspecified [Domain] Statement [Table] Statement, Scenario [Axis] ASSETS Statement Quarterly Financial Information [Text Block] Selected Quarterly Financial Data Class of Stock [Domain] Treasury Stock, Value Ordinary common stock in treasury, at cost, 6,509 shares and 8,221 shares at December 31, 2009 and June 30, 2010, respectively Cash Flow, Supplemental Disclosures [Text Block] Supplemental Cash Flow Information Proceeds from Sale of Notes Receivable Proceeds from note receivable Earnings Per Share, Basic Net income per common share-basic: (in dollars per share) Excess Tax Benefit from Share-based Compensation, Financing Activities Tax benefit from exercise of stock options Adjustments to Additional Paid in Capital, Warrant Issued Exercise of stock warrants Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Common Stock, Shares, Issued Common stock, Issued shares Other Assets, Noncurrent Other long-term assets Preferred Stock, Shares Outstanding Preferred stock, outstanding shares Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Cumulative Effects of Changes in Accounting Principles, Noncontrolling Interest Income from continuing operations before income taxes Class of Stock [Axis] Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Treasury Stock, Shares Ordinary common stock in treasury, shares Total Stockholders' Equity Balance Balance Income Tax Expense (Benefit) Provision for income taxes Preferred Stock, Value, Issued Preferred stock, par value $.01 per share Authorized-10,000 shares-Issued and outstanding-none Tax Benefit from Stock Options Exercised Tax benefit from exercise of stock options Statement, Equity Components [Axis] Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive (Loss) Income Equity Component [Domain] Paid-in-Kind Interest Non-cash interest expense Health Care Organization, Expenses, Net Cost of care Increase (Decrease) in Restricted Cash for Operating Activities Restricted cash Goodwill Goodwill Stock Issued During Period, Value, New Issues Issuance of equity Stock compensation expense Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Stock Issued During Period, Shares, New Issues Issuance of equity (in shares) Stock Issued During Period, Shares, Stock Options Exercised Exercise of stock options (in shares) Treasury Stock, Shares, Acquired Repurchase of stock (in shares) Liability for Uncertain Tax Positions, Noncurrent Tax Contingencies Cumulative Effect of Initial Adoption of FIN 48 Adoption of FIN 48 Treasury Stock, Value, Acquired, Cost Method Repurchase of stock Other Noncash Income Tax Expense Non-cash income tax expense Shares, Issued Balance (in shares) Balance (in shares) Earnings Per Share [Text Block] Net Income per Common Share Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income Net income Net Income (Loss) Attributable to Noncontrolling Interest Minority interest, net Depreciation, Depletion and Amortization Depreciation and amortization EX-101.PRE 10 mgln-20100630_pre.xml EX-101.PRE EX-101.DEF 11 mgln-20100630_def.xml EX-101.DEF ZIP 12 0001047469-10-006788-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001047469-10-006788-xbrl.zip M4$L#!!0````(`/1<_CP6)G]6WV4``+$.!0`1`!P`;6=L;BTR,#$P,#8S,"YX M;6Q55`D``SSR4DP\\E),=7@+``$$)0X```0Y`0``[#UI<]LXEM^G:OX#5UO5 M1Y5DBSHMI]-3BAW/>#N.W;'3,_.IBR(A"1V*T`*D;5[XUB/A@K+@;<,^:3/S?6M\?W%]W;!$ MZ`2>X[.`O&T$K/&7G__\IY_^J]6R_DH"PIV0>-9D95U%?]!01-8__@Z#K7=M MNS.P6BT<^CSA/CW'_UN`+Q#R(WW;F(?A\OST].GIZ02OG#`^.^VTV]U3&B!& MES3T>&>9#)8#(W'J47'J+''XJ-6V6UT['NL1NCZ8T(*15+!>QQYNHD.-B"?X M-/BR833>GC@BH7HQ\X/<\(4S([[O!'/B^.'\Q&4+F&BWVX-N.YX3B=;,*6!7 M7R_@`D=X!LN:I,&INID,76/@J2O'VJ/1Z%3>388*6C00@-JG_[CY<._.R<)I M)>L$JVQ9/R&`A=?0M\/5$I1*T,72!\&= M*D!*85P6A.0YM*CWMG&)C/_:48B2$20(:;C2UY*KU,/K4TJX)8DA.4X$<4]F M[/'TXOJ7QL]M_&./>K;]TZDY.49U6H!+8UH23IEGX@>9\/`2S.)GM5H]6+`8 M2GK/F$0"+S-ET.JV4\1>9D)\-8,ZOJ3E52;":P!]]BH$J-0J1%FP.*'L" M7-\YA"Q&KTT6HR/*XO>;R`_I;RPD%VRQ8,%]R-PO-V0Q(?PKB"DU)3);D(3' MY(8'9#PO?>K24-%H>13&J2BF7>7Y?0A6@[,O?$>(VZED:?Q,1>-G]$;GY1S_ M=%J()"7NM(BZ;W1M[?:OG?^L[E==7;N=]^B'M=Q;#NF:PU?_;Y:VE.%_/[O] MS]K^6UHMKNTKRSZ.)8W+5R2-;&*/\M@QL3=%>,C$_K741CG7>4R%^N?#Y:L0 MB*E3]K>A4[K>?HU25`V2KU9R1P%5(OQ\;\IN01P1?82U,L6($S]&"VP$LC0>[\IT5M#% M$#/H+DG`%I`G;$2X31`FQG6@\=T,W^O2BS.;3^21!!$1EM:)3]CVBMM6ED=< MNG!\\;;1ZC8LG"WO2QT9=/MGV!D#]3.!Y5'\3?8-+X"A6SYS`OHO)X3DZOWS M$K(L(CZ2<'?#1)&G;-!C@(#I,(G MT\-+RHD;WA/^2%V"P\0X\&[#.>&W2U07&LQB0JL0@NI.O=^GC(4!E(J_$Y\L M?N\,SH:]?KMCTFFW.Z-N3Q*Z*RUYB5V2):.%XR'6MR[B]%N M]^V\&*O@R5-V#3C!6D)-=PU5[@]S)!@`36R/<`NS]>O`90L2#Z[!^U`OS#;0 M&55*%NDC"Y+/:G1]]MN]87N8JLAV'*9$\-8')L059XL+0$^#"*;HN2P0[\B4 M<:+&/3C/1-S0@'&(DC&'L+YY*.__-X+;-R2<,R\52PTWU;7;(U/*+T9ND9P` MH);B.Q*0*:VC.)W!J%_`TQKH//X[SN`:DEP#Y5EW-,JA3*'EL4A?`H4P6/$< MZ^A'DHH*W/#M%*B\DSD)7.<0V<@E4?_6T-R\ZZB/V@P.:R#BZ?#-CW"C\0Z] M$3BF,.1T$H7.Q">#,]Z7)U/8,9[U!WP@N!R4IS^_?"9W-0^*-'\$" M9@22F`F$@ZE,IL1M%,J-5)C]SA'4W8F;..?K]D;]/$,[X:Q$[B7U([BZ!J$N MP:-.%8++L.9)?N_P`"Z*.$6M)$DCEJ?I;?NDWTT)*X2]&;TF^D@$:.@U)8#% M6S4:1NUC">$P-!3*XNV+L]Q-3B ME99;6QGL]_JCP:NKN+9;46?0-=L$>Q==6[%V[5'_:]1=6PEK=;0.O\+BJX+4 MA]W1*ZJ_-C&45#3]_O#L&RK!JM$\,)JL>U5A<65`/%Q.6,N:305\O=A>W`DY!7CUZ#=/B+WVS/4CM$VK8+_SJ'@=WZA&$;VR2/Z>=FO@RUP MRN@"'#$WPT4]Z7>[1O6V"<5:-,SYW>O@$Q#,J0N6>6$>R0-Q([CJJ;<3EL_ZQ$*1F M2M7I#MIK3>P*R*I*[\Y9(3]8`;@NCXCW@3H3ZN^Q_IVNS`$K"703]DP^O@[@ MAGC4=?P+WZ&+#!0I"7UO;T;L7D5N7"6-'3\NK5\:S3L[J0U*;X\ MG7`!31123]Q2]MZM/H.SO0X.Y2UZ;;,E51VAZ>97L@QX8&,7"@1.``+,"5=W MOA-@$8%EPQ*'U(Q]/6.KL#K"+83N6W79O9XL3S;15EHG`=$N(9XLK.X=G]PX M8835%]!_`8DK<661=CO=F\@!D+E6SNR*NI)NJO$'T,U!IU-%-0OPF5W!I5Z/ MV^D'%LP>"%]^(BZW4IS5O0+NB*51,",@")N#L'3W$[S9QMK47> M`*Q\5*B?Y8C*M?1:B`B?X;KEJ#2W4]4.J*>4MG&,93N>D4#F+Z_ M&G;ZW7(B*R"M9#.'(K8U:,OR>;O5;*44)TF5%7,4_2,L`F8,!^QCV/U!Q]AK MW0'GX:BM5/MTN_TS^ZC$CF&=.%_!DOSF^%&>2O4LWI9>LWU629P&GD.0MGU; M?33H&+7K2Q&WO:[O@/\V=ZE>3');Y=9O#_^C#(L[-Y+$*;9B=Y0NX3>#-U@GC(8;OLNRK"@&#SLC(8XK`FAM24P+T>`_. MLRHGZPN@/^QVS"VH4N`%+10UI";R06=H=.[781IKOP^Z81^<=-Z0-Z`JK1?, MHJ_**K?/.F:.M0&\P?.C0WW40\@B,-=)TT-L+M64_+#?R:>E5;!LU\+Z%-G# MH1&>-L,OU<7Z)'2&[8(.G@DUCQBWO9^H[^^*J]<9](;YA"$&M;:_ZP0SBKV+ M6`COG_6^1EWD@]Z9W3'Z#]NQ%%GBSJONJB7[4'1JMME+0F6Y:4=NJ;G3K=0>#3(]L`^CL]GIQ@ZPN#>W>H)>A M83/T_$KLC[T[&-F#?'ROBG0%CO`S%)@\=&B`6Z1,4-GRV,/'V6=G1B:T`[;L MP1KM&B_@+TW/L618V\,+]CN#S*&9'3"5+M[.SG'4[O>*Y;1>AZ9-B9+L=-/; M"C:2D=]ESF$Q/(;GR<5R?+7MI/LX.[ME$YG1E0NAFSF[Z@TQ(N/.8*7B1:1 MCR]2@N7#AYMWS@K[_5'';%MM0V)L1$,"[P128S[ASG#IKG,55T-AO]XQCW(5<=KX=Y-RVOM-S'#\N^SYYPCP!RJTL63<)IY*]W=^KFM>8QZ)VPE37@,BV? MVOGV6D-I$_B",CH=OE>WQ>[W!@7-G1+H%02R1[>C+9.9;2(IRV3S)G[G\%LN MWSOC29V+'RK93-3UQZOR9U7PY0*[(3L$@:8C>$$2U7'`<13.&:?_,A[UV;R@ M\0E$&7Z,CMHF%/N0L]%E'H\@W.*L)9LM-"BXV_'7R]@K$E&:L5>71*5E.;XL M#D%&J30R$:ZZXZF6256V]PHTE!*]W=)KI'VFR15G!)L-;@<::R:G1Z&RS"?L M01^6-+W-Y!59R=J@C>YB#_JZO7YW[9GK4M2UY+?G"F,%TCFN!/>DL-OMFL<3 MZLAPE]3B&W)".Y%=K2SYINBNW./\5EQ^C=(OL;67<_G?")6E+G\/^H[L[(]$ MV4'<_#\A[(3.Z$QD'G"_ M@$',IYZC'XZ&A%K`!/GU=JI/+CI^\FY8<4F%ZS-\4]L#T/_.+S@IF[SC\3L_ M?",[S)8(5SYYVYC"P)8`.SVWV\OPC26_3YT%]5?GWS_0!1'61_)D?6(+)_B^ M&>*%IB"<3M\TOIN%;_[$PF19SY[Z>=EC.7J]N-#ZVI\<_WAG^>6!")GXQA$ M:"$!^+Z+^.($/WR\?7AOC;]S%LLW_VWW[3?J]S-\"P><3N*AIP@@^;(\%'+\ M0/$#/H4H+#:ULNL@<=$$Z[&(0=:#B5@>Z-/#G%B.Z[+%T@GP]!GHLQ-Y5+^, M1"L=?)G&.H8_9:*5#"5PHW^1PU)O9K#TRP9$,T5Q';@G3*!Z)""=G3OGC]??/[MP)9L1"=TH%OG?Z>P&<(X?W[R]`9OB*61ZIYR"L MD%E7`#==:+O=^O7$&DN.@`%_I:13*`V/60$+DP4'WG"=<;A);?SF"V%Q(A\= MD;^5L[^<4.=]$A;3=V)=JWEL20.D!(@#;P>KCK>;DE['^R/2?=2F-!8J'[K` MH0%RX`/!V%W%:YFQ:JA'D)&`@*D(U"^DR+&F#N6H'HE3:6;41LO*4SH&@R!T M2NM@R;L+)!@D6]!G"R)B.!>@]C#'^I\H(.E*==M-"R.`A>:(ZQ`3`BX>\.!1 ME9`"7KTD,2Y8\0FQR/.2N-(G:&33"*2Q(@Z'Q8=/@LX""G;C!*%21NU=4HN6 M-LJ=0#A:E5(FB4_E*T35RKG9N'=BO0YWJIV!11ZA>)"W-PN7B>\W#N MA!9S91<>!DY!7*5K)3T;9]%,62\Z9NL)#$9E?G!)E"ESEBR/>G+)I4)'K(ZZ-ABT%BT85Z"Y6&ZFUEP&Q>\/4I"F?)^&'Q(R)HZ M:*'EQAXA=G(I2>,@B`#U)P*!%O0K6/?4OP"%/LD&@_<7)357L^M(D$#\$76[2.F$N3I]>95L<51=,(SB!W)0HDEOO+(#U)3Y;!9G1#(%BV.AU-*4GR647PO')5&(QQUSX\!0="3! MN*(/_D%0@*"N3_YE*1IMHDB=I@1'YG@@!(B[7$>(AYR,Y`->8-`Z)\7XI>1@ M+2%W$YAO0HDDDR\5HV0&22`O8"O"X:/O3,!BHT"Z:F04LTH60:+!0#L#Y`N8 M!`[!TDG>SX(1QH)&!5!OP-;DRZ#)I8KVMT317H&1 M/K$XQ4E7+5X*[6%W,J@'C(T^?$&PR?*G62DG4WR,6!@H728SYC3GS9B-IL^# MQ`A4;B4!%U(10K22&69&WU$I\)[6G31_H/I\#G=D)A>0$GQ+PH9Y5X+ZA,P MYA2D!H`VH<*/#CV0"8B5.Z=.R,$*X:[\BLY"?66R9%HC&.%-B:PP'#^>)8&X MUIP)V22!RUIPUD(=GH;TV(W/U\JPE9T&>@XSP+^H'T.`T2GU+L$T5%FPHBB] ME$4YEL@QC7IY5*/THT`07Q8,TIBY MLUS)$AA(188QNW/UXAES<8P\7UF(`KG$]4,9Q,*,W]D7\R01Q3-3EG$J^`SL M;D@Z,/'+3LL[V%2O/09BPJ32DV\<]!/GVT3FH$RW,@X9+DR;17(FSUBS(8.< MR`.EEO:564M1.HMW-+@MQIEU_DG8P#<.+BF):Y%82^-R'Q5,V]T-?'/9T@$: MH'19048UDTJ[[O(LW=[&%H,LF3-3%='8'O@$6 MALUL/,Q8:R;6)I'L=9A.M<03"XQD9&']D*0PA<6#+!J\9BZ_2>L3]+MQ4GQ^ MI!X`/88`L8U-.!:F)T83(4M_[75\D$%\0P%DI03$`@1]3B^"5A>4!A73&=FP M']\5+'$D4XPX4]*IK69X-`/3R#X;)?E:WK@?(GN^(+5LJDDH9-,"9TQ MYR5<;,AY`AA(F*N,OZ),XR0$C3.A?-_L5RUY40)<.[LUM;&9VZ#+.)J-3!RE M5ME@,\=P#R:@0*+=#,GK:)PUP3] M!6]:"SPVM\1M6MB&@ZD6F%TH]:1I\3F)%D[(T&-P4%`: MXG`7-!6<(ZK10O89Y@1+)[B7Z8EY5.!9-5";^[(M'D4Q)_K8@C6GLWE+ZB0- M_D#O.O&))"B2.1FF%K(K2(.Y@QN0:CZ;AD1OK@HB.R!0$4-I[<4=4JA5\"WK M4)\2#R.^JO(0,3YHJ#:FL?T4DR/;8M8,A8=-J$5REBB.">IP2;I+&RWE7BE$ M$I0[`U"A\P7A+ICJRR2=)_21X=IN3Y4]L%QPJAXN2C:J2A/G7<(()YDP`AI2 M%$8V<9?IAJBN=ZYC$S,ES\#(PSP<7Q:`H7T)!AX[:?@/RQW51EP+E.ORC*8` M$^(^%V^,G@HH++YN7+J\S1I;BO.-V:!(':L,&F2F?OD`=S+-=&1'VE4WY+$0 M%S[L+Z-E89`L0*7B>K*0<0OE*/M^,9)QOIGT.MQ\&?6I:R\94>S.<:=DIO;? M$]]2W-U,"R"96:FB1:BB!2ZJ20EYS5AYP(5K`]=KKG*W8*9Z7KE-(F6W\0G& M*7,CL;[%628`&CPR_S$A51ZNTR2D.9O1/X0B\-T8!).P65['Y3/&-,@HQ96Y M#>,DT=Q<3EE"/!,WPERAJ4,Y?)A#LH-YOV`1CSME/IDY_LL<8+J/%M+V0$3W MF9.0X_3`ZAT#N\SUX$\)IG9STN> M@L@R>(\/@3C<$]8[!O^@(QC?_U][;]K+!Q<^)4 MR9+LHUQ;4BPYR_,F!9)#$=<@P`.`6NZG?[I[!BO!320E@)I4G9@B@9GIW_1T M]\ST\@DD`0LQY,$)Q]QS4L&ORU\\]8N5>M?9TZCJIU<]]Q).[SU)O0NZ9B.L(MX,D9TLC0+JB:RWQRMW,X7[K['&*_!R13A04`K&S M>.&3)P'00\@$S*4-12QGT.N0:XP1&Y*S1Y@ZI;OV0TA^8SEP<>!DX>*[`;LC M94`"_0:E0C(NO!Y/;]3QA7(4N?MLUG4>1VUS#\J`/"@)/+J\)G]J$F+DJGN# M&.X.GJ,9>(5O8?B1![^X'(J3!=@N,LI^KH1/(0R17VBFK!/&ZX'?9`O;9>3@ M]JQH8<"`'Y(F^7$'LDZR9MS%"PLMK?&YNNZJZN81!+QMF^ MP44=_M+@G&CC,,)U^E>.\-`MS#@W(T+F>[70!^+RSSA,)\FK=HYA.K#Z&TAM MO(^W\:+:=I_0,PE=3QA:ONAG]S#F43EV2<#/'3JHT+2(T!];R>1/RP7(B#?0 M'W5AY-`-YJ5B[].\72+62 M^)[D*'/HD\*)&0HF^.^PW$+R?DF'R^MAX+42R,4\M)OI;]] M760(1XF0F1[<3&AK1R\FT:$`K_V?5`` MGS'8B"'#4/?4PR?305,X3QE[$;VJ.@F3=IOW$&BQS M3I@-8R*O++K(Z+/H`>7H5W;/W,PL$IW%+R^2$`X4"W%\%NU=DA;5N=]Q+:4= M@DA"%\H9:9&Y#BY48244"9GB'N.I3(AX)=2XV"X_E4R-U,*TTTV2"[)QY)#5 M8$>Y>4JC9I)S#NRTUF4'J=C5:0)%>U:,%7S^!98[5,B*!>PFJ[.HY;P M&W?2SY`@C'W$W$,_P$0MII&#*X8D4(A+%@$[T8Y;)>F!9K`X&V11Y(HWLE.$ M,"IW`98$[F-0\[Q@SE)#CFF)@EJP8%=;K6O([9.4Q+]F4%;QBI#27&2*^F8F7J6Q)),U<+)'@]F&T,2- M^-Z?[ZD'I-F&#KHR**/`GXC[P034O?J3Q9Y9IZB=OW,NJ)-XB,<_X-8%C5_X M`H8BQCSF;8%M[ES#"7^JW('/&Q9]0IS[BK3%^/G4&P<<;B@09#[M0? MTQM'EY&#./S!0ZM$$V2-T4[/Y7=&XH:EX.!#B06$@TT,(PP*]N:XM22K6#0X M=J8*MP1ML2!BO9>]\>?'0MQ7Q1/G[)GD!1041Q%6:*NI:?@P#]Y)S)>X=Q3U M)'%!#(F0:C!T86Z>DN6#AB90`C@)E$$5\`NQ%!RTQ\5=3FRDQF`FHD:0WU3* M."[DF^U'WJ/RKM4QF[V422<@B>+@NW>ZJAO=IC[_:WQ"%XT#QB7Q6GD6\'`( M?7?X)@6WS=1-JZ':7'X,G#M,UPQ,;4[(4EJ.)!*65$\L\Q)5ML+98*\+D>?]^H*W M(\F\UVW1S85)&;TRINI&)A9.;;55 MAFTSSG&)(5X(Y^?G,\=QP6ZQ\\-S&F3UV#05F\B<"UI66<59*/AQXYBM\L6C MR":P3Z=D#/+=,D)&=M^85XGD!Z5,%&/"(ZR!"'V+,WG]A<<,)WD5YQV?8C5+ MX>-VZD*]8GAHQ6-D)W&\"KMN%ENG'MU5)H>N/%:3CU3L$B;0C1='GS!X>BU` M/#+A"7K*FH+2H:B[Q4E$/*,Y-^+-/!ZY6'G7,LLL3J[7=6W_BKW576Q7Z*4V M1QU$R36WRO!LY/@3!034;YW3'\D=F93N5[82'HJZ(1IE*M86=GQ%$ZX4L=*'G"/?AYXJ.,ZXC3< M]1_XRN&W#W9P1P=0>.OBB4VQ<*E`9W"&V49@H)_CRPW:(L<4%%(+Y`XA^:8U M7((3OWR-\P.F)WLNN[=%-EKL!`T5W,AG#B3!VE#LN)YM&KNSL"<0"@,LVD9) MDZX#_QCME27/%TY:/#K4%]XR_`QE.@OPPB&*)6-`5>KXP4*:Z18GAU#C"69F M4[JS2EJXIJV9N M^MEUXF&XL.LYIL\?<,VSQI9#/'\5K;<&XZ).;CCP[PLI(UOD]#A=V(C53 MRO%TDH8G;;#7&:KQ^:%]=X>WY.@/@$$TL(H'PNLH]W(:+U8"WT:)0T5NPM23 M(Q=N.*9,;]E+.KS=9%Z4W@\EB0O(D"GZBF?R^>+#_V*N>^V#M"GD%%:.&LE/ MPD>)WH\3K_"K)9ZG@UP-(W'_3ZX*P+LE%5!II69Z3H)`,T!>V+D_AE`U9R6]<.T9'U30MV53` M-!6R+:G*2>#\G^_9*_(F%1S6DSA)H0K3:(;XD'\^DT]VF+"`R!F#@=JB1KC] M%6FN^"UG M1)Y&<4AMJ68T8'):SHKBU&6)#!",E1BS9*[0ZY">`%+9=<:V,?U MD5>5\Q>1!265:!YAA7:[S=8"@+N=LKNDS-7]=A!G+QB6A]C'QCQR1%=?N-?O ME)TGUF]:R3G;?2)YHF;FBQ+.DO_2"KA$VG(U=KD``,B/3(3\<>WI>,?"EUW$ MV:[.=)#AI.2*-1/$]CAU@L(E+[>HUFNUR)[\\M7W0/%%\3$>2*1"ZA/2SF)G MGODV=1E&*.?$M(BXR.WAQ6`I,C&6W(LRV"$KTSF][:%S5Y]EQ3>S`V1ND12R M5.RF!K#(VO>7G"DPMC/GEUE16D#'0=#0$P5]6/BE?3;/))^1%>\=K MXK)4R)4:OW.;"X`BHH#]=WK+7'Q0U^Z]FC9YF=WGIRQG'D!&&4'LMSV9$N/K[=S9N!"U>@P1,B++:" M=+WT/HKSK='>)]\BK2%Z^0XW([;4YK746$[B%B!O0I+9J'>8DCW;O'EP=H+8H.<:&([6#IK5ID<5F'*R@P'E1P)RPXA MN*W6*K-#BM<=FQ^P/(.#=P!QE@F7X%=VF:F2]U4IKGJ9)V2,7^F!U+;XU6,' MO/D,X^G'MHMHI1/H+;=M1DODGJZ7B'6SI??'QB]V.04UP*%`R4'8SZ>.CFP%8!JB)XGP4K%S M>3O4^,(S#@CFQEB>8HQFF[KV@$@N14['G!RX"NPA(7+1^'`V(L>E['_DP9/.RMSEG7`62=(B MYD;`FUDZ[SCJV13'IF>YDK,?S@+C>V#:*$]FY$R#-^)B&68-DA5\WRLSL^:+ M)):Q=88K7U"4)O$9Y:'Z=?5'2Y,PY\.$\1XS#;/,A&;F?\@&:B8%L[)E=?I) MOH$A1G)FTA!0-%D:JBTBJ#^7]9D+!PU8L=T9N7"*X*"0R,&'H=)X&XF8)R">.M@Z!20->:0 MC?.UYB&E!!4.2#,[6,2^^C%T?.`Y)ZS';XI!PY3=;,N!(E67Y0P@,M3PYS\926>["S:-!\KV:3 M223=H8OF/1\&1J[S8*SZ@@"6]& MK^PC\6BN,3Z*]S5D03-EP1]>!I`LKB*I:N'N/1N^GV;]F`OJ%W"1PP=."+KW M/E#L-CE7>,0PL5$ZSQF%,LDX>']*DB%,!IFKKM/G*:,R&4EB#]SLG7R>%)SV M.LS=Q7QI^D7:)U-H%"8'5RP]F=8/XO6DQZ"2BFW,!6B4ZNLM-#2_M%U04/N( MKCC]60B=A.]7J,NA?1-??COY_N7B4CRF:W_^B_*OB[/;WSXH7?P?/IZ3@-1&[JF_;FA'!^O-`2Q MD1^PBH]3Y_G;DR]?SL\4:DXTD:)G@V'O?6SP8IP9*CA_#)CKAE,;U^?'AM:@ MOZ>X"15_/SC#:/Q1C*Y/'F;X?::9($;CM_-X8AYS%/-AG5Y]_?'MDL-^H]R< MW^8&&@V78!J3X+)1E+3\:S1<]_68!N,Y+XN^R5$M::JSQ3#,7OUI:.GUI\%L MUY^&'<_#LA5[?GF6E4Y1L$H$H"H@E%L1"L9QLC0H;+MQ3 MW9[_^_;XXO+L_!*^.N;?;11_:(>\!@M].(=]*`P#U=R1_G[!CFE#PZB$K$VM MC^?WEK<.%_;][N6[3`^0=MBW!)=WV6ZKAM63P$JNK1.X5>+:[53?P]B)6+45 MWW<68O8+BAL'U7=D'(*ZJ^1*.@"944E/7Q>K>BNCN[) M=*/D8FT7ZN["NVAD;[(WV9OLK5Z]'?R>[$?SIJE\2:K`\T1`6-_B M*5-)4VJO_9AHAJIW6[4ELI*0RMV$Q+42O=5/!%1TD[9+;7>53R5[E^B]8TKY MYZ,'*./%:9V0A4>F/*&4\J0:O:U[H:'VNEIMB:PDI))5#YY5#WZ;=QI7;5>& MK!_)K9T4&E7K;5U[66^IK6Y%;NPKWYMD5LFL;VA[=\J"B(H&B$K%0S;U0R>2 M.DZ*C4KTMB:N/;73JHAA7/G>)*M*5GTC>[A;^Y%G@)AYE)_`5?J^-Y0[."DR MJM';VC<>':,B;FF5[VT35JTWI97$M4*LND2[4<!.32B9X+B)0T29H.E:;M[.'*G??D2:R=B5O=$+@*>:`<%*YF MMZMV](ILC@\*V0/8F5477+.GJ=U>102"M'J%Y6$T#:!1&?JSOLOJ8'U(NB1= M5:`K(T'X1SQ"3?X:.O=IAY@Q#JM(^2-,^+HB+^7\ZWO+\+E.5D]A2Y]\O?@" MW^;RA163=7Z]N#S__N/K^>V_;]7+JYO?3L[.%O'AM[4 MKF\;/',>S%C[SPV%>OC8P.$U&^)"1Z,.HL+^(P3S6]4T/V$OS[PRC3&?+6')AL^>/ ME"D[Q.J69EFM"V"X`:8"&F/F:,=3^K;WD]+GSC#WG:@W(9+<\N2_<5XW/JQ< MEK?\X(=[0JHL=<,ND3+;)?5G$*@@S2%1-\S*G,FWQ^S"$Y@Y:;BQ0H79T0G" M"<-96LO\,QLRK+[^FS]ARE??]I1O?A#=V7<(%7<03(J_E#__"6!N+L*,?W3+ MQ6,ETE*?\"++^:316>`P-?3`M<.0"WX[5!I)5N[CD0]*P79!3E&4'#YJ!X%3 MS!JMIFF^1:;Y.+,X)9S/Y0F'[J>^ZPRH=@F6=N=]/U$YZ.S`*(5V7``$BXY, M[$BX<-)O,.-):4,[C(M:-)4T"!USBN,\.E35V+_S`.#V63F4M)Z44P0(`L8C#?$X@&"FB/LZWTC*3<\ M$&6WJ0`+AG2XSI!GT;==RD4>CEF<&#SW>QC!/QQK(IM:YP5C8D+3JD#04X;& M(5:/CC.)TUB/L<[`,;2':RH``?0]QJJ`43;3.Z:-GP;^O1/&5?7*VH+>!J[C M\<('@M]P$*(>0U+4>B5Q)P`+**(`%X9*38.9I)7&`A#2^[ M#I&E%/)XBZDL*U.2%I\/&19D&N=]PI]4Y$Z':F=-?*#'=7XRK+F$E3-`JS*#Q2Y,XYQ))"0S07PP2WYP#OQ?6* MXD:H'%C:.VBC6?XU7G@LJ>F5-C.:80T2,4=$G]NE5P M.T6H7V)^DK6`I9MV._)2K52'"AVW"R;17CTEM!1Y#3)N6Y+.3>KU>63JD'@5 M:Q>:!<'\O[SGIP\X3;4?$=8),UV!\)L@)&A M<,8M03PVJKD"_SD3*@*X?%QBN;'1B!>I57*U?A`1L-QPP7HE$D^\/!3]V`/0 M"EPR-WGB5^PC&8HP)+`BD(?CSA:G"=B='9"%`(/MQW6(R+UY9,_<*&M## M[KAM("87;7JPN+A1GW:7-@K?<.MCB/C/.!<((4#EQL+0'S@$*$V4'?<+4F\6 M(*N@M%*+BHAAM<8(Y"&(%*HM3_.168"Q>AS96&\\S*K+H@!%6XB7*"N58_Z: MDHOL9P?K[W$5DE_.ZQF<=5C:)[1HSMB@4.605X`6%9B7%%4&3GQ@5$6K9%+G MM%"?@55VO\+^O?03*WINFT!])2H;YYHYHEC7^D6EX:VEQ;.3FZ:O0Z MM:6RDIB:%1$CE>]M33R/7L0Z*Q$QAP4C+'73J(BA^P:V=3*QYTN'RVI=M6L: MM26SDJ!:K8I(C,KWMJXR,[478=V>XW'O=BG#GP>_89`+/%V7N"F7OJWQO M;^?H3.+ZAG"MD`A8HMW>5K*'6J69DC1)FBJ0W.%0SW=N_'0-5%$U>_9FJ`ET9"<(_[BTQVK8QL>ZR;$TR?'()(C)\CDJ"6Z%B5=LIOAHXX\KPR:HLM+;::]=75%<2 M4EU&3TJM5P-<8>EWJ^^?>R@[/1E-^=+VG-Y2NV9]MW:5!%6O2OQUY7M;VY&N M8[X$C8,W"FMJOT?6\H]VK[,M[4CE41YJY\;U(.O^Z&37^1(X7#WZ^I':-= M#2*7Z+.W%?%4JPAM29.DJ0(13H=YOE.:&Z#2EZ`CFJ8%=D82RNYKO'8DBY)5Q7HRD@0_G%O>0'V M%J^_3HR^L+Y/OEY\@6]S<8'%T/NO%Y?GWW]\/;_]]ZUZ>77SV\G9N8(1KU?? M/S;$-#<4%*P?&WI3N[YM\#A8F+'VGQL*]?"Q@<-KY.+8QXEDIK82ELD'*\81 MN-26YX=C>PAOB`^-)%8G#@PB7%VJ7&X/HH\-\2$CT8=184<2@WFLZYMN0$I= M?H=1IK-E++FPV0LJ9T]5[-.MC>,!^7B1[83AC!>3Q_K@G]F0!;`+^LV?,.6K M;WO*-S^([NP[+%#.G;D?V!'Z MJ3TIP_BJ/U.@_9<\CC;]OB`*V`Z8J(V.,7E8VMU_P!KFZ:.O6LS]]FJ;JA=4V:S MW1.RF@Q3?3%!41(;63M!4P=365`KDT;\;5@2);70I(#8C8.8 MWI;1>SN'M"(2=XEP>%NWB;7R>SI$F@[>BI6^7-78NTE?KGTB*_UDJJ;9:N>? M<*AT93B2?ZQL/8:=75L/["!XE_"V*/9T&_B,=ZV,G3J",\#B?]SR$ M_R)??$\MQU?J\&J);\!T6S#A2P<_7'@#]$.XM1_C;+=.TLEN>]S#]*7SQ$8C M-L"[=I@+(BBR'Y6`?!$>6,`4"P1I^NZ4!8,XC2K\TI[_)>:$T'E4)D#*.$1^ M!_XN,XBT'K6$EI&J!`P7`P[%?6HJ,,J0B8$,'1@DS'K@3ZCMD7`$"2.8Z<@/ MGHIC5Z:!@XX0[E/,'_AHED1D*^@91CVQ/1PW[X-Y`_BESZ('QCRE[_L_N?<) MM,O?I8'%\('8"7W%'@R"&7F\`$L#-XN&/=LE[B5?!J`?!C'S`C;P[SQRT,`V M^\QC(X=[R.`_P.?W3NCX'L&8'6USN3SQO!AS\G4U18@'@G_U@DKZA M:\?_DRRE)V8'8A$MIC//F,AG`;X0TM0.LE/+'O$S0Q7TKMTTTJ8FCNOB`XC8 M.]W(KN[XIWA(T3@`8/#!-==Y?GESGZYW9K.SH/=NV;B>V?F\;+E9#$IF@8HY M&V"^3-AJTR(F,<+W>`"?6*#/!B41?L!\*'5`Y`1L.!O`"]@FB^^R\:\1"^]&O89HZ(+3.RE]G`FO"%XP_W(C/VH(P>&)IM2,\]B/4[IMP%-DIDE-@9 M30^`VZXK.-J?\N2F]"B\.@2-#];(VIH','\`S-_I>K/31<>Z%-59&+?TR;4' M/X]O!F/?9>'Q-Q9$P"F\9]0PZ+\%/0V9FX@$T@=A.)L@-9RK!MCFO8\.;2[Z M^0$9IIYE_'CVN-3Q.=>-':`3N@`9D7\W+T8X&#@65I?93G0>$@,Z<(@BXLR\$SW M(6]._)+"5`)26)22U6>GF]3=U?%`^$TX'AFTRE9++#HVLE1!7CCD@#OR701+ M>M!*#]JWY4';JC\-EK53&I9QBO2@+3F^K8B/Z)50`#2H?KGD>AM(_$M8WEE& M^.,?3K@9GO_R_!',5" MP%SD6[T%JG<'Y]T;BI.Z]+;FQ5<+:Y:H6J^^%1RJ>ZEH=IM5J>2PG02I@8O" M%WY,(L7$?EBYV])4HU41K_'*][8FJ);1[)0X?]9//M3"POC,CYBEC-@7.Q_I M74,U7T9(''QR2\ML5J50QL';#O'.3TJ&?4D&J]-2+4V6*=G)KJ+5[%5_5_&V M'!5KY:Y^B#2]`?LU=T(F/"SEV=A^S\;,3D=M=2MBAU6^M_6/Q7HO8@I(!7:8 MPOX0:3KX3=8_61@)IYW$:2SRE7OR)XZD0GL9A698FFI:%0GOKWQO&RBTBL29 M2X561^%_B#2]@1V9.#=$?SVY(WL92:OJ[9ZJM2M2]NFPO!5Z=;AQ>%M:K':! MPH=*5X8C^+EWB=N!49\S&W1M]@S,?-V`Z8 M#/G8*.2#G(:5,]"U^>_39.JO#><;.$61D1^O<\1@=-5>6;Z^PZ+R-0Y2M*91 MD1N6[<1'#6X53W#7(QTW]R8C#-74*N)L6/G>-CAGK;[[RZ%8%]SM0,J'/3EV MOYP1]M36:FOO^DM_3Z4BIQE3>U)6T=@F_.(=+T!FS98@2( M/":36^`:'Y/58A_\MK18[?QR#I6N#$?RCX?M;_1]@3?+%JY&=\S#%/KNTR9. M1[90I@BF[XG$Y.AYE'<\>F.N13,/,_=*SR+I6<2D9]&ZGD4'D$U6>A;-KU'I M650FN-X&$-*SJ,;G)=*SZ,5V]GK74JU612)B#^O,Q*I#[J?#N".4KD7[%1*: MKG;UBJ0_K7QO&V24K4B2WC=@7TC?HKWZ%H$5T3)ESLB=V`UMF8E>^A95O;>U M\TRK[:[T.=R)7.@TS>K['+ZM.]A:>=T<(DUOP'*5GD2O(&P-35.U5D5<7@[K M6*S;M"IRDB#56%U=;@Z5K@Q'\H]OS)6(>Z^\M"?1&NF+]N)%!%\Z^.&K#U3> MLF"BG+%^1(F23NVI$]FN\I79(5.N^L`^=J9.J),,HM)^35>>M#."S$RDC>\`+S3\XT1B@`3MH`"]]LKV?RLD7#I,3.7>! M/YLJ7UR_#WA]LX.?+`K3#B^\01,KK4?*-/#O'60==(ZRE7>ZII451O_.[GWW M'OGNJV][.,2)$TV0%V*G*B<,9[8W8+CT7!;!T*E4>CQJ\90]&/@S>"N?FHO3 M8B.+N0XT3,MWBFSVSBP=#C87)$-R84BAW>;8P M>KR(_3*V\!0;IF$X$`_P-,A"-^A$(9E#RL3.YKA;/CSL]?ETK>IW"YZ M^<$&L3ZS2;!#&_TG$K*PK8D?`2 M,->1\S[MS_&HR0'J(<#R1_.F"0:5Z]J!,F2>/W$\\E$E7E,%M!-\TD[;!]X) M[J`A^!9-LK1QV,2B=X\R=6CVUW%#O\QB]# MP^QQP,)DKE&I>VC`*8T1&Z(]H(R`N<$.PZ94;.O(64+C^2SPMR#17$YBIG6B M+/'592[/M)],&]_B\U45\^_8YOS+$SSB;/$A(`I+YP:I7D88)O9'XVOHA""; ML/$F6!^)O!)\AM(,WDA%Q6(!".-B*2W0.C[.YQ(Q,COS('%2!VD;]#$,D5+? M6RR:D'NU9KL,=L$2,P^,Y.'BT=9AY9>H32%X-U>;)1A*M5FJ-F%3L;[:G']8 MJ,W%6M.,M6;)N\[.E*8C=>;"*7JNSG1>2&7JS1)1>5@JTUA.XK8J,ZR+RL00 MID4JTVAVGZLRRT6+UFQI!ZTP`1F0O`_X?^_TICXO]U&AB(,6EPY:_,Q!"TH] MSU^R_F%^RD^AFJMO918>]/WQ#W_]=18>W]GV],-5<&=[SO_1>$YA2'@I1W^< M>,-K8!&8!OKS:O09V-(;@#B_@6\8SD]X!DSI^B&(_%OV&'UR_<'/O_WQ#XKR MU[CUCCXTS).@?QG]NSQI_HW-.BE$2DXLD M'N,,?N#76O3WR`9XGS[\18'Q8%1Z+ MXK80K0%'BYH!/8#O^+,06@;9CGID2H)7_`XL:K__L!3*?800ZID0PJX,(:Q7 M"&$ZHD9!4,I@Q+=&@_&L2,9JT7`(\U"#H-`5(8%O+4"TM61HL5UT2_>NR==GZ"[6^M4S?+(KQ MY25Z:%<"']-Z)8/N M93`K][ZV@ST2BM,;F'V MH5^*M1JEGEEO&:0(5I:22N"DRX.SY?9*90FH!#QZ]7QRY%9F1ZJ&)U:5"D&8Z"P9CS*TT=6U/:B`I.79J MLU:6@$K`(]FHTFRT1/^\W6B$6I6?DC1)FFH;??!V_%2'CCO;59'/-Z`.T5.U M)T]+5WH8:O+\8Y6G:KLKG016K37+M*3]61D;H'91B)(N25<5Z-K:'JU\-.SE MXJS8]8N)JDY""*VY5:'=MP*3WM2J:TM5!R:MV:NN65X=F/1F]Y5@DE;G(6A[ M29>DJPIT;6UU5OP4="V;LS[GF]51@-+J7-?JK&[.@NK`)*W.-;FI4STO8VEU MUD;;2[HD756@*R--^,>X?"/]-73NTPZQ8!+SAE2#>&6!M_G7*U-U\&'-ZW@E M>ST M2WTHU_'0KETL0)Z6H(0QEHZ*5V2$)J&+`0LB&^8@CL>/*^C"LW^WO1F\F@+6 M(KRL.E2C_9QC!L$$:_-$L-V=3YY[Q>M_P>X$G M$X;"/\RR:N@X)KW9F_]!\!YQ$$@Q[,6EZMEVQ)>IYT?SJR@M+9JLHL+P^FQ@ M@VS$QY]X0UB;_#AY%)=1.!N,177GL*G\9E-%\I3WL><^8U[^3353VSQ]]L&? MN4-Z8PQ+F+]6'/6R`JA9N2!*2\>S`E3P+Z*`V>$,F)POG`F+QOZ0UQL6+P/Z ML43AX]I5U>"%=7WSY7]OV!W6"?[.IGZ`HRFI%WPXA8!/T[.23ZA`L/*Y`$"Y M\("_)GPZ"=5^@F^EY0DJ97LP\&=\*4]]UQDX96H@Y(2"L`D8+YMN`UL3Y_JP M*H8L'`1.G_/^)@*J58UWT MI.,^:0O`=QKX(R?"NNK`:J$R"OP),9GCS4BK3[$Z$>FW/H/6XA@2E"',"_D< ML4?\#&M[B))LX(B%"$++GB`K\WK9:EI'/7DA^8:O;%6Y0S6#ZQHL`"I.'X:, MM!W::"!+08<%=XSJP/>!_!&I0NQ)B(;(?L2RRHV8E:Z)O,;[IO+-]L`TH"]) M)N2?@/=3GD/I1B-#.1[$RY&Z06@"WT6-._6Q&?%EZ`RQQCPV-,'G0>CAY$WL MGR168/`A@1BP.SL@J8_3#K+0'R2"."Y\CDWZ\'.`4MT'O7GRV^'L\G$#J!7-3'XA**"21D";2#CU9BW20.',Q=7Q9/2CX51C%6NN/;[ M#\LAV7<9[9:U]S+::1FXI66T6Y4NH]VJ2AGM9YS;[;Y@<7N+8;2Z]:?!VN;E MBM#0UNM/0\>L/PTMK?XT[)B7EDG.%RM"[OD/@3W]V.#_S@OA.?TL=&Q.[PHM MJQLF_K4J)&FY]J0]RWQM[T7'2V4*]^;T^]7U]?G9]Q]?SU4:5!;+!9LB<5;) MX7X3E6KQU(H%M#U8!LS;`.-ZUG>YMVL:@77#!A&8P1*<[_;0\5W_[BF/SR>Q MD\Q_F]DP2N1N^/X[*B!W#=OQB3U@LP@V5>XB_"1\IWXP]6&SR?(0X0[\BO;I M$J)3WZ.6Z<[AM>%XIK&R51Z:99YKW7G'M>[Z?FMZXK<6L'OFS?96F'8->'?F MOJ+OWT.&=Z&W-57?M2_102)E6J:J=W>IH:JN]8R^^@P2JK:M="=0: M7>PKL=!!@M4V6VI7>R5!M;5ML7%VU7U;%J=^&/$+K*`.ID4EN/RHVU6[K;VP MX/O:8V-J/;73V8O)57]P+$NUC!W[;!\(-C50@A*G*K2^_EHS5XN,.S06E$M5XB1Q>@W1WU.-7:=*DV:6Y*&J6P^5 M.UTX`YNM;8C*'2[<+(QF/M)+8)!F1%E?>GH+=5J5\[%KSH`62": M*A@E][;VB[7+Q"[IDG1)NB1=6^PC^<>J5'`H4UEQ#I\%>T+>C\P&6T1$9H/= M=/54*W.DS`9;#1ID-MB*T'``V6!E1MO#SVC;:>TMH6W6&OKC'\H+Y:S.;HL# ME,EM2P"7R6TS8,CDMDO`D M!DPR!_`:$,DC1NFIK/ZGFWM39 ME$Q-+A>LQ$GB5)G6)4X2I]?Q3E"UKMS+5`6;K6VMRIU0R13NNW!&[LD$W,L! MZE37^[\2`)FOE5GZU5M?EX-TN<26Y[B7*VQ%#8"NK`&PJ@9`1WLEB)885M31 MFTE86*ODU9(F29.D2=+TUFA:HJUJ>^4BD_9O;3Z!B;F?DH('!I2EJ_I^''L. M#"B]I_:LZNY[JP-41[4J?#Y0'9Q:JMFK[CE!=7#"\K#&?LI`'$9Q@TY7M7K5 M"VI_6V<%M4M2+NF2=$FZ)%V2KCE-QC_*H@VR:$,N`V2&XV31AHW-5UFT019M MJ!(-AU"T018\./R"![IN[:CBP8WSF*MWH)25.-!ZJTLA=M6?)_.&KNVBW6ZIFR>3] M:_@U6):J&_+"?@VDC(YJ:-6-#:D.4C4(*:T.6+IJM%JJ^5I.6%O;%Y4+HY1I MZ9_A9*-WNFK;W(O'9/VCF]N:KO9D^K-R<'J6:NBRH$%-]:#$J0JMK[O6NAU+ M[;1E3BN9;UTN58F3Q.GMX'2D@PUJRC2SDHGJQD1;VP^5.V"0F<2W8,%.6VV9 MRQ5.[;&1IL&Z/&3UU):NULQ$GB5)G6)4Z[592MMFIUY3E,5;#9VH:HW/&"3`.]`U9L&7LQ M90\'(*O"R8PJ`5!')A)?P4&JH5?7&[(2$+75=H5=:RL!D6ZH;>V59/42VX$Z M>C/9BVJ5\5/2)&F2-$F:9%9@F15X0W,,3-:>#)];W8714\VV!&H-H%JJ_EJY M-VL%E-Y6NUIUMT+5`>K(ZJG=ZEWF5P>@;DM]M:,9N6&L:WI'29>D2](EZ=IB M(\D_RK2P,BVL3`M;J122,BUL-6B0:6$K0L,!I(65J6T//[5MN[VGS+996^B/ M?RA+SW&X%WS_>!QWU#P9N&YK:[NQE@=8?'-WJJ,9^[(?:@U,#12AQ MJD+K$J?="J6>U5/UULLF6=O:DJK@D99,+RV7JL1)XE2!UM>V1W5=U=HROZ9D M(HG302ZVK>VLRIU8R33<6[!@IZ7J^[D\K+VX/S)-5=/DH5XY-IIJF'NY2JT_ M-B#5K8Y,;5^*31M384GS4II-6_"0H;?5EE&S]*(5/)Z2*+T*D:IKIJ6--BK@LW6ME;ECJAD*O<=L*)E&I4EH1(`F?LY=#@<@#KMZCIJ M5P(@8S].'X<#D%7=F(A*X--6S?UX>AX.1%W5,&7:P@VA?;:92N7=$FZ M)%V2+DG7G";C'_=6O6%O5176J:0@CB=.OEY\@6]S2?V+&8Z_7ER>8W;CVW_? MJI=7-[^=G)TKF$OZZOO'AICFAH(*'LR%IG9]V^#)FF'&VG]N*-3#QP8.KY&K M-C!.+`1J*V&9?(+H.+7YX=@>,DPE31\:B942IZ$D7%URG[`'T<>&^)"Q M+(91X<0F!O.XM^D)3:E#QC#*]/4L:VNQ!XCBA(KC#=S9$'C,\91A23B3@IDX M_07NNJHR]A_8/?P6C:$M>^+/H'/XQ!Y%JZ/`G\"/C/J?1;Q[8/#X-.J:GT:% M,`P8#KT[H22RT*FGV/!:)O=EWPZ=L*F4@)0NM:%;OCHVK.\Q)QUV\ND6@!CY MKNL_((J\6`=`[GL#QV5A$93(SY,/&/D3QB&%'V`F9MB,F!9X4NFSD1^P^,'( M?H1&CV!BH[$_"V$BP_9!WRD-RU;LBU73*%OLR_1@45;F"G[5/Q]W M:\G07)&/^W8<,+91M0\:?K]MDP3789_M\D.,N\OLV"/N)DI^!S[:H?W M>L;^KPYY%U9;[6@[=FLX2*`Z7=7J[=BMX2"!ZK;43F_'KNL'"=1>;NW716IK M1;#3Z,D=J8&%I^2C0Z(;:UO8B MR.J/S1X"N59`E:FI+EU*L'!L+ MENJ.$SD>"C:&KK9:.T[D>##8=-3VKB/B]RWB*VB]7^"9&@LC:;-O:K._,//5 M!IC6KE,6'PHPNJI):!9!8[1?5L\=IKF>2'/NX":%^9IG@FIG/[O%PX&HJ^TX M?]6A`62IFK67;K598)29.DJ0)A20>TV7]&?$0- MC,CJW"Z;L,F3U_!K=-'6U,ZN,Z`<)%`M2VWU)%!K6)>:I9J[SNPA[N M'\X"=LL>HT^N/_CYMS_^05'^&K]PZD\F3H3OA"?>\)1,S#OF#1P6EKQ+-BC\ M\9V-/C;.T%/['\9_;L\:?R-4*1Q4`(L2]Q@E\@=N]-+?(WOBN$\??KE%H)5+ M]J!\]R>V]XM*R*N`C#/Z2U:F9L5S9OZ>'3[;QP^75[?GRAE-*97SR$!`#A,Y M$)9ZHD]W,"0'/WQE=[;+NW+VU-4>PKYY5#MYE).CR7#B>$X8!4E$/`;)#YGK MW+/@"?\FMK?=Z"D)B!\S^',\L&$'`\W8CAO"J.\\6!L#&YH-G/!GB&^ZCMUW M7"=Z:BJ?*?S>P#_N'W>SMP_!G,ZX#OEG"< M`]=V)O`1&L>]5!+.#\]`7X'B3YPPI*>A8P>^8Y.IZS\QS`W@L>C!#WZB!_V] M,V0!?X%2"4QM6'$L;"H7'C7G^<'$QCP+LR!DV%1_!OVQ,,R/-V`#!@"%\`'7 M;"C"Q3&6W@?P;`PO2_,5X!)!>F"[!]TCQSK>O>_>X_-3>(V^>AC[T".!ZN`& M$7^,`>\_97MO*C>SP3C3FC\8V$B[[;I/RAV,"Z>`D`9:I@'".`#`,8"`A?Q! MP.0.!";#;`?I0(D*Z*\,^#O;\<(HAP*@B$C/P=M4OM'/Q$LA*VM.`%@D#:!B M/Y$5P@@X";A.&=H3@("_BV/D&^>`_3YSX-_LJT`N0#(+4VSXVV&_I9EO0YJU`O`Q8`TWM(2I@PJ0K<'CEWJ0=70FC* M&`A6YA``GXK92XFG*65%?PH+DR_)=,WFV7!L$Y(8GC^$#Y@O`\B-QC:L;4#' M'@),0"]/X(#9,=(QJO$`@3(@`X;`92F]/+:!A_J,>?CKQ'Z"S_100,PQSPDJ MT0(S`USL`&O2\&<1'6XX2)O?)S6#3P7,#H$#^\"J+`1)@#\0P\12J0^RAR5T M8%-`F>_.8OD4(O.7@_W@N,#9OB#`AJ%'L/2`B^PA4`^%>X'L*9&Y%(2>?M+W&N$94S)*Q9#P'R?,1H%MB40<3CF4@" MT!'!L+E'+<3]PL%VF`4#X(=8^=5$(UUYRM]G[E,^YM;0M&YA@OH^P(CSP%/# M^"##[2D*'&1((`0Q"!(,E*D+<\)YT9Y%8S\`$H9%:9$\/9OBG^^@VW0<8/.X M@N%HV?%\@0$;V[>,IB/%%/MMMMJ2VOQ*0ECFRME]AR#T:!`Z-ZA*(EX,B1\Y9UN MMILE#'O$4QXAH_8#_R=@C\T)X^B],IP%I(V@PR=F![C!`11L"2@/R-QZ9UI-LZ=,T6JB7U"IE-/?MK8C M?XI6V7!^X7+">\D"/('!N>G/'?ZS*L3+@QURBYGT;*JQYG@/'\3H'9PD5NB[%NA3K M.2G8Z1JJI6G/D8$9Z6,).@-.X$#O"IQOS/S3> MDPP"UKZ'OP+8.OMS6R!]7E&"S*<3CZ%H.`,TM&C#MEU7Y_-NI MFE)PX0V:]-LI#@[:OQ9'0\K-D\>".V@\\_37KZ=`E7_'2&L1.M`JO8?-*HW2 M<8B6X\,8/)[(4QA;":0>L\<^Z5X^!BTYA<'=_VP0\7.ITFZ;"U`1AU_P`43/ MQ![@F8G'1FAA%$Y MXM2);)?/8$;IB\/,S&D:'K?@H M.Q%'$M#;R^'+CJ7,"3'N?/(QKBR`L2.7Q=.!]!81YZ>IR1%;3F",T93XQP7@&>>>1+8E\@8>J M`7)59#_F.A9'B0[E+DX/?X7AS0V*0F@".:WP#/>#B!G8!K`45VEB`\J;WRYM= M%_.KYB%S/IS#@]'3=W9'`_2B2Z1CT67RMY,OYU^_GEPJOYV??+W]3;DY__[/ MB]/S&^7B\O2OORYJKMC9*:INV[T`T?[X/^QI86_D?:#W+%W/MEUX.VW\S!_, MD/[;I^EB"G3M^!^\M>SC\XUVZ: M^'.)Q\)-9$>S<&$?_V%A;II*WR[V\=EQ67`*G=_YP6)&^&H'=V@`I"Y M2P.T[``4N1O"5Y>?&\K,<_@#?,O=^)MIFEW=M-JYF5K2"Q_1Y,[U M/IS1YD'(Q5.\:04Y>'['_ MPM1._FNT#;/3;9F9D?^XP55K]MIZ!Z3!7W_=="R[HP#G M?`B]EJ6WT==\&A%;'-/(8+&D^/PY:5/R1+;K7S%:N M^_E6"SRP78>=KF9AA]E)7]S9=8`&?_1T#99G!,R*C#K%*0%,GC';6L\T\LMA M60<%NN]MQT6._.P'-[!6;MA@%M#>\-)'WYWGP6'I7=W*H[%&/ZOY<9LQ&9U6 M9R5'+AI,AGVV&H/9,1:QY:*NO_C^D';9F\^"T;8Z>>$=-Y;OXL(#"^+.@=E) M@#B/CZ6>WWVK9VGY1;A./^6B^=I^0N9Y]OHTK':K52J3\RW/]1[`!O1K>F#R M?`&AZY9>'$!YXQDCB.]*W5-RIMH6`[UE]CKMU*19TGAF",2AXM%=`-%M=S0K M'<3RYO/3L8ON33`="J;4NMT^@>CZX8FC/!`:USX_X-Q*(NB&WFD;I>-9H[^L MO2RDV2G\YZ36:8:XK017V\P:PQOTM7`*GR'/VCKL+!;-W1+S]YEV)NA4P^HL M-GY+3$GZ?NR[Z'1[3I<]%_$9_C5NK7WO)`)#M3^C8Z%;'W'",V'?=>&1)(O) MQD/MM;5XAG8[E#QY_P(CVN:'5M\Q6F23/6Z)@L"UF!WRLN;G)/-L,J,[)&(] M/#<,V!CV7\X]X]&^7_T0%&%=RJN M"38>5MOLFNT\2RYHN[@G0R'"AN=VX`&8888:6,S.P'D&S[5QHZ,5MF&KNBG@ M@@7OT#T71-V9/^M'HYD[OUEZOL9K%[':I+]%N]K,#NKY(S.T=J>]8`L[WT&) M,9H^ON76Q="Z9G?>*%W0_AJ@[';CL**+XGCNF3=;[TRK8)_!AKG5+?3,&\MW MP:\<3NV`705WMB<\.^*SG^(&;JV^K0ZHF7S?*WLIAI^%(';0A`YO0.)O/H26 MU2GL%`I-%O=F:79<^,PO[$!JGV22Y&X^"-TR"KOV=?J9V\J0WA)0/0.)KE7< MLV0;+/86LR37`*4*?*UNNX4#K44M9RWS^.`15D/RF3_];.K;7:W;-3+F^O.M<./E&WDF+CH6 M6X\XK5.0N2\XW#*A*0IJD'LW7L[0[_)J M-'?[\LD.G<%&X\[<\Q3.[S;JCLOOYE:?\!=35MGP(MZS0\YMA9A M-NC)M9`T\@P0OPM:I*FUTX&5MKV\>S'H;0;06CP`T?KZ=DO)3591;;9['5W? ME^VRLO^>U=,+1ZN[-U]6HP`(%*S]O9@P*P=B=-IS!\U[L&)6`V*T>_NQ9%9W M32=:+V'-K!Z*V6Y9FEY;BV8U@9I%!S\ULVI6TF699KMH$F]MV*SLM:WU"B=^ M+V/;K!S8L='J5=.\63;TC,%@]2IDX:PU9LLRK54_^.@@-E"Q9B%BX#Y9DN6*QX;V>&X*$B>)W=AQUZR(A=T,2:V[3^XS>5U$P?XSZ/.O)LHIWQJM[6C6V MO)\6/\]\'IJM=J=X/+1.9^N")VYAT3:NT$Z!I[>C&O2#O,#19\I6*$B>&OXZ>E' MB.?BNQ(6L&70NWFAMGZ/13%/X4KAK7_"(YH6NB0]3TSH[6Y1`:S;X8J!;FN0 M]]HMO;5\:`L-:!CS@+$A6=SH)?7-CM!+ZHF"!%R7\5#OJ]&V8P1KK&!./J/G MM5B3/[\+/68:9F<=UBSIL7S&0<^E27JN1AG/ZF>-L&-91J=TWA=WM'CV+T*, MU2B`PGP:G,Q^`N)LT..&J-#AF:W=I<#@5 MQGII<$3<[\$EP=EIRIMP@XPW`M!GYKO945CI&D*02TW7\7Y^B`.AOL(?RB-] M%?BX.L=1-/WPZZ\/#P_-QW[@-OW@[E=#T\Q?\>=?\<&&>#YZFL+ST#8E+6M0 MXW'ST)MX:AR@Q/U320!9MP.[?2-NS;7[S`71O'ZHU5P3?$`46NX'#>77W(CB MWO/=)6,R]*ZFM\U.8P,PXI?S_6-Z3&`0_';B0C_>'8#D'?^X:?R-^V#">@B% MH3E!2OAMDZA$RG.IJ;##(49]1Y7@DW03L%(94T`:8$9;GBL.TQ0H(DUCC][A M:0KH;5XLG7^FXN!)2Z'SN%X[0,Z41VZ[3\V__IK#LA3@DV"@8`K4X&-#;VHQ M-G8P6`&I>.+7$2SGXR*TN+2W9`Y_R6SSF8,1%+EF#3ZF0ZO.-FR<;V$M+JX* MR(6A[POC)-AT"UF1;Z)6*!?'OB>8TW#89\-<;*).,,^-?2.8"Z(1]>K?4#WC MD)T/^/_PY_\/4$L#!!0````(`/1<_CR#;Y?H.0H``+"&```5`!P`;6=L;BTR M,#$P,#8S,%]C86PN>&UL550)``,\\E),//)23'5X"P`!!"4.```$.0$``.U= M47/C*!)^OZK]#S[OL^,XN9N]I)+;CO:Z"!AKGX\36..L^04(23R^[@Z+C;@4F`0Y3, M+KM?QKWA>'1ST_WQW]_][>+OO5[G)YA``A@,.Y-EYSK]'V(T[?SZ"TC"SM7Q MX.1#I]<3HA%*?I\`"CN\](1>=N>,+<[[_9>7EZ/7"8F.,)GU3XZ/3_LKP6XN M>1[/HF1#/`8S&$4@F4,0L?E1@&.N.#@^_G!ZO-(1):**;Z"$,I`$;]]X%1_= MD'\YS:0'9V=G_>SMFRA%,D%>[*#_Z]WM.)C#&/36/D#1.WN(`L`S36ML[ M2@GQ6V\EUA./>H.3WNG@Z)6&78YSIW-!<`0?X;0C?GYYO*G#3HCUKT`DJCN> M0\AXG<4'SN<$3B^[`O[>"E_QE>]ELFRY@)==BN)%Q&WNVU=DS+@KQ3!A]],; M[G0QK*N-4J&Q*HT`G5]'^(76565+4%J%`$1!&F6><,N%"E'Q);O:Y!^!KPPF M(2Q\@'\FPL%&=8NB&7C%"8X1I+ECI;2?TMX,@(7PK[,^C-C;$^%>9[WC0>%> MWQ>/?Q-5&":A^/'I_REZ!A&'GSY`@G#(.2"0N^9'F/]N,7B&9S5OR2EP)(L.5!FQU'(=&G:1QGI?80;S^7'`F=<;YLS%L9S0.`5]YUP MA.,%3&AF9XF):B$S-O[A(1LZ]CECY)[-(?F,DX#;D8^>3^#UTZNH5KGGUA$U M8^>?'K*C;Z4SCLH=[TWRR)LP00$/N;-@`)/Z<6FW0LQX_;#.:\\38IL`H$7* MAT&`4SX6/\(`\G%Y$I6;IXF*&9T_'`:==>:V2%[6J;P;1"ED]>VS2LF,P'\= M!H'U!GO0_A[`4K@6#Y+Y$Y+"\!:!"8KTNER30LPH/O-P*&W"_FK&MV?@XHF$ MO3L8(@[<*`(H7OMZYG'%.Q,>[8HSG.@='P2ENT#A38\\`@O$0/09EF>%YHJ& M)`\.L6M66>V,SX]P06"`,JOYOR.8P4:>"%>@RR%MKM<-%WJ78!Z)/>!AP MPPCD5>4.R98/$4@8-UF8NQ`B6XN_IHH6+5K1WSL;]*MXTF_ADE*R%FZ.(+;' MO3V/NDHI2B"?FE*.S_TT:TKYF[#.IS14FXLBOE*OTL%0YE?:V+?G63D$V;,Z M3Y*(6FQ2?5N>(\-,YBE*;%T&G`&$(;WFX(WYV'P'6$H06XHA&T<1#`0>5"0[ M*!W&OH3W$-:Z!/,-NI9G0OMUQ!V0Q`T0T78P?8T2D`06P72%HD\[\@T'T[56 M.^/S$2Z*OO%^>HN3V1,D\4!0PR8J(4@=X81']"EW MDV)AF\?:5W"*Q32Q2`V#]`XE6(3DJ]S*H4BS7"\E=X4[R.8B)%1-VEKX<@%\ M&U_V:$-$Z9`;_@X-.$Y]OT-@.RL#FUSCJ] M_V1AW`@0'CW.0%+D.Q1UHMM92=KRS>U2-NZPQ@USP\_JM85[Z..$C4%UYAPC M3'DX_Q/&(1WCJ+S+J'CK<3J2"^)5J.`:P*S&I(^(P("-(7E&`13%TU7^XUL% M5UY4SDDSUVQNG^\@B;5!#.\`]%\9C3[NXSGQM*\G@W$56:Z\0L#O8YRQMQPW,-/E@70Y>'&39.I5[!!$Z1Y.1" ME=3&TI]:RJSY"QCC=>/_Q:EX@Z>!S&B M<.09(VB2,G'BY@F+(\M\NLU1C#(_E_8&>RJ]X&%?I7NTJ+=?`#<%/>9R& MGP7B$G-%E58F:]TMLWM!JT7`W0OR*=__H)VV`2YP6R]U;Z1%U MO2/H>Z_5*"5D^PB'])U/0T<)/5Q997?QAC1]<2M9UL<\;?]K4D(B5)WH=IB/J4H:5D1M\0 M9S2,YSSL$!FYZ@R<*A&?DB&5L-<;X'`]>PIY_4(>5N7553J]AJ1/MXHIP=>V MP^V\JBIF4@OL<-^7.\3KJN\R@U=^:G5[ZUY'U+_!M[1IG6H1?K""XJB$KKEQ_[UXNN`RFOK[F2\\`16+*<(VSHQ3O9^:4O8J. MRF\GI75+D^]83+H6!&5IC9Q.=\Q*5F1S";&0:F0P-D;5K9>LW2G'8Y#L;-X< M1QQ^*CTRI2O>PJ*F^M[!W:\0W&NOHHTIKC"E#8>13X;4`IZ"KL"WW:E0Z8;/ MZG4NN9"G<%:K3EKQA9&XQVP\JR_M^KH M=X@?6^CA39S!S'SMSKRMG?"MF7H#F<7-%EJ0TG"A!^&7U4LIUW#"0 M>#_4.-RO+8;ZS`I9VE2%A,=GJO?2"#>=JN6\OA<]R&Y2QW*6),(A]F] M8HH`PT^`)-P6.@R"-!;`P)#/1U&P=:Y/7\'C`]R'Y%(&@&-S>IPYVB^`$)!D MRQJ/@E5ZGS+Q/]0+1$HNIB/J\3+>(3F7%M38A!*7^TTKS]8Y7+6]"V6CW=QQ M]6_:[6S1QSL2Y\PYG\31O90LE6&[6L`B<P$ M4,A_^1-02P,$%`````@`]%S^/!":"#```'+X``!4`'`!M9VQN+3(P,3`P M-C,P7V1E9BYX;6Q55`D``SSR4DP\\E),=7@+``$$)0X```0Y`0``[5U=;^,V M%GU?8/^#-WWV.)EI9YM@LD4F'X6!S-A(,FW?!K1$VVQE,26IQ.FO7U*2$ULF M*9*6*,;(0Y#$NI3N/>>(O/STIU^6BZ3W``E%.#T].'IW>-"#:81CE,Y.#[[= M]L]NSX?#@U_^]^]_??I/O]_[%::0``;CWN2I=Y7]B1C->G_\#M*X]_GPZ/W' M7K\O3!.4_C4!%/;XW5-Z>C!G[/YD,'A\?'RWG)#D'2:SP?O#PP^#E>%!87FR MF"7IAOD"S&"2@'0.0<+F[R*\X`6/#@\_?CAA'CBR9S`Z>F!H**_PEH\]@>CPNSI M'IX>4+2X3S@J`W=7/X-$('L[AY#5>2:S;<61,2`\_CED*`*)C5?2@E(7`8E6 M7I9_KCOZK!*4LD&,%H/29A#C!4!I?P$7$T@V/5.(;/5R"'7]E#LLO4>33H(D M<71MK623#LWYO4B436"??PI340LZ.JBY4Z,TKV[>+\AR95IQFY9,TW69Y`_FDH$S\R(B3N^ M^'_2VS;N,=Q3X('U2'&//'-9O`+G>'&/4_XO/5LBI0AUM@TP;4>:IF*ND*AF MH#X@;X147+G8J+Y+(K0VW@E0M345]+488Z.@7M];\?VHPWK:64KU7DO%]+Y9 M,6TF`P9J6G-;I:=J9-X4Q?U8X#3/.;YLI-\E#\KK_E]G62>A0%__BN+:*+RA M?4<@H!EY4N.ML?"O^1T0KXW#&^9G<8P*`,8`Q`I"B=42D5>B,K#G[LF`.34+R!_SL@!/"&20JZ_*(5V#]U M#+8N!']U3A1EBRP1`]8C-H=$^$O@7&00#W"8\FX_E-<_MN6LJ/G8=5WD%IW' M[+HZ\L*=2C(Q)S'&)`>3,8(F&1,=MCO\%:>BA\]QX?[,AKRO3R!E%4J;O6G9 MO6_XI@$E%HV,;#0*#FX';G^JG@/^]"&E&8RKVI1<6BE,=BF@E+^5UVI36TT\ M(->C#$JL@]AC;OQG1IEX@^@=5J2*N9MB-C`6]36OK/-)QAO(,:&(P5M('E`$ MQY`@'-_`",\*!'\#258=@_7UN)).;X\+J!%NH/[T!AOV39'?3*)XLR\R(JJ, MW+O>7BXAB1#=KIA=RUM)\;_!2]$=![PSB%V+I6@>=E"+P0V":]&= MZ%(TWC;WTHC-!$:UVHQ)\#<&"9:?8=H:\Z\PH;\95,K(J$](T0LOILE0` M#F!U3;Z^$K$K%%(-8D>%7X.5T"B,VF@X%)"`Y MBPN:1M.KX=C8V1>RJE^!%8Q5[=0V($5;=B*6HR%:^Z30BMY1)0V$94(/C(/YU MB9@4WQ*-`I6J5G3@>9/(5\B*.>EK3*MIAO1:2,LD&GC;Y3%B;?#>R%&M'Q`N M\*D[O?J`2T@1M950ZMIZ,["Z@!1'!SN*Y)\]-@ M<[-.$QMXU#L!7\M^G=7*DE>^H:<2QJZ[?=ZV][3+['D"*"TWO>DV,:CLJGPK M[1RHMV/1=;^/AM'<<(--97C8&`-_/?,U-Z1[/-0&)2@:@];I--P]5*-+*:W5 M,GF'7!TJK@ M$7$04+T\%(8A-0;6J&^+PO06%6&HP,'F$/K<@X:SE-$Q>!+=R-*I"O%ZHT!) M5^&KI;E2*%]:I0\>F\'CDU"2P7@[IFU.]78A5>[MT%H3/S8&R:V/!6-QVAI/ M0]%"__H96(:T/K8%LDP0P!9`N76GQ!Q#^8C:U\O,.*2592W09@@"MH.KP\2H M-B%R(K;ES5XM$*LG,QP"<3J[@V1Q`2>,)W#EJMAK,>TWFB1HEF\14W'K4C:D MR?TV:'?"!.\$IO>W_>D*DV]I!(DXCD-,&Y>]0"KV[FJK`8N2)?0N)<-LZ7UV ML6S0PCN`[)0E7,`I)&)]$_]!3`25MVUK<2IUY%(TT`S"AQR$M'G5LTS:1!5[(,WCSFSIEM#J M*+#>*J2A_3:IV=9D"T\K]FGK\5:?Q=F1C*JG4JZ=SL?S:!2A:K5G7B"D"8:] M$)<%])+S1NN(\B:YU7YSWA;#Y'!RMF@ MUQ4X+2@(L7/L6R!V0!DO+^A(+%]0FN\]4[2QJLN68[PMGPOC60)*4'`=8/ZZ MDI1"WK>5C_W++X8TFNIINX0""*R'R#.)4O)"G&M18"8Y''+#\(6(;0(Z`IZ_ MO""=(9[O%6[P#O?ELDP*?\4X?D1)=:K"IDA(\Z@[D&85,G:!R!OA"E)W(J[E M[MP.Q,G(Z9B`O+M8RD*U`$UK$]+(T@[4Z&/$1B!X(VVU5.T.+)_?Z-KE@WKC MD$:C=Z#1,%AL!XO']6'X'A+V-$Y`*KHL(@6^%_G45UBEU<0TI-[B#J0:A8IM M(/&<2>KWSVIM0NH<[)QG:G;`&H#0#6DZLL+-*\VW=DCMMRA34M5]VJ+9:+<[ M65YRR0;(TH2+Z\'H-'&1\V=@&5[FV0"1)G$KLI=NJ;V=8\+$:.LP?8#E-U!4 MYPTU)N'EGPV0J0T8FP#BA`S;LI7T\0TI-55S;6()H%C&X`\ MKM?D8:"(P?@A-'OM8D1NV"R)HJVCR8?`_'X.63B.(Y-+][.*7_-YY17J]>W8\M;)3K@ M8\MW:VC?3C$/^Q3SQHZX?NV'FK^=;_UVOO7;^=9OYUN_G6^]5^=;GR4)?A3= M%=Y[NL#9A$VS9'LP3C&JZ5(VI%K`U])-)YSP3@!W,$RZ-B(OUXN):4AMNR=Y M&,&";>#S.Z?\XE?M['*-:4A3()[(-X(%V\#7[9NO'.TTM`YI4K/+]U\^UFD% MHL.MGB8T!&9$\]N++T,>0Y-\O6]:&0%BYXDH4E0%MGNIE!VI%(RF\< MSM@<$_3/UI=`FQF'M"RI$U$H@=D2@Q["3D4PI#0S$L"F84@+"#LDOP**@G@9 M=)V2KCZ(R-`ZI,UD'=*O.##("D1_0_LO0V&&28)%B9#.`?`D"!MTL`.870BC M)C$PL+0<8-HW)>AR`F/TNF->F@W46-DQOA]CBG60R-CN-`O8\D:=`IB8VG&^ M'P.%1KC(B.^^Z=\XW:MPJD*ZQL*.Z_T8%]3!43TM38:6?HW;IX$PG0`*^3__ M!U!+`P04````"`#T7/X\J5%B(,!&```JO`,`%0`<`&UG;&XM,C`Q,#`V,S!? M;&%B+GAM;%54"0`#//)23#SR4DQU>`L``00E#@``!#D!``#M?6MSY,:1[?<; MO7G^/CHZ8:)&7?[_-:HPH>EG_\=E]TZQ_>O'BRY=GJ M,,3<4$9>UDU6SK=E/+!"=^2_O.'2KW[\\<<7_->M:)VK!"GLJQ?_\>']]?P> MK[*C7@%U_E/-__B>S+.&]ZFU[4@KP?[KJ!4[8G\Z>O7ZZ,VK;Q_JQ3/:SPC] MH2(%_HB7B/WST\?S;7$<:%._V-1'=UFV?L%^?U%DM[AX4>([9D%:6P;]TWV% ME^I:%E4E]*0&J\$/1[02H@;_=P^H>5SC/SZK\]6ZH%WQ0M2/%_F>_BR%&)ZA M3T0UA05ZH/BAP>4"RT8S6#)75;_)'DA)5CFNO]WO``K_XPM<--N_L-;\>/3R M5=L:^>=?C^=SLBF;^B.>X_QS=EO@"]R<;*H*ETU;*]ZJ/SZ#B#9YPUH,$N5M M+1AS2-7V8-N'*%_0W]B_&6OXL%=%!PV0:1C<7M/L1>PVL,(UV532'VD]6:3! MY=&GZV?_UH*@#F6&*,X,2:0_B!KL],QQU7(AJ^:61DB)%W-"_77='.VT9UF1 ME9-1N?9/)@74$.30/\3)8*([:9,\N>),%1>FT#'EEM3X?2+"5#W"%+BN4584 MY`N+RFA)*K0@F]MFN2E0UBJ0)?K=J]F;?_D!L<&+_NOWW_\KRAIT2H%6M[A" M;U[-$`L1_/<_;4J,WKQD?WE%_Y_6:(WG3?X9%X]3I"1*S4DC)0>-U9O5IF"C MT&5SCZL3LEI7^!Z7-37-.9W'K/![4M>TGI?+FVP_-GIJ=Q'=2QL>Y%W@M7'? M"R1X*/#O&;.SM[B(`Z,=9"2@T7,&_@T?-YB7TQ+2N&@`E[8#B0O&CA][%4Y" M>0(<@0)\-`@#0N.&KGW,H]3@7":2RP7C\A/A+WHR!!YIN+K*'E=T ML*QOR/'\?S9YA=]NZKRDLQ4L:G:2U??RE\6>'_BH0H<:%VRU?WHAA`TR_AUB M\,H6E#%3*J,.=SND,.SV]T4"Y_1J:]\S70`ZK_0JE@1QPCR@!/B/?XMVS`?? M5AF>K%RASMDN4\T7*7GY&=>-('!>HML><4M!W#DC;C9QXGHQ:*P%R&+!#9`5 M5UF^."]/LG7>9,4>^2Q2[8+"(@5=.*AA-!,KBW#@0@#2(A/#M_J(`3!22X@4 M,R*0T>3,72W;F^!8P`C4(*`9-XB4(-D8,^AX)%A3@"-*@ODD28`&9\%80:[= M2GM'JE.YD7:X&:39(O?1;0.BERXT3+J`:X*G%T1@2/7O$Y./[6R6MKC;7<2= M[?B$._$!W)%QV06AYZ=>!9,P7H`B>X`G!B#$&`42\/9PD_\Y'2P6I"BR*LTF M2C!AT1-@[$BCT'5#EU=L/7"Y?)>7M+(Y'1V)6/\^B(LW@I`(< M:CQJ[JX8-JRX-]O@E2>7%]>7[\]/CV_.3M';X_?'%R=GZ/J7L[.;ZP1.Z&%T MZ7L0S<[EG,HA_AV=S,'X\O/M+5FSP'D^= M=&1ON^D`?0P$^IW2R]Q4P_S,H^TF1^/;.>5";$CV`&?L2W:+B3AH`L_S(8-P M/9!FYWIN!1$_0T/F8SXNXZ$98?XU$/'XAB+N`"?-,C0AFD5GV:^O_7GVZQL7 MIJUQE9,%'3 MH"&F?_]*0&<"FL?;X6:[Y^6\PEF-3['XYWG9+GBOLD>VVJ55IW^I-GCQ/L]N M\X).T7&]1^TP$&F40!#@!-FO%/7&9R!6V!0Z1G<9?+R%1\_;`KYAWYVV6Z&R M$!X&9#&H5TX"QX]".A$)_*"ZR!!8%1*)4)"Q*XJ_QX"*,)D?V`6V7%_WN)Y) MKA=/E>OH:9-])BB&(`_*2QL'BH\V.Y>\Q@'RJ)237F)IL0I/O$.9_')Q,O+-;LQ2]<[ M\A"'YHN/NZ)V^6!5]`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`'LG/29Y#49>H]`PPT_(N)-TP!ED MI)F,CP:,+*Y.Z>N-`PPB`=Q+/FQX\&_R(T/(D)"*=B-%?U8I^TT;BY3L5YL4 M,*!K8-01W"8<%K)!+3+X"(_,X]TY@YE-N(-&MJ._#8Q`30*)JS!:@F0C1,Y0 M&O!0>3.9H=J%%FAP7HP6^-85GN>\TUGNEA6IFOP?_#\/@I]5A[@1V5.'=C,F]H'VDZ(:O;O.0U ML8=?-R79J8Y*0'>!H:JG$(ZZ83,*G^:;CD5+.-3#&W'"X<4(X68PU<[A'(LB MGM:&3%:\G,='-4($C\R_@^?L_D3RLD%_P66S27/9)X!R:%J<&RGTGV45R\-< M7^&*WS0XS8M-!$:A%(#$5QDJ0;(2H&0')A"1J<)F.M!_-Z3>JL^+DBFW5]7LZ+#;MKQ>(T3R.RP0N9 MT8H.=8`=LTAP[U,XT+75E04B4-$/;LE"_,-25 M-AMSMS`N9>6V8B!H;X4=JWHD.AU!.YIQXTMDKM]1P[%W+)K'#[BY)XOS[K7U/8=RTG%(QFH'U:;`=E`-3L+JVG9S M$FPVT7W.\+X1N50%)!*8J`>:)I.J0^/V\F#;-7?2ISH41/P,;4V%[4Q\C\KO M&,4_&79$SDF"T144;A?<9(DVM(RR)D6^8-5`]>:VSA=Y5B5[!F$P/HP46/DZ M[6U6XP6[$HG+6O5!RBS4/MEJ%H(^TJI$40=4BVQ8!(4TQT!?KGYTR_11'R#% MRZL0:XEXJ!;M/:YJAB)`2T!FTR`B0D0A9O^,JUMBFOL&6O^"E$?\<3*>2X+M M#G6=BQ_8OZ>X:^U`!#0L$\*)H$DD8A..L`P*#01?&;!KDL0#W,]97K*A][(4 M2Q_^9>MR>[5'*.4TZZ,K4H@V1C[+I;VF*YL75Y<7[X_/SV^.3M% MUS?T'Q_.+FZNT>4[='YQBAZ-.'5=8I+?9`_VC7N( MZ`[=+:).G%=CF38@+1HQ^`]IH'V[D65W&N_;F8-5^WN+:H5]=[#`$B>+`9]= MA=(9KA!A<169+PEW`1V8@5)38[R8N?]B6'./J^VS8"`Z=Q\]^=*.2;:@J9;=#DVS_QFJ4K5^-:=J2C3.WX.7N0W^A94KDO>5$F$F!!%L^%(@:27]?"X7/`OR_>D6%`CBD-%]B2_(+7#E+\P M-??\J2ZM\%..EFG5H0M,>2/.C]^>OS^_.3^[1L<7;(O_\N3??[E\?WKV\?KW MZ.S/G\YO_C-MZF`71D@W@FHK4WK"RE,E^G2PP&0\GD;]-G^36W"A-7F.E$MQ9W)W$-P,RB-).2G&S(X=1 M2N1*AA!KRKRR1N,AB35^U#4'V(!8:@V;\2.D3S!,3TU;=%/RS4@MW_!DL]`P M0<<_ODS$5BC(6".Y_(>\)!6-..U";,_VNI]EP[4_`^/"OKXZ.&BEPB*$N?*V MH\=[0]G!PW`7A%VI:6@="K9EW1:2@*L6FPFR[@MUA-6J$ZL](''&0CBS4(2] M%V^KMXILHWA2ID0Q;3E2&+K`S4E6WU]5Y'.^P(NWCY]JO#@OW^5E5L[9Q\-Y MDW\6\R7U+H8_@.S+``!@L`MN8RA,6+@,[2#3Z4QVI6=9D"^UN`2[;#%1M@5- M\?)3,(FD0[KC="X;4`<2RU03='O%>L1=.;ZGJB1V;T-.%8WA]3!YNY@4TW0[>&S0H-R?$]UFA6:]%/Y9N"L<-/."K?0 MDYD5FAH+F!4JU'V<,L098\P*`:[CJ3[S=EIS(X&MJ+&".J%#W<S!%5X\?3(*?#T)&:G>,-$5V&4/4H%:5V<+U7=S#>^?5KG*V+O:Z9BN:,1>I.TD=NBJ4"3F#@>&1#U5]!)Q M`ING0<4K*9,Q&8I@,V^3:;)8:F0BG"+Z:C9ESR:.\&S\X>]$U_?L%-[GK&`9 MGZ]PE;,4T+OI"!0#@(\Z='QPP58O!;P0PD87_PZQ+='%0[[T7WJX,R20D2*Y M2B+_\&IPWWU<`#KG\BJ6!!$#$E)#W,D;(,(8.@AM>PD*ZNI('W MK4("+FOZ57"T_;&CWX$XT?89)-IIC*W^,<*4T=D2+`)50FEL8R`?:XSDQ)?5 M75;*-\)/MH^:B/?#KVAWTZB3B6R_\J!35FR3HP*>$QL*7O;W8/#`X!2[?'60 M&ZR4L&`Y;.>;,A#U"IZAG:+Y1*-?.$O8O2T>=>6/F--U8)\0,2AV(5TH&ZSZ M9'"^0P:Z@0/BL(5$&'A'\^J?<8FKK/BM."#ZZH&33P5\DJUSNE:F4\<]+W57 M[%*KNRI&RB7<(?OE$U;H#YM36-<5L?(*\ZE`[\HXSXLY@8RP6NZ(N`%7AR<= M5A0)3D2KX`4PU;N?Z_FJITA%[$%9#C!]UJ'ITFZLA3&K#GL[K,+WN*SSS[C[ MA$-K=;F\R1Y`F[WA0.UB-QP(NJSU+DFS@`W'"URJ1NHZ:UK.,``>5M5)9V`'/FBLEY<>D4335C.(1>W)IF)'#U6^HA3HNX=:P,4C=A`,7J"6BS"%,S3! MRO/V=0RIG8K<)K/TIE8[8GL,5D,00)>#IS@F=MG$(':U/G4>;-ZY[#KQ&@5Z MSM)S5?F<+O71`O,W2VLV^?[=JW^9???]O_+-H=^]?CG[XRI6CRU95_Z:@/CIR.\.KCZ@H1%WJ">,?AMBRON(CYO MH=&25-_(/=V1\B:%,4EXI2-&Y[&^A9-0ED`&BS`/#<*(,'$>BLFI-GEC\!(] M&6*..=O^N)T]6.?=%M'^#-PFZC(7UV`99N4VC0CS5ZB!2F*K$JWR>C"%I2:+F-- MY=GV"3\OPBMW16CE<)-7_(C(6USB90XY+A4*TT[N0V&@LWS/8#MCB>:/K^XR2Y'C3W),J_T=W6FF[ MTP41WFYL@83!^U@F--VV%4@G=)<*WDSCII2$$4]PS9!`0AU4DG6^@WW;[2:3 M2G\1#X(FCK:#[1TY4-Q%)M1X:6"',E8.0X\)?(9E%<5C]"(K-G=/W'!ZDM655F:9"Z> M7$/CDVT"<5Q4A_YEL>$GF,0W`D,<-RLHXKA%P2..JQ'M<=RB%R^.0YH,]K,V M=G=P\NMG8M<"&?XPC*O5U)YE*4+I61:CNH9QD#^XJD4.XU'I54MZ91/G%!J? M5..%ZS6NFD>V]]\B[:+PX*S%TH9ENT9P0`8VT.PK M'&3&O[PT?&JS!4IU<]S!JMOXJU78<1([+'&R&##:0ND,5X@38>/QA1,%=T0I MITD4E)HI8X50>:KPAAS/:6TJ+%[>X7_;#Z$`47!<-&!IXB)$(S`N@AMHXGE[ M*)MR1,*@'DX*KD.:L1,4#0H]JD-@B9.YS$'1@9KP&L9(>A&')_3O]YG8),BG MQP^0(:<2L[1QU1;!K(KME-!=T3<0:I&!8=&N'SE(`KO",63N32]GN_/+,;P$ MRA5-3-6J&R*LO4B]F]IY`)J2^KJ:K_H@\3F,-E<9K=--E94U>X:)E(`3E1Z:VSS>[IK@5-]@:%TV<'>`T(3A MGKUAO-;`,1$'17W4$<]!^Q-&.*^#?C]KMGNA)(0,L$SHOD[GK1\EGWI\HI[0 M6)CE)>+8#.P^7XNO@GH*/P&JHDES=;2A9BU'P\OE>U+>W>!J=8IO&_Y&!9]- M7./YIE+=^O51A0\9<&S=F.&!$#IH^':(<=1H0=D:G,$>T9"P0@QXUOOO=N[W MGF>FNKPM\COAO#/Y[)#XN:M!$H_UZ)#=T04.T'=9CV))$'',`TR`D_FW*,8: M91!&;Q?2I$3%EK\+"BN?$Q),+3B124?DJ1+6BSDC;TJ](Q6MK=SD-6* ME/RD1S3O(0'TXNP=09L,H?J2L.OOZ]YNJH`3)Z<3KM$!C5)M M$.G5#I?D@"(.EN(`H\*VX<'$=JUSS"V?F,RBW9_)W_4;;LV.SG@?74WFZ^^&F#9]-.\+H)M1](Z)PZ MH&=@.28,3W.F2T\2QI]VMNR$T9\P^Q5.0KD!VY<)\1MG=$)G7&*F?NH-3D M&2VDLH\9>'&6526-[O7Q?+Y9;?B^_"E>YO/\,+!"%;;A%:P`#K(V1%VH!>N% M!ERW)AO#KH!"+19ZWD-#$BZ-"SD:O@W"-K6^-X&+(!Y&A85E1W]P58L2HN/3 M"TNLZ1()C<^DD6+T]?P>+S;LS@ZK!ZVA3.3$TV5U'TMKW1=X;WW9__[ZP(`> MVL!`E`@N&=A%$\J-%DH6Z:S.,)WO^M>`1#+'")[-EM7M6[-_WF1%OGSD::'G M9%-"D@5&0#KP=G\D9[]W+DH]PXL!&#;UB]9[IM65+(-]*-N6PO=HNW)06]"( MI^?B<5($E0`\573QKY0BSOCS#3(KC1SRL="B$^M@4-/H:M80[+Y>D6O%`-F%JH4EP M:ZP(SCXXL!.%^OO%)I$V1IM$H$%9@:&)PB;)P+!K;0CLXTW:2^\`"\DHJA#L M4=L$0T"]#PJ,=LK9!2%FMKXB&KUR]GW M__K]9)^3!),*#<6JL4)B?E?FRWS.+FV*&3>-V%>DR.>Y8:O82:D-FVY*T$`* M0M6$5C?=P&#KT7R30W9PJ,-#+6#RF:X/(V28!JGV7,RM*.)I;5!P]W$>']48 M<]_(_-NL5EGUR"*]A8K39A^:%OW&&@6:K.&/OUPNV9&^=P7Y4A_?TJ$]F^]_ MR8:(MA$?(@J-\_`:PA4"(SJX>:9[PI<7UY?OST^/;\Y.T?4-_<>'LXN;:W3Y M#IT<7_^"WKV__&N2'4>X65O',6CTW`6"2]R[=`S7X#"5`8@&3:0`5IB&KCDJ7&!\E,"=X!81U)?*=K1W(Q$'#IH'/KN,X7,U;][ MT5&]^33$._-^3X6G?T=>W[]]TFF>_[:\]^W_'KS]`7C_%]])DQ7Z`=;/;C<, M%.V&C]W!OH MO$0M5B(&FJJ^PT.%8,=&$PH!]U+:-9!X_NYT4[']0USE9"&>Q=NIYD>`ASQYAB[)2E>A$SRJ3240_W5E!/. MWK+*KPXDEI&2>?U?Y3-RQ^7B8WYWW]27FZ9NLG)!Z[S'?8BHM`)(%.BS)BSU M[!>D$3:XP1MH<+<61&3NY#"HAY/`W1Q,*AS+I-!Y$`B6.)D+,L=VX#)<(4+$ MCDL6,FV&H-04&2MP8E81O#C^C*OL#E]LV-3MV@>F^S.I_#1C2SKGD\L^B&C69J<*>QS`(QR$@&Z9-X MXQ@''\^[0>0QCF%J!*MC6PJVN;6%&`&C%\@5`Q"&&[EB$==EW+KEQI[>J.7` M:]V8-25BCS1:]3(2:S^D:&6@HX>U$+-4V!A@J3WP`TJBCR;ZRN[P^4"LXZP> M@0![)/FVJ99X:@'7/4\#Y=0B<78U',#"<"]D_4J`[2^!Q!,30]=$/?3B>]ACA ME(?I>`?4""-Y9G>]\KRD4U!\7M*),?W+GH%M8K+E5C&@@^MPU"YOE0X+`K!& M&7C9`2"!,$,M1@*:`DTG2*L3[EALA2-@LT#"#9"?,.&=SO1\7"4"&V27YEQ_ M:@Q`*2@P4K`[Q4M<57AQDSV(H'N!FPO:;\KSC#!AV7=`86#X,Z.I@R!0)RP4 MNC33X`(M#*(XJ#U;2Z'H_VW!$OB%DX6%=YA5.AY]!'#KO,)INOL* M<'OJ`^G!27@(J-$A?.XXP#D,EA\H+])+,V1.+8?^E31=QDM\7^(WKJ'_>3/^S^Z)KE056N2212W@9% MI8UWOZ4:^AM73$)34^<+;NZ**%(I[*H>YDQ0]$)ZYK4NFO*43>,_S[--_C$ M%@YM\?JYX5-G9O5BA'`EF&KG7HY%$4]K0_:YO)S'1S7"[E=D_EWC`O.$W"HB MGF9--FW2H6FQ;J3@?U)D=2VS\"DWJ/0"LC<-`M!SM;8ZV,0"3]9:&F`Z6LM4 M^84)GA\AX7Z8U2R"Y(=BO2.V>@@"[9MQ?EC>T.&99OX8?;Z M]:OM'SS>S9@.C5!\'HTU+LNLU->;];K@R\2L`#P][*K6CN&N:M"1'8BKCJ/. MVH'S`*].,,T.*"!BB#/4Q^R]$Y?\^0Q/?LC)!%"Y-\5P+8YXVQX2YCV=RD\Y MPH(M.B-W:+BE9^(7Y8(XB*9(PI'&B*N*S#%>U.]HMUYG[(53=K.U_DC'[_RS MX@LM6%[V.%P>.!Q8`=7C`%PM;`!P;*_!SUHDQ!B/&!9;)'(TU,$E\#57DPLG MLVIUS@4O@+B;$Q+379W`42M"%!^*5B6[QEY-GTUH9#J-%)W/LJK,R[OZ"E?\ MJKPJ.X-11G:B6088>94@ZFAK%@V+L("V&.C?:B.J+E*4I,M*`K&4H+M2LF.X M&8C`K``)C!#^`20C!,`PJU_@]I(76E.[]S-\B*0>/_%$'@M2%%E5YCCNK[)'M[B$B_SA@=@62F\."&K-2YKOJB0'S[*NV.V8Y0W MM-C]0!@#JPV84;"@@36D,$T`C@(9&*CC]:$IH/-2^(4+68Z<,+?.C1>H7]8, M;4M#77$I_#PB/>4H$8+8"QM1*D;B4@\T.D4,'A$18XQV25R'^3];.UFS0IZF>Z#?H'^,-$P?+_Y[(Y_^OB''BT7.JI<55UF^."]/LG7>9(5, M;W.N>N;`6[\]+NNM#SU1ZUJ`)N6--TS@R=RP_C$=WNV0F4=TV(B!L\^#$G[6 MYD5"HH04YWT#627"A#-*[]"P=P5(.&-`*8("_380)<)(.!RSSPX&NR\R0=>3 MH2YZ8MP=[1N'O'/*O\A?9=5EQ0].+_C'^789?/"APT5I^[7#20G\R0."JOON MX:0;^O'#O?G&K>KVFK0\<$01$:G$1:*%.'[4[>,EV;OVX$3[.02BVM_$=BJ* M>-H;]G7$PWU\5*-\)QF(@;5@X)HR\#/GW6C[A0$D1--BX5C'HKJ:+,+1<@3K6P3,%#R32>!GZ=8$,+,)=]#(*A,(*\%4 M:825)@$=+`+1$B0;X]A0'!K(L"D[5IP/G1@+T.`T&"G.73;WN)(Y5G19QXPR MLIO,,L`(IP11QS>S:%AT`[3%=$2::7=YG5)FR(,82O!9*=F1V0Q$8$:`Q#,( M_0"2$6)9#*,7I+P[HN6L4)8JJS'K[.J:4N*_'#QWV2KWQ@;W19='1+'<`37%`+NB^Q86_)`76B+ZICL$A."WMO MZZ2;&_JP"(U&HY'"KT@2_9[4_$CD"2F;O-S0ZERN<<6_3=9O\9)46,C=L/2% M'_*25'GSV&:6/BX7NRAG_[.A/W_`S3U9=.FH]S_$CU#R-F5^^I+!6?C',L=H MY8<-?*/9TIANGA]`?,[POA$'+KJ*H:YFZ)97#8GRD"BPEPR>;:<(*%[O&3I[ M:*J,M-1H8EG!VM2DR=KD2G2V7>-[P.^8G][1&=.#.2W0\GY,-*_Z.1K>\ MG.?K`LM5#:T5[=^"_93T>82Q/%\&^805Z*?P3]]J,KJ;F*=#":OUZ^NQ`UY7 M`]!4S?Q.SX3C'@]X\R[@D8.`ES@9\M=X\UN.-YU;C96DKY_WQ)3B5">WG[)/ M*^>:N<]2,:!TI#Q^YE8YY,U)GO'48C?AY%II1:(_+>!AOC]SKXWQ*15X+L!! MX_`3:ZP#-0!(ZZ?7@8_2.+<:_$EV[$,T[@PX^%IK/[C@4HCJ\UV4@S/NWN&L M%_=+;RRF3>>PC"_9T"38-E)4WTE@)'8D]WAJD%!E2MN3\$F5)B#4BS638,1D M::I6.&1+NTZUP6TWCN"X0DZ3Z&H/1)WI:J_CG5.F"7W->MPH&2$(AA@:D#@M MV<<-J.W1(,8?<Y!GCVP&[E8 M7M=5?J[62NU\6M9+.7T&/H#1O<5N%H[Q@=72(OM'`78%72*@YQ(CQ;H09C9! M:HWL_I:Z'HQ`30+_-F:C)4@VPKPYE`97%?FO5R M]O+E2[D7<"0OF;"TZ+UCD$KW--H="B(]I03NQSJ[AK!=CES8RS2:3_,J7:&@23!MMTU<>AA`;!2QS%AT\ MRZ8V';8QR>X?N#'*NAZZ`53202/2X1M["TT/`73O#LNMG@YHA.,X`,L*IS%J M*([E&($/C^;8^S1AVC9E3IX/_&D>Q1<2D#P\I9I#X7"-T$1IX!8:DZ+M9$$[ MZK*@)=J.A35C+U640:6?%@J"3#SZ,QGK/^(FRTN\:/,<*QEG%I)=9Q$".@*H M/A#1,.I#&F/@?*N^34*=@.H@(TE^JV4[8ENPB$LWI0O@\[FXQH,7_'(V&U4J M?(_+.O\L#TDKV>2LU^;9=-:##@:>#?'4#APD_'K!-&!TB.*N/MK!;.^$">P4 MZ0<]^=&.)5#UWKCB7"()-$>Z'/:[$S[EZ[-&F3;GO%$&FDL>4!F`9)@#`5IB M2LRYMYA(^20NQ$[""922O:311B#BT%/IO@3Q&=R_Y^R"C;AKL_\A2"O0?@?2 M"T`_`QT@:+X"Z>4"/P)9FF#Z*""6`D=,.>6]6:M9Y)>?`['>1KX>@@"Z'/39 MQ\8NFUB,1!;^QKT@Y=&I`Y:7_067!X8M*Z`ZBL'5PH*:8WL-;B"0$(-"?:Q9>XJ' M91#`*:*>J\V%CUBU.H^!%T#<[0F)F*Y>X*@5(9[&X]4)H<&*+-$\S1TT/_*@ MD=DS4C2F2RQVU!^?8O'/\_(C'1JJ?$X79/QU6U+)^]N&]W7"0!P.2'J4HCT_ M&8(5?+PRN+O,IR\Y+'K>%O`-N[#2E2$>=F9G\K;%I'TM*[`#]LYO>D#M'.P+ MJ0J)1"CSD!'%26.T=\?T^S&G8_V+$M^Q'9TQV-^C.9O23Y_-@10::=SXF9#% ME[PH]DBV_V=I^8,_`T-^JZ<.X@>_AH5E=24-5&L5$G!,TZ\B!K8_=E'M0)QH M^PPR6=486_UCA*GGD[4$\C'%2![,3_N(@ZJGFXK&E"M^I8F?X;S`7_@OAR=M M''2V)VY<=%PN:]I`U5'#337T+(YSVXUG!"R)^E@9?+W3T&0_-""$T+O.8.+N0R%;Q.-6E8G]ZH0GQ:X+1 M_6RU+L@CQB(]"37Y/9UM7E&#.T1[*P8@^MLQ(HP&T,9&0!K8;8'=91U`YKU7 M:!-^Z(C!)H![:Z%@[FZO"$@2CW:)P+<)\<#GG')K!_ MPB:-X]W!":65?39IN37A7P%0&`B_NQ/JN($H`P]I8=0^?.0WW:6>.,PUCF03 MI.ZT1B^1E\IQKT*C9!ZG=$IA@],>JM.(I-,=9!@R-M]S[&D?CYS"CH69$\9! M9D_5ZIZZHFP^J;-WP!AB=A\?U>%&"U\&'FY<\'2EXII^BEPT`8S3#0XC46Z* ML3]@Z0(`@(P)0RY>#"5XC!4C+%_`710XADQN`0,G%V!P\9L'0JH`BP"#+6+@ M/AP*,_3`--`Z9DIC5?BB9L)L'FEL4V39/9[364IUF*O&+JG/S7T@Z9^CNX72 MY*0!*`3FHH&VSCEW]PRU0.-DZ;[*' M*U+S9`7Z]\@]-&7W^F@"8ZQ_<[SUPR*P=U\87&V+R0\E;U%Y`MDMKGB]4B`G M<#Y_MDAG=`#HG-.G5!)L&G.(=X#5Y%+W0H@P#`S!5<9)\;;='2[G:<[+_[:Y M.-K#$MTKNN(1W4DKEQ7'"[$`NUR^.[_X[H<]3KNJM4^=N:I!WSL#XFH> M/7/5#AL]_#K!=+=L_R5D-EF3F*@%97^CL.B['U*\2N5'#^&I4.7>\U2NQ1%O MTX.>1?/S*3_E"$-$=$(^/@F8VD>"$MY,<"8*2LV4L<[>\`U_\25U_U2-XJ?VO(SJ)^A) MF)ZNYEU&E43@Z15MA4WG4N17PV2/`!EZ7+"R+]#[H*Y2(\;>!!WIT%-#+P`Q M$^1A11][R2<54Q^IL!D-A5K-UVBZ9T^5(G##V1X\_6HZ5?^F3FHKTU^W3]'? MX(?F+2WO[WN4L,JUR6VMC!<2KBBSSAN5IW^/4X0_;5S$/?@`_AJDI2_=S8,YC345AU!2YZV?L/XO- M@I^])A7_O''<-%5^NVFRVX(O>=C*A90-K4W!Q%*F2-;92)*W^[W_N.&!#K'U MF"4%\E9+$YA4`J!(1)JLT$\G^,&%#4F#_N(Q<$QJF M0EDE_-$9I?-:_PJ0<,9`0G2HWP:B1`CVPS'[0UZ2BIV0;9\HF*$R22KV.+1% M3XRW(XUK)] MT*X;M(S`4_)#]KOI,/W.NY6B8/[D#SON1@N?]C[@L+X@HUGD0GI'J@>J/4E" M*LNE@+A%:S98!RLEPB[M-#PZV:;B5U=,Z8JC?3;C9W[O2;&@$V'QV&F$<3DN M:#^'4SQ0E[Q.P:6J/U=$Q@X\03=`]YK.WO6*^ST2!4Y[;C((J44L-DCEB$_;F]`_ESNE]R;=N=/(X/%.K*;U M*WG6]:L3/2$G%;@=@("?VOSK15R>";LJFOLD=6 MOQ-ELBVSD+2;10BX:%2CJ+^=6F3#%G60YI@284AU)/5GZ"19\BZ0N82;J44[ MK[%`$:`I(",#B(D0T0@?+V,9?RWTIV5S-*S1QPMDU08OVLQ;%$L;R\QR73BS MR,$CFAI(&]0LXL%Q#=(N,[L9`NI!)(YN(`-N`YQ:>H?N%D`"-PXPTH&H"I2. M$^\BD:+H(";'!92(#"-%0'Z%7O%QA9WZ:S^P**>D5YF"?)'0^FE#(J"Y9!;Q M+\Z0?"0":%C\CMJ3UA0FJC,1VVM1_:,1NH\.HM14:2RB\54$C$#,O5P8$2I' M8G,1G'LE6ER)BAEAZ$OK3W/%B83GKU-0?)\[HL2%%D59+$+CY\ M0J,1:JS-I,5_;WIU83G)&KRJ;\A'S+HV+_#.G:H;0\/_BJ0S7L@[H]A&1MGR4;2OP4XK=H;1NU6XR#5QJ M;Z\J5?O(.'0<(]S?D./%@K_1D15764ZK>Y*M\R8K>*Z>VZQFF7U7+"TEOU;U MD3VK6^<-OL;5YWR.Q5M[K#?N2H["MXK(&&VZU%B`/H: M!&+QRCPG7-T5)9WDO7KY\OLW+_D4C_WE5SHC9>\TX%,L_GE>?L"+?)X5)T66 MK]KS*\?E@N\:R]]ZWW7W7#\6G'W"%+GBPF"Q0,,F.G$[T1!NVH+0\[:H;]CL M12(B45Q[3(\GEQ"?:EJ!]TE/-$3K%C),1YO'X$GR-6KJVV2T;>DW%_Q<]_A) M.#]74B#MB9MH[=\9'T-1N_%O>O[C=C\B7FEQ?9;THCY3_7./2E*MZ)Q>%9VQB1_W2QRLN<#=[L,?&V+M]^=<101TRS9G!> M*\"G/*3H.6.5N/:WNMF7CF^\N!2:P&?&;DL''`CO/KJP1F#EGR@2W< M35$I5F_"VEY&DGC*L[-.JV;/#G.;SMD'R)C.(3>_J,BFZ`UE8K^+CCO98M%N MA_4.Z5$_*DEYU/U%GN_K.UB*H<:A)QS7V2[K:Q\OCK*>[L[1O:/=<4)*6LR& MEG2YG:.\Q=2D\F++3?:`V;C6/I6AR=\6%Q3T!3-">9IH%KL^:MF M[YT?YB^H*Q-UA=(Y*2NU]P8]%E/C[9,J"?-`1NXC,F3?6S_3Q/?-F-!1\S>/ MPVU.ZGE':G)`ZO;<^9;4J_UW@IX>J?<_ST3`WOE(,V$'=/Y2&K7,(9PP_E?3 ME'YXO5FQ26(W#USSUPW;">+!_/"YG!Q^@[(E+6K[YZ(;HS#/D(96N+DGN]?@ M;C>-RJUG=,;95!FIZ$0UJZACL_L&,T1[:E/(O8_EDJ[N:U93\9&W9CLKFM!#/L2'/JX6?1D>?-X\Z4D\V-ISP5 MCN=/*::[42>XDYC2#C^)G?*<->[($S[6#.<-P\P](\\VIS*_?!HS2OFQK3>5 M[$\R_QFGE?]$[AQC>J@Z;JC.U`B0M$_RX,6)O@'(ATW4P*T"'&/?O6:1,E\H MI!7$N%HIIT=WST1,QY$X@,RATL2H6/=PF$"`@,$4B3P.&8PD[ M=$^5Q*7R>[P]0O_(OTW>XZQH[N=9A5LU<4:?91&A`W=)&O2(&XJ5+_B(*X5R MD2QH5ZC53#'\3IR848ZTJ(_8JV,:3!APE,6E4/EI%J02(0,KL'G6A)"*6X8I M!T=@6XA/VP%916,:-^I`&=7&XUP8`C;A,)^G5F?<\(.E/;'7;:"S=BZEY^*G6_JAJZ_*K&8?B97ZS6[S:\MH,KKO\MD,%NT M;]$G+I-M_R3P^S5&2YPUFXK%OYR?L=V>CN4URVM$RV+3AJSL&I.7^6JS0ME* MO+=1K_$\7^9X>YEO6]SS3;WA!X$SVA9V`FK.+'B'&7Z%/^-R@[^9<166H2`K M'UF!%=M:U/U86>K>I/UU5V4K=D08B\._6;^. MMX^BCK*3V?E?=EPX$W_N%4#_NB,H#W+E%=K4O/@E-0';=.`U:TO5=7K?BB)/ M6\T6TMINIXPF7[9=WE6_H-U6U+N=]B4O"O1,$F0+5M.^*>\DIW9:DC7MB31I M#W;>F9]4HY)[-DQRY.SI!,T8T[I33"E&"7Y"_Y=WQZ)[I6GSL?JH`BYM^5=( M=)H/0."U+>^.,-UHD*!(HO;R4O1OWR;-1.S54!+>39;+,"D9$_?JUJ#$F?>( M(^YM%=M,Q&DGHE[MW+TRXH#0NS.2C*^.U[>\D/TY&_L"UQ"T95FRT3XWV5RO M07R6TB9AX%^!2(G1(\XJ])S.@V[Q(Z$49Q.%W3M<[*K7XYPJT6D-HSZNONG= MJF+R[:PQDV\7\6E5]B`_U][1J1?+*HJ.BYK,VBDW_R"T*2N1I.H?;&Y(-6YQ MB>F<*LFI^'\"=XJV8Q7G<4Y=A@=U"=YI'6!PA\M:O4ZT!`XN+;4N:%7/IB=) MWP!LQ>'D7J^T-[L'H!-GVP4XP5^SJLIHB#NO:QK@3GGRFROQ[C=;HM47^`O_ M:?].N[.>G>2^51&=Y:P=1GC/]ANHWR(B`8D$IDR'*U/HLJ=%\!EBF[_$Y\SVIFB=)_=*RACT2PG=5U&^$](:1 M1'X6^]9C_-Z\V*QNV63QH"_9Q7[>SXM^.C`VH4PQ?7-OZ,YX!%;O1J84;AXG M@9!D"9TBE60N^';U0]`L[?J<2F'^'>VE\-*!;0T%?==F?WNI`IPIL71A(F+.%=8WI`*T$9L/:%AI1;-2!;]]W M3^"&@122+NF*TKFG=_DDCJG\SI5NBB;_"VGP"5FM2,G7@!\PFZWL4=@N*/L1 M(`AT.G#=H.*!1U"!#3.=1&,01PR#O3E`0<1\,,6Y,*CYI!OHY7NGPNR8Q+7S M_/;7Y-%Y&T\4_RF/PSG[?ZK$J=Y/2](O:GP#7YHWA:'7'#6:R<\SGK0F8YG0SRU M(VQ^>':%[548N1,J-X53S%\\J=!.7*#JO1F+U_P:IS@JQ;?D!&E_7\NK:#.YW]0>@>N_AX:SJN0G MH=9T3*_EGJ\0K_":5NL^XVD/JXRJ\)21['P5RWZ^H>-#*RAKUA-JLT_VF,UITN'6TY(U@+:0RFVO'Z;3N;VT1\.^R;0S9P^]QN6L,-$ M>/3VX)E`U(&BOS%8Q''_ZRLS?9D9X_OYVPT-%[BNK_$=BR"]#2Q:8C'G)6IV M7GQ49<=ZJ0)G60$M\@<(NG*'O;3!3I@2*,"$,)<,*!'C.^7;%'Y-Y0=W`1. M&,(1Z85.$)T;^I5,(IC#RQ%_%DG7K?RTRLG.L\L!G0E:,:!TF),`6V5P"(F0 M@/I02TF::\4[2ML1B6-'>5'U`CM3L=GFB]C8_0^I"X=O2*`<=S\6(YVW.ET\\_D;QL M_D+GHFS+V.H#?LK2#I[*0"\/:E<(1)A'AW2*P8_[L'QUQH%1BYS`>8.H(EW6 M#:-S5,^R20RC^!T;S6N98!,ONKQP5MJZJK7'1UW5H$=(_5KAIQQXE-2K"RP? MWEK`7G[>)*^9>9%`NAA4N_^.F6-Y)*S3_;;^Q6W&*VHC.P%APNWV/DP8NJ'O M4D\7EX=&FK;I!0SB."GVY5T,V>[$&W5Z>^\P;.+3A5X49_>-;W"U.L6W M[)#V2;;.6;IH]LSXY6V1WP&C;RB,[,U@&*##1&IU'+`P)XO3998;Z4>L!,2* M$)OTHA#$2T&]8E(FXOFB=2P?7A\0UI?\)PIWKM_;]&P>5_KE!J(K+ MD4&WFKLK1CA!XM3L:1X/=#-VNV$"T-P[%0(MA_AW<,`K*?PA%BO'0+*RIV"R M0']PJ:2#1I@'.+30_I($ATF63!YF0DEVH\I^6G@;,O'H/<\-_?5:'(_,BI.L MOG]7D"\NAX*\];=;^+[ZX+W[L`8&HH3NU@?UCG&;OD-&#!HQ[,2GH$+)L]V7 M=X3I;\C[UH!$LI'?R2B1A_(C.P7-YH7W^9IM,WX4IZ*OLJIYO.F=C+:?EHJ% MUYZ@BH8'/545N4,BHP:>OHK;FZ8363*_Z4Y1?-DG"T.\--0O+L5!K;'>`"SVEI?][0XG!5/+[+RZR[_)'DA)5BSM(S?"IGZQJ8_NLFS-;/'C"UPTV[\?\[R@J43?$>JZZS`UWB^J>[1_NMQSUGFQRKGKMW_.UFBWWW_YAZKFVK@N968]-V"(8J&&!SJ\-)F"'_Z M9'/+8Q9QU+BJR!SC!7_FD%7N`WL+@Z4#99<<"C8"LIGNY?*\"T5[-`Y`D+8( M00`.,>'-#,8)<]W@/C)XIWCJ%8`NEZA71`+?#J>7='4/H,[S M0VI!HMG0/`AYP&O&I""D"%D^AB3[EMET0I5_97(R)D?)U'F]N:WQ_VPHWMEG M^G^`3R5`^>VG$:@\^%.(6X4=M4(_=3BUUOAIHT5"'"K)APPWTVX_7%C4^A\J MH"40SQY--LOKD@WNU;#6YJJ":QRDY;1K.&?BA%;;62]6ODU@FQU\J$Z>E,39 MY*U/V155F3/MI2B290+[V9(4QPZGRSKEHADCW]F`!/M**;`E#T@E^^X]_9'^ M-_TO^B\L\1;]C_\/4$L#!!0````(`/1<_CREO1*-5AP```W;`0`5`!P`;6=L M;BTR,#$P,#8S,%]P&UL550)``,\\E),//)23'5X"P`!!"4.```$.0$` M`.U=6W?C-I)^WW/V/W@\SV[;R4PFW2>]<]QV.^--=\MCNY/9IQR*@B0D%$OA MQ6WEUR_`BRR1N!5(@A3;#W-IJPH$OOI0N!4*/_SS:14O7KT^S7[>B,14)LF+/3__S\<.]OR0K M[V3G`S%]$V=__`"^EV28:MM^))7@_SHIQ4[XGT[.OSGY]OS54SP[9C@?'?T0 M04#NR/R(_^_GNQL==ESL]#YA%ER1,)G,[Q/P?U]",&,,>/]'2I,-:P3_XIME M1.9OC[D]3DK`^6?_:J2<;-;D[7%,5^N`H7)J7]5W7L"1O5\2DMQZ$?OLDB34 M]P)=-;6*G5014ZO6*[)CF1O6A5<$8DT: MGZ;QR<+SUOFW`V]*@M.0++B[VO^^J,,%493K%1J\NWU_PGI[,T(##?J1?0^88-'!>^#VF8:(UN7V('C;KPF0>+*?]TS+[]OT##Y&>&+?L)T1"3 M4CJH_#LV+,]I[+@9,7P&U%&!Q6_)%'BT?".!-F7 MXB5=(8>?YV<_FK;$LN(LFPFI%$PXIK\`E,"\2+M@$D&)( M;U!(!U7G_R_[5$IFDS6?E>*,H-;OH,+YW%D[FN:>,$'PF;"DVE`%UASX\KK8M0D`?%9]V:C6I20*-A< MTY!-!JD77'F)AQ@KC((05E%[E8BLMKMFO(C$XB86WY[?'[&=__2F.G`FO_V3%@O\FM& MWM^J*B1.UQG?3_PE#;9KY7D$*R3.-.%?VZWH&Q/]HP2.E(B`"6*L+:YL>\D: MQ*9X-XSK3S^1C="X$AFD=;\9DW5ED(`19D[L6S;H@7U2XG%V?T):\]MQ6%.( M!*@0G3]6S2@005KSNY%94X0(F"#FQ+:7:<21 MNF8+%"_X/^)%8O>K$T/:^!_CL+$6%3!%SN$<^!>V5OPIA"_A/?%B",GL)HY3 M$@GGPAI9I-6_'X?5S:`!%(8.[?\S!"EK[\>D[UED(`1 M9B[7N+G#N2-KB/B&*=\C2\5F5HNB]S/&9&X--("!T*'Q,^Y=LN%E`9%X>T,H M@37UJ/:NQ(B``6`.#7N;3@/J7P?@53=4I;]CC3JJ+2L1'J`%RZ6;S@]5^$%= M=K(23]*$QS7R4%"QLS90P)I$/M:"(``#Z?3/;!\G9#OV%RSOU4';JU<@:-> M#DF5?)-E.-PXPFZ3R9$`8[AZH`)?,NJ)4),2TJ`NA23!P'=.+3E1AZ7&"`ER M.WSXX;1Z7-O2(6[#J$W;H]WR:Y.Y^FN28UY;]<*LUNKMGAB3(-G^I=I5BS\; M`_5LR`=FDW>L1K];8J8H"0F?JB2;TVSVXYRP!='L0]XBJ2_(J)VP93+))-MT M(@V9M^]0L(5QY](&^-"B#9TZ*6$0I:T/*@ICI0=^'N\M=C9:N<*V>CGW[F,2 M+;R0_IE!?PEA#`&=E<:^W3'+9+X-/-Q&/1GXE*Z*+Q#MK'BWWJ>S&8TI,_>] MCE2+NY?.((>NS>EVMF0116H]5S+ZEM:--2VF'/R;%M/#'$I54^ET":54@H-3 M&HD;:HE9E;F19:'9'`EG!K`SG%.'8WX7S=;-J+Z@=2YVRH7A+97=.Y+RXMHE MK*9LA.(5UL^1<$H%)$BED3B21BS:=Q^XHKC30$(.=D9RZC1,;L59!^<+R]8Z M"JQ:N=.(57/O'%AEUA![P8\1I.OX)O2#E._V2VNN<1MM%?<,8#O%C<356/*P MLB%L6$BV*=R6`:!M8SIU2?)KZK:.:+=$K?LQ$RX'83-A]Z[FEH1QOFR>)$L2 MW0*K$4EHE*V4BUH;N)BFQ10P-2YF)"X%Q:U]1Z)6Y>ZC,[L9J$!-8[K[5R];NL")5RTQ"C8MBK50UZQW@P8VO6-1L.#/*>6J5?Q6$U+YU[,QCK0 MP*AN3TL-,V5;GYU*R]>?I%JH5H*;4*H]A(WFU=M>OC?8)C77*->8"(V1^)0& MQ*D]$ MZG7=X:G,C^"4"G202B/Q)FUQJ[(U8ULJ]S-(0X"=Z9QZ&Z-\W;9N1E*XUJV@ M]0I3X_74V]HICV*E4GO'DG*I'E8/W.BU,_;JS$@I5$Y[U$*'VG'- M#"LZ5ZWI9+-[-4I@AJ/C4U3%:PWVIZ9[A1J7[3)91J:7\EJ>Y M1BWYA5X#V36'TC.QE*@>:VJT][-8Z%$$"]`=]&/)*Y%2>@C3=@WY(LRRP*&]<"-PB(J>V^EN]@'B:M<6_H9.['UF,VD%'O/>\>Y3`QL)6(0OK6"9`&)08N^,&Q>S MW](XCQ3X!*'/6I?UC@>X(S[[-PW(7BT?H)GW M$8:63_-80;(.2,:I<':QXJ%^?XI\*T9EF$"H7*HI[A]LKSS38<\(0;"BF!C M=9?KM(@G`;DB^?_NM+W($2*/P4`J#NL%["%LD%E@"/;(]\BI.S9+CBB/GLQ. M2"$2`*/E%Z:0-GUGKWL#%L86T-.\%#$M4=`+*8HW7H]T+1^Z8$,&H8^"AO> M#?C\T_>CE!F>>E,:F`W"F$+&LFH?!AM1R"M=H;GMU&R5)]6J?/@CF?&P\LO` MHZN=KV>]I?@-PT&[XI!L_/L+&U5LM+2!D)=-[#F8X;M`C2T$D4-X71')U.]> MAG'$,"Z`VV`HEQEI@$&8UL&7+H?MKR@0#XL^*LRSKT/P".8T$<1VUG\H$\+7 M?SC4[>UV>641$9R=4=?Q!#G*?;NI/&RC0:RX00'#BK_L,%;K5S&VX;:8-5',VV<`/CFH]MBM+R M,!DT_&!OM/[H6.:4(3'#:3+G2!6_S'2$-%`=S?;P("EI8@`1*8T-YW+*Y1,R MRR(B[SU^[9']999R&(APZ]AA+@\7>MPS M<\H]"_11R]V!>+Z/7I)&--EDV;(#GEN.01;S?$S2<=:^A.==..L2W![F#I72 M%ILR(G^*`5[@8=%VZ]OG%DD,[3<`#0H85GQIAQN`)EC(/:(QDLXX_4WA/?,[W^DAMHSKV34`3`YL/UHK2\E3K%@:`)H9SO@*^AHC5-HW$7\L MN4K MV2MRRDL+]%$KHP'XRYLX3EFUR"3*]U;W'S,7N$BU@F`G2*/0?8X(IQL_EORT M6(Q7':<&9\!;Q1DALP/P,+N[Q^OQR&K$+Q*0B/*X]L^J"];,HVK`N];,7I&9TDN@X&&K7&:#,=%%RN&R2P2>ED1+OP^?/ MKV>6#%+>Q5`RZ'TX^WKY4\7;70ZMLI'W/@D]9H>+)RI-12Z2*5\`4,K8;#AW M8'9MBO(C18YR8 MA]BQJ;,WJ?9K<'C/4/7XK$;SQS_Z(;W%`U"J]Y^:4OWE$92#?@1%GJ!@)[WP M)80)#5,V%2VNW$$8OR-SX-&R169"PI\@_TA#X#$WDK2_[1:*/GL;["YQ&XN. MEK&M99ANQUHN4Q'L95TK#U^R:$"0S0[]48M^9_6/,Y@'^!Q MZ7':\#$#\2I[:5$ODB2BTS3AH_0#\$2JK/H,=_;IA82`UOKCN;G14LRG)8S5 MYYWP-NB':RH>67/$ZO&$0_%.@W[>*POLX&%($5FRD9(^DN M,XOM,31_@KK"AI9*0_.GZ3'VH/G3%JC0LGW<'1S5*UQ6MGI<^(70Q3(ALXM'-CU;D$_I:DJBR3P+K8PG:1(G7CAC0^<[+Z9^A256 MNFC>C-@CV0$(C9#OFUE7-$C97VM5->.63AO)KM=?(;NT$,KY98:^N[L#7A2R MK_/HGC(4O.:CE#+H4X`QTT6-%!A!V9OI"V9JC%^1PII_U"MP'58"`@CAM-H- MW*;]8^OU[?_/YT?%SJ/D,!*O.-`SI";K&CP&8(^TBO@PWW.O@_BC>IE[O),2_S,K.37L;P*T@][Q)""!FV'C"@Y MF;=!&CJA%AO->QS]D$0#+I@:P!EM?O1HR%W<)+RB\1IBRIL]F0NS[!K)MAOA M\-51R`QC0!FCH\T9]*:,)47^,=0CQ#[X@4#9:+NG)[=S\"^0#R?G8SLL1.PG MCNQ5\#OR2,)4D&UO_\]CV3]L8^^YA@W(\!I6))9)"H?F!14XME!0]_>QNW%) M.(X)KL48!VYI,T.T986>MI&,;FM4@ZJ97VV^&>7DRP4=^OBR@RWF\/CP4VO0TW,&H.]+$_10PG^U>0\H`H8>ROT7V2CDHO8.^J M=+?+^('QM"M0U?'"S>WUDFZF"R:]I)MY23?C.-V,@]0D68KP)00,X5B4DM%E MFI(6TWV\I+DXW#07!W0Q>3O"/-S,4U($6J4[PW=$1\685:**,^BJ\\5YG'VN9$$/[;"=V>@ M@VL#.UP1L.D$3_7,YC9IQ!VR*F6_33+CQ^^?2.33N':QPUI_+/&:K1#9 M'D5H;(*^J9;?86O`-8,"L`N7P7+-UM)B*B)+4S#5Q`9RJAI;<%"3E5^\*/+" M)&^.Q>Q#J(^83HCU1Q)/ZFQ^($;1<,!7F,`JP*LH+Y9UD4_D2_93=6F$UAN) M0VS:S?9)A"XMN]N-AAZL[>7,_55>]S(8FQ$:!?88C:\R5Z#$J6%P`PN8W1W? MI:LT8$U])._G<^)G:9=9E_."BUD._F1^??/I;]]7S^60:BZ.Q`Z&/&CPP!;P MOI<5V316-EZB=!R'?`V;0#CD-*O3OH8&(H- M9"K%`Q?3:)-5,FOMA?]'2B.^1Q@G>8Q4=2Z%4"DG4QB5KS+OEVPVA0$.;(#N MAVDY^GV^6520(UQ$DBK1%,A[VZTS"HAW.[:_>G7 M;ZIA)0(][#'6B-[%DTVL1"B!%-I!FKY]PY^?6_B+ZH-V:_9/'J_,BAL#"WJ; M+!<5SJ..^`DGA'RO3!5#J)(=ULL_K037*)L+*%R4"@YO)N>L&:0 M69F#56A>M9#5>=8!V%73:C##Q9DERU-8H07%/UJ%5QR`Y22M!34.[CRK[^>' M4&0FNSPN]K)8/:NSG@.P+QX(L$;/_8I4="M&_PZS7F=8\\]D>?W"])-67QR[6GEVM/AWOM*<\0)W%9XA\'ZIN,-C\ET9KB=H(:`<4QE,Y8LI"IC28E1D4AVVM#P0=6>#M<[[.&49]-@FV89*D]EFM^ M[7'*%DAH:`.7:UQ(66WNB$]8S=@$YA-)"B#JRUJMJ(/[=8\DFL(A<<@(-\#@ MZ_`$'J+D@40K>:XXE8B#"/J#8X,2+S#!TYGUKPI#/'A/>7.DKL%`QG):I:@5K:>K#)W5N<"#:MMN*#3@&Q]R/NG(F^LQ+(8E;%<8(.O MXQF^<&IO:7&K6WSNYO1-SJ'JT_>^K/;HT8#O%EY#=.\%Y)ZP$8,FK$SI$(U1 M*5,#851<;P+WP8LC`3$P&($-ILY(]8%Z4QID=6'K$>,X)ZS:0$,^/MB'$Z`1 M`%O4^N"".@Y!+SBL8`0T[@(6F)91X88BBL$41>='A+?>ACLK]>&@6&@LP0H& MME%S1'$\*$$.S+!UR88H93:IM:E."+7<6#8(.^*$!CPP1EC-#$E*P(]D1GTO MN`P\NE)W?`/)L23=[<+2)O`!`F4K:V<;3L4GM!W;3'@LF[U=V-P00%R0]K%1E4GG%'ZG`/S,U8.9L1S4#6YZR?Y#$]Z4;!#= M:9WV&!NC.L)YCA,&66$-36SDS&]5'ZJM+I@D/Z./5LY>N%2LH62(@@[M/F8R M\BF,R_FNX[F+Z_U5R82F)^O?EK9YSM)888%"8CPALZ[YH`(5##!W=UGP.1&4 M\%Y@Y>=:KDN9ON/XC+V,A\.BC?&Y7"5I5_W.H-P6#???ZG6R>>)9)(F<>*% M?)RJ,,A$="QG@]URQPA)P"#N,EY`E\Z+/P_]B223^8/W5(\BL-$>RZYE:#TY`L.(8'2R$%@,)G2WHB0CMK MJPIYVBVT?+V@W4+=GH(.@K6R95R3U?3VA:CV+`/=V'HP$>+R;6ZE.)*QKU_V MOFM[WVI\#>+->V;4YAJBSZ%/(KX"8I.'6XBS=;3\X-9"L\#;1M/MBF58E$3M MH]J`"PULXG`Z45S]N`R\."[RVJH>I)');0=]G9S-GEQ[S#'/A7JD2(8J;1P8 M(^#N1&:G&L*W:>0"Y9F,7&`@QM204F+7JE9V8")O*^B1L`M03X.$_@P)T3TY MHQ&[\R]3KDQ/F5IM0%^AVXVID^UELUJ%SZ00!?>+=@BY8K2*?) M/`WJ"5TE5R5M=,=R3-_*`Z9V"$(CZ!V>W)>)I'=2PHJ99"(ZEM/Z5HAC!!A@ M@'5&BVR;^[E>VGRL&M&Q',2W0@LCP``#;+_>0KIS:B@]EO/T[GR&>"L3!6]/ MX>AL"C^)LI;.LB/:6Q)E[WY7F()3&LN5W58(@X2N%IIN!G9/],G?B+](DR5$ M],_G=^*%M)$)CR5]9`=TD4)6HXD:W%[I<1/'J1$U]@7'DE^R,UI4X))00@1J MKW20AXP:2KM(0WG0Q)#$AZ+@[>/ZD^%D!*'A(J#D8*B"P0TL8.Z#,IH)B($D M>BOM:^&(:NYAC&M_G!#..C126"Z,>U]5!Y:(![W.-FJUD4\U3$2Q;!CW9JD1 M8B)*]#_%V(M$SRM5H8-"`LN"<>^-JH"JQOR+<'R)TG,\]>!@[4,\CLR*:"[*+\? M3KGPU(L)^\?_`U!+`P04````"`#T7/X\V]+:,/T(``"]4```$0`<`&UG;&XM M,C`Q,#`V,S`N>'-D550)``,\\E),//)23'5X"P`!!"4.```$.0$``.U;;7?B MNA'^WG/Z'U0^M>>4`,G=[28GV7L(D%U:`MDU^])/]PA;@'IEF97D3?CW'^7!.R91S/SZ&4D#=>_/OD,?2="TH#?U%IGS1HBW`T\RFUT^OW:KV___*?KO]3KZ!WA1&!%/#19HKOP/U3)$'W]@KF';INM\]>H7M>B MTIT3'R/`YO*F-E=J<=5H/#X^GCU>G`5BUCAO-EN-K_<#Q\C5(L$K1OGO&])/ M$\$2^8N&?CW!DB3B_HSQ#7$?SPACF,\)9FI^Y@8^*+::S=<7S41'D&EN"Z\; M\#81#&5]AO%B)6P$0]F(GVOYRWJS5;]H;6G4L5*Y6O!.T$FHB$QIB8`1N4O% MO-C=DEHN=NN8%SMTM(BW95CL]ZM&]#(M2BT\4"X5YNZ*AR=F$?XZ`-;6DML, MQ_VA=7EYV3!OH?LQXA.N[@+A=\D4APRL_A9B1J>4>#6DL)@1-<0^D0OLDH,[ M`'1+A*XQYX'""CJ[^:Z?+!:43X/X*SS05EPE?>TCF2)CUQ46KN;#;GUC(8(% M$8H"!ZGN:@#FIN_I3EM/C/IM(<@9A"81R32P&4O]&EH@$L)C?!BLK4P@%%4: MXR$EA;28_#O";-60[B4W-4G]!0/[&B_CO(M94>=!Q0W9'M\[:Z&RNNZ1:5'7 M085R:O>\NY(IJ^,,3XHZ#BJ$Y?L\T*_+XVZLK?!3P`,?Y,YVK1P-'O#HFT=H M'3RLKV?L9XN/-0!:=0P2B'HWM5O,](3NS`F!54"_^O2QOV]F-8UO:*Z:2!I9 M]]FWL.`W41TY,"69Z1T^=T9#9S3H=]OC7A?=M@?M8:>'G/>]WMBY;FSK;T.' MDG@C_M9\WIX28^U8Q*:Y-9\U4 MG%NI<,;P[[XW'#MH=(?ZP\[HOE]B'3%KXQK!A_5B0;?;!T7P)E MB7[ZH]ZT1F`HA58UCM(K^`,6X,R<*`K6'9\(;,+LR0I>'9X5H+]N(/^M:E1U MJ719($-!]+F)%S+2[W_&+#26P/JL/0[=G(CC$5P:)@BE+`:(V,$NCJ$MMV(=.3 M!EG";///@'+U&9R#5T?3:<6TDWB>(3$-9C(3`X<2O.HRIS\%NAN'@+70EP\Z M1,=REH-F9^LBPU8:!JUQJLO2+:P<4ZH>(/A'<[.!86?DEPPCL3(RVM7E81#P MV9CHFY.)WBMU\((JS`8$2S*:,#H[;?0.GXW.)-(2=BW]DN(ATD5&N+@E. MN%A$-\>8)<>PQQ\W'0QK)^O-CF1]C8G$_@^53HV.I_NF`1K M1O@I6RX;I'UWG$TQ4EC1&I5&JS!K1"A,^4<2627G=*%C;;X3[P$+M1P+2,JP M>U+N4;09^\"\S+(;X:.-!@S/<1/(M('2C527]-M04DZD=,A,#XAGF&@MB/:! MFMV=)5`HQOIC=C4K&6'$A7[\(81^3`1;WE&.8>["K(L5/GI]M*/:SX>;V>4Q MAD,K/+0"1!JQNOP-B8HRO0.1<%*@?UP]L&6/;@"G"0#71"!(BAD ML*K&5:8,XX3[M#U8>^H[K)=JN^H[_KA:6R?\$TF^A>!.[SO\.7[?L`EC'U;9 M,Y&U/C(`_\>$7#?2-;CP;;-&]YKZBT`HQ#,EO[N+F*/:\T'@&HC MO3I[DEY2(Y??GJT4^L!6+TRK]41/-WY1;YV;LK_C3-`1C$!V#PP*$)U()V+C=U)0(8;CH:5\7 M)_]FJRUJQTHUXX^]HBDE2V%QF.C2W:@I"9,Y"(=:ZIT(PL5-S?S(XHK""EU# M4:5N]`0@*)_UX;F>(6LH>@J9%0V\L9'S0A%OM'(=G&(FTQY^P0)VK4KVI0R) MUPUU$P\&TN1IS2N9N%E$X01?#=:)OFZ1.8(41F0/N"&'8J%G;MF%X2K^ M(8ZV?!P,`ZZO\Z!W,QU\#AL/(M4V]S\&NF1=Q3AY3SR=!0XHGE!&=;5[)Q3" M9$.I4-BDCO<*=@]$8;'<]FL2%9C=U%P![:I=[D:KJBK@;>Q"AV'JRP>\U#9O MN6H7^4G\[)(I`9.]CL'4YV:&P11UNI]N.EY0IZ21V)X>HKMZ/@/;5Y^C#5;O M:4&X))E17T2C;(-YK^V'>_EC*?;(9#?#1WC=I8*XRB'B.W5))Y#KOKOR+/9I MM=X54_E)XA#1-PBDO!.!']U6A.#)NE[EED#R0NXI#X19R*+%*0G*"?HO,AG\ MP!"EKF>A8YP:L+UH/U'XA"[0Z)+H?Y_O6BV3H93-%U*!.Q6GI&-R:_F)"VR[ M5#(WJB'<6FUL`B^\N&RYX6D"^7 MH^FBQ'SW]DJ5RZG#ZOCRW3U!OUR!R.[F+1/68;+E<5RH!>N9N'?_<=S2U_XXXTYN+Z[TLL_BN&#[^ M%U!+`0(>`Q0````(`/1<_CP6)G]6WV4``+$.!0`1`!@```````$```"D@0`` M``!M9VQN+3(P,3`P-C,P+GAM;%54!0`#//)23'5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`/1<_CR#;Y?H.0H``+"&```5`!@```````$```"D@2IF``!M M9VQN+3(P,3`P-C,P7V-A;"YX;6Q55`4``SSR4DQU>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#T7/X\$8-$)H(,```&UL550%``,\\E),=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`]%S^/*E18B#`1@``*KP#`!4`&````````0```*2!@WT` M`&UG;&XM,C`Q,#`V,S!?;&%B+GAM;%54!0`#//)23'5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`/1<_CREO1*-5AP```W;`0`5`!@```````$```"D@9+$ M``!M9VQN+3(P,3`P-C,P7W!R92YX;6Q55`4``SSR4DQU>`L``00E#@``!#D! M``!02P$"'@,4````"`#T7/X\V]+:,/T(``"]4```$0`8```````!````I($W MX0``;6=L;BTR,#$P,#8S,"YX`L``00E#@``!#D!``!0 52P4&``````8`!@`:`@``?^H````` ` end XML 13 R11.xml IDEA: Document and Entity Information 2.2.0.7 false Document and Entity Information 9999 - Document - Document and Entity Information true false false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Document and Entity Information 0 mgln_DocumentAndEntityInformationAbstract mgln false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Entity Registrant Name 1 dei_EntityRegistrantName dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 MAGELLAN HEALTH SERVICES INC MAGELLAN HEALTH SERVICES INC false false false xbrli:normalizedStringItemType normalizedstring The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false 4 Entity Central Index Key 1 dei_EntityCentralIndexKey dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 0000019411 0000019411 false false false us-types:centralIndexKeyItemType na A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false 5 Document Type 1 dei_DocumentType dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 10-Q 10-Q false false false us-types:SECReportItemType na The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type should be limited to the same value as the supporting SEC submission type. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, NCSR, N-Q, and Other. No authoritative reference available. false 6 Document Period End Date 1 dei_DocumentPeriodEndDate dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 2010-06-30 2010-06-30 false false false xbrli:dateItemType date The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements this will be the filing date. The format of the date is CCYY-MM-DD. No authoritative reference available. false 7 Amendment Flag 1 dei_AmendmentFlag dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 false false false false false xbrli:booleanItemType na If the value is true, then the document as an amendment to previously-filed/accepted document. No authoritative reference available. false 8 Current Fiscal Year End Date 1 dei_CurrentFiscalYearEndDate dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 --12-31 --12-31 false false false xbrli:gMonthDayItemType monthday End date of current fiscal year in the format --MM-DD. No authoritative reference available. false 9 Entity Current Reporting Status 1 dei_EntityCurrentReportingStatus dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Yes Yes false false false us-types:yesNoItemType na Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. No authoritative reference available. false 10 Entity Filer Category 1 dei_EntityFilerCategory dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Large Accelerated Filer Large Accelerated Filer false false false us-types:filerCategoryItemType na Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. No authoritative reference available. false 11 Entity Common Stock, Shares Outstanding 1 dei_EntityCommonStockSharesOutstanding dei false na instant No definition available. false false false false false false false false false false false false 1 false true false false 33381346 33381346 false false false xbrli:sharesItemType shares Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument No authoritative reference available. false 12 Document Fiscal Year Focus 1 dei_DocumentFiscalYearFocus dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 2010 2010 false false false xbrli:gYearItemType positiveinteger This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. No authoritative reference available. false 13 Document Fiscal Period Focus 1 dei_DocumentFiscalPeriodFocus dei false na duration No definition available. false false false false false false false false false false false false 1 false false false false 0 0 Q2 Q2 false false false us-types:fiscalPeriodItemType na This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. No authoritative reference available. false 1 12 false UnKnown NoRounding UnKnown false true XML 14 R10.xml IDEA: Subsequent Event 2.2.0.7 false Subsequent Event 1050 - Disclosure - Subsequent Event true false false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Subsequent Event 0 mgln_SubsequentEventDislcosureAbstract mgln false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Subsequent Event 1 us-gaap_ScheduleOfSubsequentEventsTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE ESubsequent Event Stock Repurchase         On July 27, 2010 the Company's board of directors approved a stock repurchase plan which authorizes the Company to purchase up to $350 million of its outstanding common stock through July 27, 2012. Stock repurchases under the program may be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions from time to time and in such amounts and via such methods as management deems appropriate. The stock repurchase program may be limited or terminated at any time without prior notice.</td></tr></table> NOTE ESubsequent Event Stock Repurchase         On July 27, 2010 the Company's board of directors approved false false false us-types:textBlockItemType textblock Describes disclosed significant events or transactions that occurred after the balance sheet date, but before the issuance of the financial statements. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 11 false 1 2 false UnKnown UnKnown UnKnown false true XML 15 R8.xml IDEA: Business Segment Information 2.2.0.7 false Business Segment Information 1030 - Disclosure - Business Segment Information true false false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Business Segment Information 0 mgln_BusinessSegmentInformationDislcosureAbstract mgln false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Business Segment Information 1 us-gaap_SegmentReportingDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE CBusiness Segment Information         The accounting policies of the Company's segments are the same as those described in Note A"General." The Company evaluates performance of its segments based on profit or loss from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes ("Segment Profit"). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Intersegment sales and transfers are not significant.         The following tables summarize, for the periods indicated, operating results by business segment (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 123pt; BORDER-BOTTOM: #000000 1pt solid">Three Months Ended June 30, 2009 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">160,190</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">343,181</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">70,565</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">61,865</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">635,801</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(88,851</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(309,770</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(44,427</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(443,048</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(49,286</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(49,286</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(38,008</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(16,910</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(12,469</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(6,870</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(74,257</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(28,677</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(28,677</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">188</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">209</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">424</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">2,136</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">3,211</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">6,168</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">33,519</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">16,710</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">14,093</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">7,845</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(25,466</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">46,701</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="70"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 75pt; BORDER-BOTTOM: #000000 1pt solid">Three Months Ended June 30, 2010 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Medicaid Administration </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">160,982</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">368,011</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">105,263</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">67,993</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">39,409</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">741,658</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(90,583</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(311,609</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(70,286</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(472,478</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(54,771</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(54,771</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(37,716</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(15,458</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(15,401</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(5,922</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(34,039</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(108,536</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(31,081</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(31,081</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">194</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">172</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">368</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">114</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">22</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">2,836</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">3,706</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">32,877</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">41,116</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">19,944</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">7,414</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">5,392</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(28,245</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">78,498</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 114pt; BORDER-BOTTOM: #000000 1pt solid">Six Months Ended June 30, 2009 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">318,943</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">665,041</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">144,124</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">127,208</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1,255,316</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(178,637</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(601,916</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(94,213</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(874,766</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(101,358</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(101,358</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(76,533</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(34,206</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(25,507</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(13,264</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(149,510</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(56,488</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(56,488</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">520</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">444</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">794</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">4,218</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">6,624</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">12,600</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">64,293</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">29,363</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">25,198</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">16,804</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(49,864</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">85,794</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 54%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="150%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="58"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="46"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="73"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="70"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="6"></td> <td style="FONT-FAMILY: times" width="61"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" nowrap="nowrap" align="left"> <div style="MARGIN-BOTTOM: 0pt; WIDTH: 66pt; BORDER-BOTTOM: #000000 1pt solid">Six Months Ended June 30, 2010 </div></th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Commercial </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Public Sector </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Radiology Benefits Management </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Specialty Pharmaceutical Management</th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Medicaid Administration </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Corporate and Other </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Consolidated </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Net revenue</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">322,684</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">717,479</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">214,720</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">136,131</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">78,697</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">1,469,711</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Cost of care</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(181,255</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(620,671</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(147,231</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(949,157</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Cost of goods sold</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(111,067</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(111,067</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Direct service costs</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(75,184</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(33,005</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(30,239</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(11,473</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(66,627</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(216,528</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Other operating expenses</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right"></td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(61,343</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(61,343</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense(1)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">432</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">373</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">761</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">257</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">40</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">6,371</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">8,234</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit (loss)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">66,677</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">64,176</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">38,011</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">13,848</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">12,110</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">(54,972</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">139,850</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div> <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt; POSITION: relative; TEXT-ALIGN: left"> <hr style="COLOR: #000000" align="left" width="26%" noshade="noshade" size="1" /> <dl compact="compact"> <dt style="MARGIN-BOTTOM: -9pt; FONT-FAMILY: times">(1)</dt> <dd style="FONT-FAMILY: times">Stock compensation expense is included in direct service costs and other operating expenses, however this amount is excluded from the computation of Segment Profit since it is managed on a consolidated basis. </dd></dl></div>         The following table reconciles Segment Profit to consolidated income from continuing operations before income taxes (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="18"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="50"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="5">Three Months Ended June 30, </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="5">Six Months Ended June 30, </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2009 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2010 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2009 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">2010 </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Segment profit</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">46,701</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">78,498</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">85,794</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">139,850</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Stock compensation expense</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(6,168</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(3,706</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(12,600</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(8,234</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Depreciation and amortization</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(10,516</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(14,235</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(21,559</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(27,657</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Interest expense</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(657</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(584</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(1,084</td> <td style="FONT-FAMILY: times">)</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">(1,269</td> <td style="FONT-FAMILY: times">)</td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times"> Interest income</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">1,734</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">803</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">4,045</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">1,620</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="bottom" bgcolor="white"> <td style="FONT-FAMILY: times"> Income from continuing operations before income taxes</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">31,094</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">60,776</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">54,596</td> <td style="FONT-FAMILY: times"> </td> <td style="FONT-FAMILY: times" align="right">$</td> <td style="FONT-FAMILY: times" align="right">104,310</td> <td style="FONT-FAMILY: times"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div></td></tr></table> NOTE CBusiness Segment Information         The accounting policies of the Company's segments are the same as false false false us-types:textBlockItemType textblock This element may be used to capture the complete disclosure of reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10% or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 false 1 2 false UnKnown UnKnown UnKnown false true XML 16 R3.xml IDEA: CONSOLIDATED STATEMENTS OF INCOME 2.2.0.7 false CONSOLIDATED STATEMENTS OF INCOME (USD $) 0020 - Statement - CONSOLIDATED STATEMENTS OF INCOME true false In Thousands, except Per Share data false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 3 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 4 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 5 Net revenue 3 us-gaap_Revenues us-gaap true credit duration No definition available. false false false false false false false false false false false terselabel false 1 true true false false 741658000 741658 false false false 2 true true false false 635801000 635801 false false false 3 true true false false 1469711000 1469711 false false false 4 true true false false 1255316000 1255316 false false false xbrli:monetaryItemType monetary Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false 6 Cost and expenses: 3 mgln_OperatingNonOperatingIncomeExpenseAbstract mgln false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false 4 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 7 Cost of care 4 us-gaap_HealthCareOrganizationExpensesNet us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 472478000 472478 false false false 2 false true false false 443048000 443048 false false false 3 false true false false 949157000 949157 false false false 4 false true false false 874766000 874766 false false false xbrli:monetaryItemType monetary Total costs of health care costs, net of recoveries of stop-loss insurance. Costs of services rendered (including costs of services rendered but not yet reported). If a provider of prepaid health care services is obligated to render services to specific members beyond the premium period due to provisions in the contract or regulatory requirements, the costs of such services to be incurred also should be accrued currently. Costs that will be incurred after a contract is terminated, such as guaranteed salaries, rent, and depreciation, net of any anticipated revenues, should be accrued when it is determined that a contract with a sponsoring employer or other group will be terminated. Includes also losses recognized when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated, i.e., when it is probably that expected future health care costs and maintenance costs under existing contracts will exceed anticipated future premiums and stop-loss insu rance recoveries on those contracts. Includes also the costs of stop-loss insurance premiums. Includes also contract acquisition costs (e.g., costs associated with marketing of subscriber contracts and member enrollments). No authoritative reference available. false 8 Cost of goods sold 4 us-gaap_CostOfGoodsSold us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 54771000 54771 false false false 2 false true false false 49286000 49286 false false false 3 false true false false 111067000 111067 false false false 4 false true false false 101358000 101358 false false false xbrli:monetaryItemType monetary Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 false 9 Direct service costs and other operating expenses 4 mgln_DirectServiceCostsAndOtherOperatingExpenses mgln false debit duration Direct Service Costs and generally recurring costs associated with normal operations except for the portion of these expenses... false false false false false false false false false false false terselabel false 1 false true false false 139617000 139617 [1] false false false 2 false true false false 102934000 102934 [1] false false false 3 false true false false 277871000 277871 [1] false false false 4 false true false false 205998000 205998 [1] false false false xbrli:monetaryItemType monetary Direct Service Costs and generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No authoritative reference available. false 10 Depreciation and amortization 4 us-gaap_DepreciationDepletionAndAmortization us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 14235000 14235 false false false 2 false true false false 10516000 10516 false false false 3 false true false false 27657000 27657 false false false 4 false true false false 21559000 21559 false false false xbrli:monetaryItemType monetary The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. No authoritative reference available. false 11 Interest expense 4 us-gaap_InterestExpense us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 584000 584 false false false 2 false true false false 657000 657 false false false 3 false true false false 1269000 1269 false false false 4 false true false false 1084000 1084 false false false xbrli:monetaryItemType monetary The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 34 -Paragraph 21 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher OTS -Name Federal Regulation (FR) -Number Title 12 -Chapter V -Section 563c.102 -Paragraph 9 -Subsection II Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 false 12 Interest income 4 us-gaap_InvestmentIncomeInterest us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false -803000 -803 false false false 2 false true false false -1734000 -1734 false false false 3 false true false false -1620000 -1620 false false false 4 false true false false -4045000 -4045 false false false xbrli:monetaryItemType monetary Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 14 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Article 5 false 13 Total cost and expenses 4 mgln_OperatingNonOperatingIncomeExpense mgln false debit duration The net result for the period of adding the operating and non-operating income and expenses. false false false false false false false false false false false totallabel false 1 false true false false 680882000 680882 false false false 2 false true false false 604707000 604707 false false false 3 false true false false 1365401000 1365401 false false false 4 false true false false 1200720000 1200720 false false false xbrli:monetaryItemType monetary The net result for the period of adding the operating and non-operating income and expenses. No authoritative reference available. true 14 Income from continuing operations before income taxes 3 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 60776000 60776 false false false 2 false true false false 31094000 31094 false false false 3 false true false false 104310000 104310 false false false 4 false true false false 54596000 54596 false false false xbrli:monetaryItemType monetary Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Subparagraph 1(i) -Article 4 true 15 Provision for income taxes 3 us-gaap_IncomeTaxExpenseBenefit us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 25348000 25348 false false false 2 false true false false 12695000 12695 false false false 3 false true false false 43363000 43363 false false false 4 false true false false 22637000 22637 false false false xbrli:monetaryItemType monetary The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph a, b false 16 Net income 3 us-gaap_ProfitLoss us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 35428000 35428 false false false 2 false true false false 18399000 18399 false false false 3 false true false false 60947000 60947 false false false 4 false true false false 31959000 31959 false false false xbrli:monetaryItemType monetary The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 5 -Subparagraph b Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) true 17 Other comprehensive income (loss) 3 us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false -285000 -285 false false false 2 false true false false 66000 66 false false false 3 false true false false -259000 -259 false false false 4 false true false false -220000 -220 false false false xbrli:monetaryItemType monetary This element represents Other Comprehensive Income (Loss), Net of Tax, for the period. Includes deferred gains (losses) on qualifying hedges, unrealized holding gains (losses) on available-for-sale securities, minimum pension liability, and cumulative translation adjustment. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 22, 23, 24, 25 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 false 18 Comprehensive income 3 us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest us-gaap true credit duration No definition available. false false false false false false false false false false false totallabel false 1 true true false false 35143000 35143 false false false 2 true true false false 18465000 18465 false false false 3 true true false false 60688000 60688 false false false 4 true true false false 31739000 31739 false false false xbrli:monetaryItemType monetary The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a true 19 Weighted average number of common shares outstanding-basic (See Note B) (in shares) 3 us-gaap_WeightedAverageNumberOfSharesOutstandingBasic us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 33323000 33323 false false false 2 false true false false 34955000 34955 false false false 3 false true false false 33849000 33849 false false false 4 false true false false 35578000 35578 false false false xbrli:sharesItemType shares Number of [basic] shares, after adjustment for contingently issuable shares and other shares not deemed outstanding, determined by relating the portion of time within a reporting period that common shares have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 171 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 false 20 Weighted average number of common shares outstanding-diluted (See Note B) (in shares) 3 us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 33800000 33800 false false false 2 false true false false 34992000 34992 false false false 3 false true false false 34434000 34434 false false false 4 false true false false 35686000 35686 false false false xbrli:sharesItemType shares The average number of shares issued and outstanding that are used in calculating diluted EPS, determined based on the timing of issuance of shares in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 false 21 Net income per common share-basic: (in dollars per share) 3 us-gaap_EarningsPerShareBasic us-gaap true na duration No definition available. false false false false false false false false false false false terselabel true 1 true true false false 1.06 1.06 false false false 2 true true false false 0.53 0.53 false false false 3 true true false false 1.80 1.80 false false false 4 true true false false 0.90 0.90 false false false us-types:perShareItemType decimal The amount of net income or loss for the period per each share of common stock outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 false 22 Net income per common share-diluted: (in dollars per share) 3 us-gaap_EarningsPerShareDiluted us-gaap true na duration No definition available. false false false false false false false false false false false terselabel true 1 true true false false 1.05 1.05 false false false 2 true true false false 0.53 0.53 false false false 3 true true false false 1.77 1.77 false false false 4 true true false false 0.90 0.90 false false false us-types:perShareItemType decimal The amount of net income or loss for the period per each share of common stock and dilutive common stock equivalents outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false 1 Includes stock compensation expense of $6,168 and $3,706 for the three months ended June 30, 2009 and 2010, and $12,600 and $8,234 for the six months ended June 30, 2009 and 2010, respectively. 4 18 false Thousands Thousands NoRounding false true XML 17 R4.xml IDEA: CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) 2.2.0.7 false CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) (USD $) 0025 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) true false In Thousands false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 3 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 4 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 CONSOLIDATED STATEMENTS OF INCOME 0 us-gaap_IncomeStatementAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false 3 false false false false 0 0 false false false 4 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Stock compensation expense 1 us-gaap_ShareBasedCompensation us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 true true false false 3706000 3706 false false false 2 true true false false 6168000 6168 false false false 3 true true false false 8234000 8234 false false false 4 true true false false 12600000 12600 false false false xbrli:monetaryItemType monetary The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock options, amortization of restricted stock, and adjustment for officers compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 4 2 false Thousands UnKnown UnKnown false true XML 18 R9.xml IDEA: Commitments and Contingencies 2.2.0.7 false Commitments and Contingencies 1040 - Disclosure - Commitments and Contingencies true false false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Commitments and Contingencies 0 mgln_CommitmentsAndContingenciesDislcosureAbstract mgln false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Commitments and Contingencies 1 us-gaap_CommitmentsAndContingenciesDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE DCommitments and Contingencies Legal         The management and administration of the delivery of specialty managed healthcare entails significant risks of liability. From time to time, the Company is subject to various actions and claims arising from the acts or omissions of its employees, network providers or other parties. In the normal course of business, the Company receives reports relating to deaths and other serious incidents involving patients whose care is being managed by the Company. Such incidents occasionally give rise to malpractice, professional negligence and other related actions and claims against the Company or its network providers. Many of these actions and claims received by the Company seek substantial damages and therefore require the Company to incur significant fees and costs related to their defense. The Company is also subject to or party to certain class actions, litigation and claims rel ating to its operations and business practices. In the opinion of management, the Company has recorded reserves that are adequate to cover litigation, claims or assessments that have been or may be asserted against the Company, and for which the outcome is probable and reasonably estimable. Management believes that the resolution of such litigation and claims will not have a material adverse effect on the Company's financial condition or results of operations; however, there can be no assurance in this regard. Stock Repurchases         On July 30, 2008 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $200 million of its outstanding common stock through January 31, 2010. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 3,866,505 shares of the Company's common stock at an aggregate cost of $136.0 million (excluding broker commissions) durin g the year ended December 31, 2008 and made open market purchases of 1,859,959 shares of the Company's common stock at an average share price of $34.39 per share for an aggregate cost of $64.0 million (excluding broker commissions) during the period January 1, 2009 through April 7, 2009, which was the date that the repurchase program was completed, the $200 million authorization having been exhausted.         On July 28, 2009 the Company's board of directors approved a stock repurchase plan which authorized the Company to purchase up to $100 million of its outstanding common stock through July 28, 2011. Stock repurchases under the program could be executed through open market repurchases, privately negotiated transactions, accelerated share repurchases or other means. The board of directors authorized management to execute stock repurchase transactions under the program from time to time and in such amounts and via such methods as management deemed appropriate. The stock repurchase program could be limited or terminated at any time without prior notice. Pursuant to this program, the Company made open market purchases of 782,400 shares of the Company's common stock at an average price of $32.75 per share for an aggregate cost of $25.6 million ( excluding broker commissions) during the period from August 17, 2009 through December 31, 2009. Pursuant to this program, the Company made open market purchases of 1,711,881 shares of the Company's common stock at an average price of $43.46 per share for an aggregate cost of $74.4 million (excluding broker commissions) during the period January 1, 2010 through April 1, 2010, which was the date that the repurchase program was completed, the $100 million authorization having been exhausted. Acquisition of First Health Services         Pursuant to the June 4, 2009 Purchase Agreement (the "Purchase Agreement") with Coventry, on July 31, 2009 the Company acquired (the "Acquisition") all of the outstanding equity interests of Coventry's direct and indirect subsidiaries First Health Services Corporation ("FHS"), FHC, Inc. ("FHC") and Provider Synergies, LLC (together with FHS and FHC, "First Health Services") and certain assets of Coventry which are related to the operation of the business conducted by First Health Services. First Health Services provides pharmacy benefits management and other services to Medicaid programs. As consideration for the Acquisition, the Company paid $115.4 million in cash, excluding cash acquired and including a payment of $7.4 million for excess working capital with such amount being subject to final adjustments as provided in the Purchase Agreement. The Company funded the Acquisition with cash on hand.         As of June 30, 2010, settlement of the working capital receivable and certain contractual liabilities remain open and therefore subject to further estimation. In addition, the amount recognized for deferred tax liabilities may be impacted by the determination of these items. The Company will make appropriate adjustments to the purchase price allocation prior to the completion of the measurement period as required.         The Company reports the results of operations of First Health Services within Medicaid Administration.         Effective July 1, 2010 the Company discontinued the use of the name First Health Services Corporation and officially changed such name to "Magellan Medicaid Administration, Inc."</td></tr></table> NOTE DCommitments and Contingencies Legal         The management and administration of the delivery of false false false us-types:textBlockItemType textblock Includes disclosure of commitments and contingencies. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 14 -Paragraph 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 9, 10, 11, 12 false 1 2 false UnKnown UnKnown UnKnown false true XML 19 R6.xml IDEA: General 2.2.0.7 false General 1010 - Disclosure - General true false false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 General 0 mgln_GeneralDislcosureAbstract mgln false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 General 1 us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock us-gaap true na duration No definition available. false false false false false false false false false false false terselabel false 1 false false false false 0 0 <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> NOTE AGeneral Basis of Presentation         The accompanying unaudited consolidated financial statements of Magellan Health Services, Inc., a Delaware corporation ("Magellan"), include the accounts of Magellan, its majority owned subsidiaries, and the variable interest entity ("VIE") for which Magellan is the primary beneficiary (together with Magellan, the "Company"). The financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the Securities and Exchange Commission's (the "SEC") instructions to Form 10-Q. Accordingly, the financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments con sidered necessary for a fair presentation, have been included. The results of operations for the six months ended June 30, 2010 are not necessarily indicative of the results to be expected for the full year. All significant intercompany accounts and transactions have been eliminated in consolidation.         The Company evaluated all events or transactions that occurred after June 30, 2010 and through the date we issued these financial statements. The Company did not have any material recognizable subsequent events during this period.         These unaudited consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements for the year ended December 31, 2009 and the notes thereto, which are included in the Company's Annual Report on Form 10-K filed with the SEC on February 26, 2010. Business Overview         The Company is engaged in the specialty managed healthcare business. Through 2005, the Company predominantly operated in the managed behavioral healthcare business. During 2006, the Company expanded into radiology benefits management and specialty pharmaceutical management as a result of certain acquisitions. During 2009, the Company expanded into Medicaid administration. The Company provides services to health plans, insurance companies, employers, labor unions and various governmental agencies. The Company's business is divided into the following six segments, based on the services it provides and/or the customers that it serves, as described below. Managed Behavioral Healthcare         Two of the Company's segments are in the managed behavioral healthcare business. This line of business generally reflects the Company's coordination and management of the delivery of behavioral healthcare treatment services that are provided through its contracted network of third-party treatment providers, which includes psychiatrists, psychologists, other behavioral health professionals, psychiatric hospitals, general medical facilities with psychiatric beds, residential treatment centers and other treatment facilities. The treatment services provided through the Company's provider network include outpatient programs (such as counseling or therapy), intermediate care programs (such as intensive outpatient programs and partial hospitalization services), inpatient treatment and crisis intervention services. The Company generally does not directly provide, or own any provide r of, treatment services except as related to the Company's contract to provide managed behavioral healthcare services to Medicaid recipients and other beneficiaries of the Maricopa County Regional Behavioral Health Authority (the "Maricopa Contract"). Under the Maricopa Contract, effective August 31, 2007 the Company was required to assume the operations of twenty-four behavioral health direct care facilities for a transitional period and to divest itself of these facilities over a two year period. During March 2009, the Company began the operation of two additional behavioral health direct care facilities. In 2008 and 2009, the Company entered into agreements to transition all behavioral health direct care facilities over various dates. All of the direct care facilities were transitioned as of December 31, 2009.         The Company provides its management services primarily through: (i) risk-based products, where the Company assumes all or a substantial portion of the responsibility for the cost of providing treatment services in exchange for a fixed per member per month fee, (ii) administrative services only ("ASO") products, where the Company provides services such as utilization review, claims administration and/or provider network management, but does not assume responsibility for the cost of the treatment services, and (iii) employee assistance programs ("EAPs") where the Company provides short-term outpatient behavioral counseling services.         The managed behavioral healthcare business is managed based on the services provided and/or the customers served, through the following two segments:         Commercial.    The Managed Behavioral Healthcare Commercial segment ("Commercial") generally reflects managed behavioral healthcare services and EAP services provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members, as well as with employers, including corporations and governmental agencies, and labor unions. Commercial's contracts encompass risk-based, ASO and EAP arrangements.         Public Sector.    The Managed Behavioral Healthcare Public Sector segment ("Public Sector") generally reflects services provided to Medicaid recipients under contracts with state and local governmental agencies. Public Sector contracts encompass either risk-based or ASO arrangements. Radiology Benefits Management         The Radiology Benefits Management segment ("Radiology Benefits Management") generally reflects the management of the delivery of diagnostic imaging services to ensure that such services are clinically appropriate and cost effective. The Company's radiology benefits management services currently are provided under contracts with health plans and insurance companies for some or all of their commercial, Medicaid and Medicare members. The Company also contracts with state and local governmental agencies for the provision of such services to Medicaid recipients. The Company offers its radiology benefits management services through ASO contracts, where the Company provides services such as utilization review and claims administration, but does not assume responsibility for the cost of the imaging services, and through risk-based contracts, where the Company assumes all or a subst antial portion of the responsibility for the cost of providing diagnostic imaging services. Specialty Pharmaceutical Management         The Specialty Pharmaceutical Management segment ("Specialty Pharmaceutical Management") generally reflects the management of specialty drugs used in the treatment of cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis and other diseases. Specialty pharmaceutical drugs represent high-cost injectible, infused, oral, or inhaled drugs often with sensitive handling or storage needs. Patients receiving these drugs require greater amounts of clinical and financial support than those taking more traditional agents. The Company's specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, and governmental agencies for some or all of their commercial, Medicare and Medicaid members. The Company's specialty pharmaceutical services include (i) contracting and formulary optimi zation on behalf of health plans and pharmaceutical manufacturers; (ii) dispensing specialty pharmaceutical drugs on behalf of health plans; (iii) providing strategic consulting services to health plans and pharmaceutical manufacturers; and (iv) providing oncology management services to health plans and state Medicaid programs. Medicaid Administration         The Medicaid Administration segment ("Medicaid Administration") generally reflects integrated clinical management services provided to the public sector to manage Medicaid, pharmacy, mental health and long-term care programs. The primary focus of the Company's Medicaid Administration involves providing pharmacy benefits administration ("PBA") services under contracts with states to Medicaid and other state sponsored program recipients. Medicaid Administration's contracts encompass Fee-For-Service ("FFS") arrangements. Corporate and Other         This segment of the Company is comprised primarily of operational support functions such as sales and marketing and information technology, as well as corporate support functions such as executive, finance, human resources and legal. Summary of Significant Accounting Policies Recent Accounting Pronouncements         In June 2009, the Financial Accounting Standards Board ("FASB") established the FASB Accounting Standards Codification ("ASC") as the source of authoritative accounting principles recognized by the FASB to be applied in the preparation of financial statements in conformity with generally accepted accounting principles ("GAAP"). This statement has been incorporated into ASC 105. This guidance explicitly recognizes rules and interpretive releases of the SEC under federal securities laws as authoritative GAAP for SEC registrants. Such guidance was effective for financial statements issued for interim and annual reporting periods ending after September 15, 2009 (the quarter ending September 30, 2009 for the Company) and did not have an impact on the Company's results of operations or financial condition, but changed the referencing system for accounting standa rds. All public filings of the Company now reference the ASC as the sole source of authoritative literature.         In June 2009, the FASB issued Statement of Financial Accounting Standards ("SFAS") No. 167, "Amendments to FASB Interpretation No. 46R". This statement has been incorporated into ASC 810 "Consolidation" ("ASC 810") and amends FASB Interpretation No. 46 (revised December 2003), "Consolidation of Variable Interest Entities" to require an analysis to determine whether a variable interest gives the entity a controlling financial interest in a variable interest entity. This statement requires an ongoing reassessment and eliminates the quantitative approach previously required for determining whether an entity is the primary beneficiary. This statement was effective for fiscal years beginning after November 15, 2009. Accordingly, the Company adopted ASC 810 on January 1, 2010. The adoption of this standard did not have a material impac t on the consolidated financial statements.         In January 2010, the FASB issued Accounting Standards Update, ("ASU"), No. 2010-06, "Improving Disclosures about Fair Value Measurements", ("ASU 2010-06"). ASU 2010-06 amends ASC Topic 820, "Fair Value Measurements and Disclosures", to require a number of additional disclosures regarding fair value measurements. Effective January 1, 2010, ASU 2010-06 requires disclosure of the amounts of significant transfers between Level I and Level II and the reasons for such transfers, the reasons for any transfers in or out of Level III, and disclosure of the policy for determining when transfers between levels are recognized. ASU 2010-06 also clarified that disclosures should be provided for each class of assets and liabilities and clarified the requirement to disclose information about the valuation techniques and inputs used in estimating Level II and Level III measurements. Beginning January 1, 2011, ASU 2010-06 also requires that information in the reconciliation of recurring Level III measurements about purchases, sales, issuances and settlements be provided on a gross basis. The adoption of ASU 2010-06 only required additional disclosures and did not have an impact on the consolidated financial statements. As the Company does not have significant transfers between Levels, or any Level III measurements, no additional disclosures were necessary. Use of Estimates         The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates of the Company include, among other things, accounts receivable realization, valuation allowances for deferred tax assets, valuation of goodwill and intangible assets, medical claims payable, other medical liabilities, stock compensation assumptions, tax contingencies and legal liabilities. Actual results could differ from those estimates. Managed Care Revenue         Managed care revenue, inclusive of revenue from the Company's risk, EAP and ASO contracts, is recognized over the applicable coverage period on a per member basis for covered members. The Company is paid a per member fee for all enrolled members, and this fee is recorded as revenue in the month in which members are entitled to service. The Company adjusts its revenue for retroactive membership terminations, additions and other changes, when such adjustments are identified, with the exception of retroactivity that can be reasonably estimated. Any fees paid prior to the month of service are recorded as deferred revenue. Managed care revenues approximated $573.9 million and $1,128.1 million for the three and six months ended June 30, 2009, respectively, and $591.2 million and $1,174.6 million for the three and six months ended June& amp;nbsp;30, 2010, respectively. Fee-For-Service and Cost-Plus Contracts         The Company has certain fee-for-service ("FFS") contracts, including cost-plus contracts, with customers under which the Company recognizes revenue as services are performed and as costs are incurred. Revenues from fee-for-service and cost-plus contracts approximated $9.7 million and $19.2 million for the three and six months ended June 30, 2009, respectively, and $48.9 million and $98.3 million for the three and six months ended June 30, 2010, respectively. FFS revenue for 2010 includes the activity from the Medicaid Administration segment. Block Grant Revenues         The Maricopa Contract is partially funded by federal, state and county block grant money, which represents annual appropriations. The Company recognizes revenue from block grant activity ratably over the period to which the block grant funding applies. Block grant revenues were approximately $29.3 million and $54.7 million for the three and six months ended June 30, 2009, respectively, and $30.7 million and $56.8 million for the three and six months ended June 30, 2010, respectively. Dispensing Revenue         The Company recognizes dispensing revenue, which includes the co-payments received from members of the health plans the Company serves, when the specialty pharmaceutical drugs are shipped. At the time of shipment, the earnings process is complete; the obligation of the Company's customer to pay for the specialty pharmaceutical drugs is fixed, and, due to the nature of the product, the member may neither return the specialty pharmaceutical drugs nor receive a refund. Revenues from the dispensing of specialty pharmaceutical drugs on behalf of health plans were $53.6 million and $110.2 million for the three and six months ended June 30, 2009, respectively, and $58.7 million and $119.7 million for the three and six months ended June 30, 2010, respectively. Performance-Based Revenue         The Company has the ability to earn performance-based revenue under certain risk and non-risk contracts. Performance-based revenue generally is based on either the ability of the Company to manage care for its clients below specified targets, or on other operating metrics. For each such contract, the Company estimates and records performance-based revenue after considering the relevant contractual terms and the data available for the performance-based revenue calculation. Pro-rata performance-based revenue is recognized on an interim basis pursuant to the rights and obligations of each party upon termination of the contracts. Performance-based revenues were $2.0 million and $3.3 million for the three and six months ended June 30, 2009, respectively, and $4.8 million and $5.8 million for the three and six months ended June&nbs p;30, 2010, respectively. Significant Customers <ul> <li style="list-style: none"> Consolidated Company </li></ul>         The Maricopa Contract generated net revenues that exceeded, in the aggregate, ten percent of net revenues for the consolidated Company for the six months ended June 30, 2009 and 2010. The Company also has a significant concentration of business from contracts with subsidiaries of WellPoint, Inc. ("WellPoint") and with various counties in the State of Pennsylvania (the "Pennsylvania Counties") which are part of the Pennsylvania Medicaid program.         Pursuant to the Maricopa Contract, the Company provides behavioral healthcare management and other related services to approximately 727,000 members in Maricopa County, Arizona. Under the Maricopa Contract, the Company is responsible for providing covered behavioral health services to persons eligible under Title XIX (Medicaid) and Title XXI (State Children's Health Insurance Program) of the Social Security Act, non-Title XIX and non-Title XIX eligible children and adults with a serious mental illness, and to certain non-Title XIX and non-Title XXI adults with behavioral health or substance abuse disorders. The Maricopa Contract began on September 1, 2007 and extends through June 30, 2012 unless sooner terminated by the parties. The State of Arizona has the right to terminate the Maricopa Contract for cause, as defined, upon ten days' notice with an opport unity to cure, and without cause immediately upon notice from the State. The Maricopa Contract generated net revenues of $351.9 million and $400.9 million for the six months ended June 30, 2009 and 2010, respectively.         Total net revenues from the Company's contracts with WellPoint were $88.5 million and $87.1 million during the six months ended June 30, 2009 and 2010, respectively, including radiology benefits management revenue of $81.6 million and $79.3 million, respectively.         In July 2007, WellPoint acquired a radiology benefits management company, and expressed its intent to in-source all of its radiology benefits management contracts when such contracts expire. The Company has a radiology benefits management contract with WellPoint that converted from an ASO arrangement to a risk arrangement effective July 1, 2007. Such risk contract has a term through December 31, 2010, and cannot be terminated early, except for cause, as defined in the agreement; the Company has received notice from WellPoint that it will allow this contract to expire as of December 31, 2010.         Net revenues from the Pennsylvania Counties in the aggregate totaled $153.7 million and $169.9 million for the six months ended June 30, 2009 and 2010, respectively. <ul> <li style="list-style: none"> By Segment </li></ul>         Two customers generated greater than ten percent of Commercial net revenues for the six months ended June 30, 2009 and 2010. The first customer has a contract that extends through December 31, 2012 and generated net revenues of $116.8 million and $126.9 million for the six months ended June 30, 2009 and 2010, respectively. The second customer has a contract that extends through June 30, 2014, terminable without cause upon 180 days' notice after June 30, 2012, and generated net revenues of $42.2 million and $36.8 million for the six months ended June 30, 2009 and 2010, respectively.         In addition to the Maricopa Contract, one other customer generated net revenues greater than ten percent of the net revenues for the Public Sector segment for the six months ended June 30, 2009 and 2010. This customer has a contract that extends through June 30, 2012, with options for the customer to extend the term of the contract for three one year terms, and generated net revenues of $72.4 million and $72.6 million for the six months ended June 30, 2009 and 2010, respectively.         In addition to WellPoint, one other customer generated greater than ten percent of the net revenues for the Radiology Benefits Management segment for the six months ended June 30, 2009 and three customers generated greater than ten percent of the net revenues for the Radiology Benefits Management segment for the six months ended June 30, 2010. The first customer has a contract that extends through May 31, 2011 and generated net revenues of $42.5 million and $34.4 million for the six months ended June 30, 2009 and 2010, respectively. For the six months ended June 30, 2010, the remaining two of three such customers generated $53.4 million and $25.9 million of the net revenues for this segment.         For the six months ended June 30, 2009, four customers each exceeded ten percent of the net revenues for the Specialty Pharmaceutical Management segment. Such customers generated $42.4 million, $26.8 million, $19.3 million, and $15.2 million of net revenues during the six months ended June 30, 2009. For the six months ended June 30, 2010, four customers each exceeded ten percent of the net revenues for this segment. Such customers generated $43.3 million, $30.4 million, $18.3 million, and $17.1 million of net revenues during the six months ended June 30, 2010.         For the six months ended June 30, 2010, five customers each exceeded ten percent of the net revenues for the Medicaid Administration segment. Three of such customers generated $11.5 million, $10.9 million, and $7.9 million of net revenues for this segment. One additional customer generated revenue of $15.8 million during the six months ended June 30, 2010, and this contract is scheduled to terminate on September 29, 2012, unless terminated earlier by the customer. Pursuant to a competitive bid process, the customer is expected to award this contract to a vendor other than the Company, with such transition scheduled to take place on June 30, 2011. Although the Company anticipates that its contract with the customer will terminate and the contract will transition to a new vendor on June 30, 2011, until formally terminated, the Company is obligated under the contract until September 29, 2012, and up to 18 months thereafter upon mutual consent. The remaining customer generated revenue of $9.5 million during this period, and this contract terminated June 30, 2010. Fair Value Measurements         The Company currently does not have non-financial assets and non-financial liabilities that are required to be measured at fair value on a recurring basis. Financial assets and liabilities are to be measured using inputs from the three levels of the fair value hierarchy, which are as follows:         Level 1Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.         Level 2Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).         Level 3Unobservable inputs that reflect the Company's assumptions about the assumptions that market participants would use in pricing the asset or liability. The Company develops these inputs based on the best information available, including the Company's data.         In accordance with the fair value hierarchy described above, the following table shows the fair value of the Company's financial assets and liabilities that are required to be measured at fair value as of June 30, 2010 (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="39"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="36"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="11">Fair Value Measurements at June 30, 2010</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Level 1 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Level 2 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Level 3 </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Total </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Cash and Cash Equivalents(1)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">66,249</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">66,249</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Restricted Cash(2)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">87,416</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">87,416</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Investments:</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> U.S. Government and agency securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Obligations of government-sponsored enterprises(3)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,980</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,980</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Corporate debt securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,589</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,589</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Certificates of deposit</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Taxable municipal bonds</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,726</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,726</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom">  </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">388,710</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">390,895</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div> <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt; POSITION: relative; TEXT-ALIGN: left"> <hr style="COLOR: #000000" align="left" width="26%" noshade="noshade" size="1" /> <dl compact="compact"> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(1)</dt> <dd style="FONT-FAMILY: times">Excludes $163.8 million of cash held in bank accounts by the Company. </dd> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(2)</dt> <dd style="FONT-FAMILY: times">Excludes $36.3 million of restricted cash held in bank accounts by the Company. </dd> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(3)</dt> <dd style="FONT-FAMILY: times">Includes investments in notes issued by the Federal Home Loan Mortgage Corporation, and the Federal Home Loan Bank.</dd></dl></div>         All of the Company's investments are classified as "available-for-sale" and are carried at fair value, based on quoted market prices. The Company's policy is to classify all investments with contractual maturities within one year as current. Investment income is recognized when earned and reported net of investment expenses. Net unrealized holding gains or losses are excluded from earnings and are reported, net of tax, as "accumulated other comprehensive income (loss)" in the accompanying consolidated balance sheets and consolidated statements of income until realized, unless the losses are deemed to be other-than-temporary. Realized gains or losses, including any provision for other-than-temporary declines in value, are included in the consolidated statements of income.         ASC 320-10-65 applies to debt securities only and provides guidance on the recognition and presentation of other-than-temporary impairments. In addition, additional disclosures are required related to other-than-temporary impairments. Under this revised guidance, if a debt security is in an unrealized loss position and the Company has the intent to sell the debt security, or it is more likely than not that the Company will have to sell the debt security before recovery of its amortized cost basis, the decline in value is deemed to be other-than-temporary and is recorded to other-than-temporary impairment losses recognized in income in the consolidated statements of income. For impaired debt securities that the Company does not intend to sell or it is more likely than not that the Company will not have to sell such securities, but the Company expects that it will not fully r ecover the amortized cost basis, the credit component of the other-than-temporary impairment is recognized in other-than-temporary impairment losses recognized in income in the consolidated statements of income and the non-credit component of the other-than-temporary impairment is recognized in other comprehensive income.         The credit component of an other-than-temporary impairment is determined by comparing the net present value of projected future cash flows with the amortized cost basis of the debt security. The net present value is calculated by discounting the best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Cash flow estimates are driven by assumptions regarding probability of default, including changes in credit ratings, and estimates regarding timing and amount of recoveries associated with a default. Furthermore, unrealized losses entirely caused by non-credit related factors related to debt securities for which the Company expects to fully recover the amortized cost basis continue to be recognized in accumulated other comprehensive income.         As of December 31, 2009 and June 30, 2010, there were no unrealized losses that the Company believed to be other-than-temporary. No realized gains or losses were recorded for either the six months ended June 30, 2009 or June 30, 2010. The following is a summary of short-term and long-term investments at December 31, 2009 and June 30, 2010 (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="11">December 31, 2009 </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Amortized Cost </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Gains </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Losses </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Estimated Fair Value </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> U.S. Government and agency securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">378</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">1</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">379</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Obligations of government-sponsored enterprises(1)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">11,297</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(8</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">11,328</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Corporate debt securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">208,832</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">458</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(302</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">208,988</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Certificates of deposit</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Total investments at December 31, 2009</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">230,257</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">498</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(310</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">230,445</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>   <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; WIDTH: 80%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="11">June 30, 2010 </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Amortized Cost </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Gains </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Gross Unrealized Losses </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Estimated Fair Value </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> U.S. Government and agency securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,184</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">1</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,185</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Obligations of government-sponsored enterprises(1)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,961</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">19</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">6,980</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Corporate debt securities</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,834</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">128</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(373</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">215,589</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Certificates of deposit</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">9,750</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Taxable municipal bonds</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,740</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(14</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,726</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Total investments at June 30, 2010</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,469</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">148</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(387</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,230</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div> <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 10%; PADDING-TOP: 0pt; POSITION: relative; TEXT-ALIGN: left"> <hr style="COLOR: #000000" align="left" width="26%" noshade="noshade" size="1" /> <dl compact="compact"> <dt style="MARGIN-BOTTOM: -11pt; FONT-FAMILY: times">(1)</dt> <dd style="FONT-FAMILY: times">Includes investments in notes issued by the Federal Home Loan Mortgage Corporation, and the Federal Home Loan Bank.</dd></dl></div>         The maturity dates of the Company's investments as of June 30, 2010 are summarized below (in thousands): <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="51"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Amortized Cost </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Estimated Fair Value </th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> 2010</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">112,837</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">112,805</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> 2011</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">122,468</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">122,257</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> 2012</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,164</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">2,168</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Total investments at June 30, 2010</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,469</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">237,230</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         The carrying value for the Company's current assets (other than short-term investments) and current liabilities approximate their fair value due to their short maturities. Income Taxes         The Company's effective income tax rates were 41.5 percent and 41.6 percent for the six months ended June 30, 2009 and 2010, respectively. These rates differ from the federal statutory income tax rate primarily due to state income taxes and permanent differences between book and tax income. The Company also accrues interest and penalties related to unrecognized tax benefits in its provision for income taxes. Stock Compensation         At December 31, 2009 and June 30, 2010, the Company had equity-based employee incentive plans, which are described more fully in Note 6 in the Company's Annual Report on Form 10-K for the year ended December 31, 2009. The Company recorded stock compensation expense of $6.2 million and $12.6 million for the three and six months ended June 30, 2009, respectively, and $3.7 million and $8.2 million for the three and six months ended June 30, 2010, respectively. Stock compensation expense recognized in the consolidated statements of income for the three and six months ended June 30, 2009 and 2010 has been reduced for estimated forfeitures, estimated at five percent for each period.         The weighted average grant date fair value of all stock options granted during the six months ended June 30, 2010 was $11.78 as estimated using the Black-Scholes-Merton option pricing model, which also assumed an expected volatility of 31.7 percent based on the historical volatility of the Company's stock price.         The benefits of tax deductions in excess of recognized stock compensation expense are reported as a financing cash flow, rather than as an operating cash flow. In the six months ended June 30, 2009 and 2010, approximately $3.0 million and $0 million of benefits of such tax deductions related to stock compensation expense were realized and as such were reported as financing cash flows, respectively.         Summarized information related to the Company's stock options for the six months ended June 30, 2010 is as follows: <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="55"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="44"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Options </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Weighted Average Exercise Price</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, beginning of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">5,185,091</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.19</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Granted</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">850,255</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">42.72</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Forfeited</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(182,355</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">43.28</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Exercised</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(475,403</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">35.99</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, end of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">5,377,588</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.93</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Vested and expected to vest at end of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">5,240,347</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.94</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Exercisable, end of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">3,169,066</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39.28</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         All of the Company's options granted during the six months ended June 30, 2010 vest ratably on each anniversary date over the three years subsequent to grant, and all have a ten year life.         Summarized information related to the Company's nonvested restricted stock awards for the six months ended June 30, 2010 is as follows: <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="44"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="54"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Shares </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Weighted Average Grant Date Fair Value</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, beginning of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">28,910</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">30.27</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Awarded</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">22,309</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39.23</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Vested</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(28,910</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">30.27</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Forfeited</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right"></td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, ending of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">22,309</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">39.23</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         Restricted stock awards granted during the six months ended June 30, 2010 generally vest ratably on each anniversary date over a period of one year subsquent to grant.         Summarized information related to the Company's nonvested restricted stock units for the six months ended June 30, 2010 is as follows: <div style="PADDING-RIGHT: 0pt; PADDING-LEFT: 0pt; PADDING-BOTTOM: 0pt; MARGIN-LEFT: 20%; WIDTH: 60%; PADDING-TOP: 0pt; POSITION: relative">   <div align="center"> <table cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="FONT-FAMILY: times" align="left"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="45"></td> <td style="FONT-FAMILY: times" width="12"></td> <td style="FONT-FAMILY: times" align="right" width="7"></td> <td style="FONT-FAMILY: times" width="54"></td> <td style="FONT-FAMILY: times" width="12"></td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <th style="FONT-FAMILY: times" align="left">  </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Shares </th> <th style="FONT-FAMILY: times"> </th> <th style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" align="center" colspan="2">Weighted Average Grant Date Fair Value</th> <th style="FONT-FAMILY: times"> </th></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, beginning of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">184,454</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">34.99</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Awarded</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">101,812</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">42.75</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Vested</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(84,533</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">36.19</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="white"> <td style="FONT-FAMILY: times" valign="bottom"> Forfeited</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">(1,680</td> <td style="FONT-FAMILY: times" valign="bottom">)</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">37.37</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="HEIGHT: 0px" valign="top" bgcolor="#CCEEFF"> <td style="FONT-FAMILY: times" valign="bottom"> Outstanding, ending of period</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">200,053</td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom" align="right">$</td> <td style="FONT-FAMILY: times" valign="bottom" align="right">38.42</td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr> <tr style="FONT-SIZE: 1.5pt; HEIGHT: 0px" valign="top"> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 2.25pt double; FONT-FAMILY: times" valign="bottom" align="right" colspan="2"> </td> <td style="FONT-FAMILY: times" valign="bottom"> </td></tr></table></div> </div>         Restricted stock units granted during the six months ended June 30, 2010 generally vest ratably on each anniversary date over the three years subsequent to grant. Long Term Debt and Capital Lease Obligations         On April 30, 2008, the Company entered into a credit facility with Deutsche Bank AG and Citigroup Global Markets Inc. that provided for a $100.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2008 Credit Facility").         On April 29, 2009, the Company entered into an amendment to the 2008 Credit Facility with Deutsche Bank AG, Citibank, N.A., and Bank of America, N.A. that provided for an $80.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2009 Credit Facility"). Borrowings under the 2009 Credit Facility matured on April 28, 2010. The 2009 Credit Facility was guaranteed by substantially all of the subsidiaries of the Company and was secured by substantially all of the assets of the Company and the subsidiary guarantors.         Under the 2009 Credit Facility, the annual interest rate on Revolving Loan borrowings was equal to (i) in the case of U.S. dollar denominated loans, the sum of a borrowing margin of 2.25 percent plus the higher of the prime rate or one-half of one percent in excess of the overnight "federal funds" rate, or (ii) in the case of Eurodollar denominated loans, the sum of a borrowing margin of 3.25 percent plus the Eurodollar rate for the selected interest period. The Company had the option to borrow in U.S. dollar denominated loans or Eurodollar denominated loans at its discretion. Letters of Credit issued under the Revolving Loan Commitment bore interest at the rate of 3.375 percent. The commitment commission on the 2009 Credit Facility was 0.625 percent of the unused Revolving Loan Commitment.         On April 28, 2010, the Company entered into an amendment to the 2009 Credit Facility with Deutsche Bank AG, Citibank, N.A., and Bank of America, N.A. that provided for an $80.0 million Revolving Loan Commitment for the issuance of letters of credit for the account of the Company with a sublimit of up to $30.0 million for revolving loans (the "2010 Credit Facility"). Borrowings under the 2010 Credit Facility mature on April 28, 2013. The 2010 Credit Facility is guaranteed by substantially all of the subsidiaries of the Company and is secured by substantially all of the assets of the Company and the subsidiary guarantors.         Under the 2010 Credit Facility, the annual interest rate on Revolving Loan borrowings is equal to (i) in the case of U.S. dollar denominated loans, the sum of a borrowing margin of 1.75 percent plus the higher of the prime rate or one-half of one percent in excess of the overnight "federal funds" rate, or (ii) in the case of Eurodollar denominated loans, the sum of a borrowing margin of 2.75 percent plus the Eurodollar rate for the selected interest period. The Company has the option to borrow in U.S. dollar denominated loans or Eurodollar denominated loans at its discretion. Letters of Credit issued under the Revolving Loan Commitment bear interest at the rate of 2.875 percent. The commitment commission on the 2010 Credit Facility is 0.50 percent of the unused Revolving Loan Commitment.         There were $1.1 million of capital lease obligations and no Revolving Loan borrowings at June 30, 2010.</td></tr></table> NOTE AGeneral Basis of Presentation         The accompanying unaudited consolidated financial statements of false false false us-types:textBlockItemType textblock Description containing the entire organization, consolidation and basis of presentation of financial statements disclosure. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS140-4 and FIN46(R)-8 -Paragraph 8, C1, C7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 2-6 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 94-6 -Paragraph 10 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 46R -Paragraph 4, 14, 15 false 1 2 false UnKnown UnKnown UnKnown false true XML 20 R5.xml IDEA: CONSOLIDATED STATEMENTS OF CASH FLOWS 2.2.0.7 false CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS true false In Thousands false false 1 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 5 Cash flows from operating activities: 3 us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities include all transactions and events that are not defined as investing or financing activities. Operating activities generally involve producing and delivering goods and providing services. Cash flows from operating activities are generally the cash effects of transactions and other events that enter into the determination of net income. false 6 Net income 4 us-gaap_ProfitLoss us-gaap true credit duration No definition available. false false false false false false false false false false false terselabel false 1 true true false false 60947000 60947 false false false 2 true true false false 31959000 31959 false false false xbrli:monetaryItemType monetary The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 5 -Subparagraph b Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) false 7 Adjustments to reconcile net income to net cash provided by operating activities: 4 us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 8 Depreciation and amortization 5 us-gaap_DepreciationDepletionAndAmortization us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 27657000 27657 false false false 2 false true false false 21559000 21559 false false false xbrli:monetaryItemType monetary The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. No authoritative reference available. false 9 Non-cash interest expense 5 us-gaap_PaidInKindInterest us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 361000 361 false false false 2 false true false false 456000 456 false false false xbrli:monetaryItemType monetary Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by (used in) operations using the indirect method. No authoritative reference available. false 10 Non-cash stock compensation expense 5 us-gaap_ShareBasedCompensation us-gaap true debit duration No definition available. false false false false false false false false false false false verboselabel false 1 false true false false 8234000 8234 false false false 2 false true false false 12600000 12600 false false false xbrli:monetaryItemType monetary The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock options, amortization of restricted stock, and adjustment for officers compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 11 Non-cash income tax expense 5 us-gaap_OtherNoncashIncomeTaxExpense us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 18039000 18039 false false false 2 false true false false 13343000 13343 false false false xbrli:monetaryItemType monetary The portion of the noncash component of income tax expense for the period other than the portion from the net change in the entity's deferred tax assets and liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 12 Cash flows from changes in assets and liabilities, net of effects from acquisitions of businesses: 4 us-gaap_IncreaseDecreaseInOperatingCapitalAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 13 Restricted cash 5 us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false 35956000 35956 false false false 2 false true false false 40956000 40956 false false false xbrli:monetaryItemType monetary The net cash inflow (outflow) for the net change associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as operating activities. This may include cash restricted for regulatory purposes. No authoritative reference available. false 14 Accounts receivable, net 5 us-gaap_IncreaseDecreaseInAccountsReceivable us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false -2445000 -2445 false false false 2 false true false false -19880000 -19880 false false false xbrli:monetaryItemType monetary The net change during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 15 Other assets 5 us-gaap_IncreaseDecreaseInOtherOperatingAssets us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false 5674000 5674 false false false 2 false true false false -23604000 -23604 false false false xbrli:monetaryItemType monetary The net change during the reporting period in other operating assets not otherwise defined in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 16 Accounts payable and accrued liabilities 5 us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false -25050000 -25050 false false false 2 false true false false -23960000 -23960 false false false xbrli:monetaryItemType monetary The net change during the reporting period in the aggregate amount of obligations and expenses incurred but not paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 17 Medical claims payable and other medical liabilities 5 mgln_IncreaseDecreaseInMedicalClaimsPayableAndOtherMedicalLiabilities mgln false debit duration The net change during the reporting period in the medical claims payable and other medical liabilities false false false false false false false false false false false terselabel false 1 false true false false -7638000 -7638 false false false 2 false true false false -14259000 -14259 false false false xbrli:monetaryItemType monetary The net change during the reporting period in the medical claims payable and other medical liabilities No authoritative reference available. false 18 Other 5 us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false 4454000 4454 false false false 2 false true false false 973000 973 false false false xbrli:monetaryItemType monetary For entities with classified balance sheets, the net change during the reporting period in the value of other assets or liabilities used in operating activities, that are not otherwise defined in the taxonomy. For entities with unclassified balance sheets, the net change during the reporting period in the value of all other assets or liabilities used in operating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 false 19 Net cash provided by operating activities 4 us-gaap_NetCashProvidedByUsedInOperatingActivities us-gaap true na duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 126189000 126189 false false false 2 false true false false 40143000 40143 false false false xbrli:monetaryItemType monetary The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 20 Cash flows from investing activities: 3 us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 21 Capital expenditures 4 us-gaap_PaymentsToAcquirePropertyPlantAndEquipment us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false -21681000 -21681 false false false 2 false true false false -12457000 -12457 false false false xbrli:monetaryItemType monetary The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph c false 22 Purchase of investments 4 us-gaap_PaymentsToAcquireInvestments us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false -96515000 -96515 false false false 2 false true false false -144370000 -144370 false false false xbrli:monetaryItemType monetary The cash outflow associated with the purchase of all investments (debt, security, other) during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 17 false 23 Maturity of investments 4 us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 84959000 84959 false false false 2 false true false false 161449000 161449 false false false xbrli:monetaryItemType monetary The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 31 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 16 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 18 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 false 24 Net cash provided by (used in) investing activities 4 us-gaap_NetCashProvidedByUsedInInvestingActivities us-gaap true debit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false -33237000 -33237 false false false 2 false true false false 4622000 4622 false false false xbrli:monetaryItemType monetary The net cash inflow (outflow) from investing activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 25 Cash flows from financing activities: 3 us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 26 Payments on long-term debt and capital lease obligations 4 us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false -588000 -588 false false false 2 false true false false -3000 -3 false false false xbrli:monetaryItemType monetary The cash outflow associated with security instrument that either represents a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. The nature of such security interests included herein may consist of debt securities, long-term capital lease obligations, and capital securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph b false 27 Payments to acquire treasury stock 4 us-gaap_PaymentsForRepurchaseOfCommonStock us-gaap true credit duration No definition available. false false false false false false false false false false true negated false 1 false true false false -74427000 -74427 false false false 2 false true false false -64019000 -64019 false false false xbrli:monetaryItemType monetary The cash outflow to reacquire common stock during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph a false 28 Proceeds from exercise of stock options and warrants 4 us-gaap_ProceedsFromIssuanceOrSaleOfEquity us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false 17148000 17148 false false false 2 false true false false 1101000 1101 false false false xbrli:monetaryItemType monetary The cash inflow from the issuance of common, preferred, and treasury stocks, stock options, and such forth. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 19 -Subparagraph a false 29 Other 4 us-gaap_ProceedsFromPaymentsForOtherFinancingActivities us-gaap true debit duration No definition available. false false false false false false false false false false false terselabel false 1 false true false false -1504000 -1504 false false false 2 false true false false 2531000 2531 false false false xbrli:monetaryItemType monetary The net cash inflow (outflow) from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18, 19, 20 false 30 Net cash used in financing activities 4 us-gaap_NetCashProvidedByUsedInFinancingActivities us-gaap true debit duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false -59371000 -59371 false false false 2 false true false false -60390000 -60390 false false false xbrli:monetaryItemType monetary The net cash inflow (outflow) from financing activity for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 31 Net (decrease) increase in cash and cash equivalents 3 us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease us-gaap true na duration No definition available. false false false false false false false false false false false totallabel false 1 false true false false 33581000 33581 false false false 2 false true false false -15625000 -15625 false false false xbrli:monetaryItemType monetary The net change between the beginning and ending balance of cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 true 32 Cash and cash equivalents at beginning of period 3 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false true false false periodstartlabel false 1 false true false false 196507000 196507 false false false 2 false true false false 211825000 211825 false false false xbrli:monetaryItemType monetary Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 33 Cash and cash equivalents at end of period 3 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false false true false periodendlabel false 1 true true false false 230088000 230088 false false false 2 true true false false 196200000 196200 false false false xbrli:monetaryItemType monetary Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 2 29 false Thousands UnKnown UnKnown false true XML 21 defnref.xml IDEA: XBRL DOCUMENT No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Direct Service Costs and generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Long term liabilities that are payable after one year (or beyond the normal operating cycle if longer). Includes the amounts accrued for tax contingencies. Also, consists of unrecognized tax benefits. No authoritative reference available. The net result for the period of adding the operating and non-operating income and expenses. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Medical claims payable represents the liability for healthcare claims reported but not yet paid and claims incurred but not yet reported. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The net change during the reporting period in the medical claims payable and other medical liabilities No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Other medical liabilities consist primarily of "reinvestment" payables under certain managed behavioral healthcare contracts with customers and "profit share" payables under certain risk-based contracts. Under a contract with reinvestment features, if the cost of care is less than certain minimum amounts specified in the contract (usually as a percentage of revenue), the Company is required to "reinvest" such difference in behavioral healthcare programs when and as specified by the customer or to pay the difference to the customer for their use in funding such programs. Under a contract with profit share provisions, if the cost of care is below certain specified levels, the Company will "share" the cost savings with the customer at the percentages set forth in the contract. No authoritative reference available. No authoritative reference available. No authoritative reference available. XML 22 R1.xml IDEA: CONSOLIDATED BALANCE SHEETS 2.2.0.7 true CONSOLIDATED BALANCE SHEETS (USD $) 0010 - Statement - CONSOLIDATED BALANCE SHEETS true false In Thousands false false 1 USD false false shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Current Assets: 2 us-gaap_AssetsCurrentAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 3 Cash and cash equivalents 2 us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 true true false false 230088000 230088 false false false 2 true true false false 196507000 196507 false false false xbrli:monetaryItemType monetary Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 false 4 Restricted cash 2 us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 123703000 123703 false false false 2 false true false false 159659000 159659 false false false xbrli:monetaryItemType monetary The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Audit and Accounting Guide (AAG) -Number AAG-BRD -Chapter 4 -Paragraph 80 -Subparagraph Exhibit 4-8, 3 -IssueDate 2006-05-01 false 5 Accounts receivable, less allowance for doubtful accounts of $1,358 and $1,667 at December 31, 2009 and June 30, 2010, respectively 2 us-gaap_AccountsReceivableNetCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false verboselabel false 1 false true false false 116879000 116879 false false false 2 false true false false 114434000 114434 false false false xbrli:monetaryItemType monetary Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false 6 Short-term investments (restricted investments of $102,922 and $120,676 at December 31, 2009 and June 30, 2010, respectively) 2 us-gaap_ShortTermInvestments us-gaap true debit instant No definition available. false false false false false false false false false false false verboselabel false 1 false true false false 195416000 195416 false false false 2 false true false false 162922000 162922 false false false xbrli:monetaryItemType monetary Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Subparagraph g -Article 7 false 7 Deferred income taxes 2 us-gaap_DeferredTaxAssetsNetCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 57329000 57329 false false false 2 false true false false 57329000 57329 false false false xbrli:monetaryItemType monetary The current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating los s carryforward should be presented as a reduction of the related deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 false 8 Other current assets (restricted deposits of $15,467 and $20,838 at December 31, 2009 and June 30, 2010, respectively) 2 us-gaap_OtherAssetsCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false verboselabel false 1 false true false false 57035000 57035 false false false 2 false true false false 62737000 62737 false false false xbrli:monetaryItemType monetary Aggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 false 9 Total Current Assets 2 us-gaap_AssetsCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 780450000 780450 false false false 2 false true false false 753588000 753588 false false false xbrli:monetaryItemType monetary Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true 10 Property and equipment, net 2 us-gaap_PropertyPlantAndEquipmentNet us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 109323000 109323 false false false 2 false true false false 108219000 108219 false false false xbrli:monetaryItemType monetary Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 12 -Paragraph 5 -Subparagraph b, c Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false 11 Long-term investments (restricted investments of $60,230 and $41,814 at December 31, 2009 and June 30, 2010, respectively) 2 us-gaap_AvailableForSaleSecuritiesNoncurrent us-gaap true debit instant No definition available. false false false false false false false false false false false verboselabel false 1 false true false false 41814000 41814 false false false 2 false true false false 67523000 67523 false false false xbrli:monetaryItemType monetary Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 12 -Subparagraph b Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 17 false 12 Deferred income taxes 2 us-gaap_DeferredTaxAssetsNetNoncurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 2757000 2757 false false false 2 false true false false 17725000 17725 false false false xbrli:monetaryItemType monetary The noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 false 13 Other long-term assets 2 us-gaap_OtherAssetsNoncurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 2372000 2372 false false false 2 false true false false 2703000 2703 false false false xbrli:monetaryItemType monetary Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false 14 Goodwill 2 us-gaap_Goodwill us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 426471000 426471 false false false 2 false true false false 426471000 426471 false false false xbrli:monetaryItemType monetary Carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of FAS 142 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 43 false 15 Other intangible assets, net 2 us-gaap_IntangibleAssetsNetExcludingGoodwill us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 59405000 59405 false false false 2 false true false false 64812000 64812 false false false xbrli:monetaryItemType monetary Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 42, 45 false 16 Total Assets 2 us-gaap_Assets us-gaap true debit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 1422592000 1422592 false false false 2 false true false false 1441041000 1441041 false false false xbrli:monetaryItemType monetary Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 true 17 Current Liabilities: 2 us-gaap_LiabilitiesCurrentAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 18 Accounts payable 2 us-gaap_AccountsPayableCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 24655000 24655 false false false 2 false true false false 27086000 27086 false false false xbrli:monetaryItemType monetary Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 false 19 Accrued liabilities 2 us-gaap_AccruedLiabilitiesCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 71141000 71141 false false false 2 false true false false 93760000 93760 false false false xbrli:monetaryItemType monetary Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 false 20 Medical claims payable 2 mgln_MedicalClaimsPayableCurrent mgln false credit instant Medical claims payable represents the liability for healthcare claims reported but not yet paid and claims incurred but not... false false false false false false false false false false false terselabel false 1 false true false false 153976000 153976 false false false 2 false true false false 143669000 143669 false false false xbrli:monetaryItemType monetary Medical claims payable represents the liability for healthcare claims reported but not yet paid and claims incurred but not yet reported. No authoritative reference available. false 21 Other medical liabilities 2 mgln_OtherMedicalLiabilitiesCurrent mgln false credit instant Other medical liabilities consist primarily of "reinvestment" payables under certain managed behavioral healthcare contracts... false false false false false false false false false false false terselabel false 1 false true false false 86704000 86704 false false false 2 false true false false 104649000 104649 false false false xbrli:monetaryItemType monetary Other medical liabilities consist primarily of "reinvestment" payables under certain managed behavioral healthcare contracts with customers and "profit share" payables under certain risk-based contracts. Under a contract with reinvestment features, if the cost of care is less than certain minimum amounts specified in the contract (usually as a percentage of revenue), the Company is required to "reinvest" such difference in behavioral healthcare programs when and as specified by the customer or to pay the difference to the customer for their use in funding such programs. Under a contract with profit share provisions, if the cost of care is below certain specified levels, the Company will "share" the cost savings with the customer at the percentages set forth in the contract. No authoritative reference available. false 22 Current maturities of long-term capital lease obligation 2 us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 533000 533 false false false 2 false false false false 0 0 false false false xbrli:monetaryItemType monetary Obligation related to long-term debt (excluding convertible debt) and capital leases, the portion which is due in one year or less in the future. No authoritative reference available. false 23 Total Current Liabilities 2 us-gaap_LiabilitiesCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 337009000 337009 false false false 2 false true false false 369164000 369164 false false false xbrli:monetaryItemType monetary Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true 24 Long-term capital lease obligation 2 us-gaap_LongTermDebtAndCapitalLeaseObligations us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 559000 559 false false false 2 false false false false 0 0 false false false xbrli:monetaryItemType monetary Sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer plus capital lease obligations due to be paid more than one year after the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section H false 25 Tax Contingencies 2 us-gaap_LiabilityForUncertainTaxPositionsNoncurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 121762000 121762 false false false 2 false true false false 118859000 118859 false false false xbrli:monetaryItemType monetary The noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 48 -Paragraph 6, 7, 8 false 26 Deferred credits and other long-term liabilities 2 mgln_DeferredCreditsAndOtherLiabilitiesNoncurrent mgln false credit instant Long term liabilities that are payable after one year (or beyond the normal operating cycle if longer). Includes the amounts... false false false false false false false false false false false terselabel false 1 false true false false 2631000 2631 false false false 2 false true false false 2526000 2526 false false false xbrli:monetaryItemType monetary Long term liabilities that are payable after one year (or beyond the normal operating cycle if longer). Includes the amounts accrued for tax contingencies. Also, consists of unrecognized tax benefits. No authoritative reference available. false 27 Total Liabilities 2 us-gaap_Liabilities us-gaap true credit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 461961000 461961 false false false 2 false true false false 490549000 490549 false false false xbrli:monetaryItemType monetary Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. No authoritative reference available. true 28 Preferred stock, par value $.01 per share Authorized-10,000 shares-Issued and outstanding-none 2 us-gaap_PreferredStockValue us-gaap true credit instant No definition available. false false false false false false false false false false false verboselabel false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:monetaryItemType monetary Dollar value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) whether issued at par value, no par or stated value. This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false 30 Other Stockholders' Equity: 2 mgln_OtherStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract mgln false na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 31 Additional paid-in capital 2 us-gaap_AdditionalPaidInCapital us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 638367000 638367 false false false 2 false true false false 614483000 614483 false false false xbrli:monetaryItemType monetary Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of APIC associated with common AND preferred stock. For APIC associated with only common stock, use the element Additional Paid In Capital, Common Stock. For APIC associated with only preferred stock, use the element Additional Paid In Capital, Preferred Stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 false 32 Retained earnings 2 us-gaap_RetainedEarningsAccumulatedDeficit us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 616870000 616870 false false false 2 false true false false 555923000 555923 false false false xbrli:monetaryItemType monetary The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 false 33 Warrants outstanding 2 us-gaap_WarrantsAndRightsOutstanding us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 5370000 5370 false false false 2 false true false false 5382000 5382 false false false xbrli:monetaryItemType monetary Value of warrants and rights outstanding. "Equity warrants and rights outstanding" represents derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 00-27 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 98-5 false 34 Accumulated other comprehensive income (loss) 2 us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false -145000 -145 false false false 2 false true false false 114000 114 false false false xbrli:monetaryItemType monetary Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at fiscal year-end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, and unrealized gains and losses on certain investments in debt and equity securities as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 26 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 false 35 Ordinary common stock in treasury, at cost, 6,509 shares and 8,221 shares at December 31, 2009 and June 30, 2010, respectively 2 us-gaap_TreasuryStockValue us-gaap true debit instant No definition available. false false false false false false false false false false true negated false 1 false true false false -300247000 -300247 false false false 2 false true false false -225820000 -225820 false false false xbrli:monetaryItemType monetary Value of common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. Treasury stock is issued but is not outstanding. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Note: number of treasury shares concept is in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Technical Bulletin (FTB) -Number 85-6 -Paragraph 3 false 36 Total Stockholders' Equity 2 us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap true credit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 960631000 960631 false false false 2 false true false false 950492000 950492 false false false xbrli:monetaryItemType monetary Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 25 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 26 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A true 37 Total Liabilities and Stockholders' Equity 2 us-gaap_LiabilitiesAndStockholdersEquity us-gaap true credit instant No definition available. false false false false false false false false false false false totallabel false 1 false true false false 1422592000 1422592 false false false 2 false true false false 1441041000 1441041 false false false xbrli:monetaryItemType monetary Total of all Liabilities and Stockholders' Equity items. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 true 38 Ordinary common stock 0 na true na na No definition available. false true false false false false false false false false false http://www.magellanhealth.com/role/balancesheet false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false false 5 USD true false false false mgln_OrdinaryCommonStockMember us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_OrdinaryCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 6 USD true false false false mgln_OrdinaryCommonStockMember us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_OrdinaryCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ na No definition available. No authoritative reference available. false 54 Current Liabilities: 2 us-gaap_LiabilitiesCurrentAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 66 Common stock 2 us-gaap_CommonStockValue us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 416000 416 false false false 2 false true false false 410000 410 false false false xbrli:monetaryItemType monetary Dollar value of issued common stock whether issued at par value, no par or stated value. This item includes treasury stock repurchased by the entity. Note: elements for number of common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 75 Multi-Vote common stock 0 na true na na No definition available. false true false false false false false false false false false http://www.magellanhealth.com/role/balancesheet false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false false 7 USD true false false false mgln_MultiVoteCommonStockMember us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_MultiVoteCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 8 USD true false false false mgln_MultiVoteCommonStockMember us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_MultiVoteCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ na No definition available. No authoritative reference available. false 91 Current Liabilities: 2 us-gaap_LiabilitiesCurrentAbstract us-gaap true na duration No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false xbrli:stringItemType string No definition available. false 103 Common stock 2 us-gaap_CommonStockValue us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 true true false false 0 0 false false false 2 true true false false 0 0 false false false xbrli:monetaryItemType monetary Dollar value of issued common stock whether issued at par value, no par or stated value. This item includes treasury stock repurchased by the entity. Note: elements for number of common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 2 41 false Thousands UnKnown UnKnown false true XML 23 R2.xml IDEA: CONSOLIDATED BALANCE SHEETS (Parenthetical) 2.2.0.7 true CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) true false In Thousands, except Per Share data false false 1 USD false false shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 $ false 2 USD false false USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 $ 2 Allowance for doubtful accounts (in dollars) 2 us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent us-gaap true credit instant No definition available. false false false false false false false false false false false terselabel false 1 true true false false 1667000 1667 false false false 2 true true false false 1358000 1358 false false false xbrli:monetaryItemType monetary A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false 3 Short-term restricted investments (in dollars) 2 us-gaap_RestrictedInvestmentsCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 120676000 120676 false false false 2 false true false false 102922000 102922 false false false xbrli:monetaryItemType monetary This element represents the current portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions. No authoritative reference available. false 4 Restricted deposits (in dollars) 2 us-gaap_OtherRestrictedAssetsCurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 20838000 20838 false false false 2 false true false false 15467000 15467 false false false xbrli:monetaryItemType monetary Other short-term assets not otherwise listed in the existing taxonomy that are pledged or subject to withdrawal restrictions. No authoritative reference available. false 5 Long-term restricted investments (in dollars) 2 us-gaap_RestrictedInvestmentsNoncurrent us-gaap true debit instant No definition available. false false false false false false false false false false false terselabel false 1 true true false false 41814000 41814 false false false 2 true true false false 60230000 60230 false false false xbrli:monetaryItemType monetary This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions. No authoritative reference available. false 6 Preferred stock, par value (in dollars per share) 2 us-gaap_PreferredStockParOrStatedValuePerShare us-gaap true na instant No definition available. false false false false false false false false false false false terselabel true 1 true true false false 0.01 0.01 false false false 2 true true false false 0.01 0.01 false false false us-types:perShareItemType decimal Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 false 7 Preferred stock, Authorized shares 2 us-gaap_PreferredStockSharesAuthorized us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 10000000 10000 false false false 2 false true false false 10000000 10000 false false false xbrli:sharesItemType shares The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 false 8 Preferred stock, Issued shares 2 us-gaap_PreferredStockSharesIssued us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:sharesItemType shares Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false 9 Preferred stock, outstanding shares 2 us-gaap_PreferredStockSharesOutstanding us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:sharesItemType shares Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false 14 Ordinary common stock in treasury, shares 2 us-gaap_TreasuryStockShares us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 8221000 8221 false false false 2 false true false false 6509000 6509 false false false xbrli:sharesItemType shares Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false 15 Ordinary common stock 0 na true na na No definition available. false true false false false false false false false false false http://www.magellanhealth.com/role/balancesheetparenthetical false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false false 3 USD true false false false Ordinary common stock us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_OrdinaryCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 4 USD true false false false Ordinary common stock us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_OrdinaryCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ na No definition available. No authoritative reference available. false 24 Common stock, par value (in dollars per share) 2 us-gaap_CommonStockParOrStatedValuePerShare us-gaap true na instant No definition available. false false false false false false false false false false false terselabel true 1 true true false false 0.01 0.01 false false false 2 true true false false 0.01 0.01 false false false us-types:perShareItemType decimal Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 25 Common stock, Authorized shares 2 us-gaap_CommonStockSharesAuthorized us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 100000000 100000 false false false 2 false true false false 100000000 100000 false false false xbrli:sharesItemType shares The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 26 Common stock, Issued shares 2 us-gaap_CommonStockSharesIssued us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 41602000 41602 false false false 2 false true false false 41044000 41044 false false false xbrli:sharesItemType shares Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 27 Common stock, outstanding shares 2 us-gaap_CommonStockSharesOutstanding us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 33381000 33381 false false false 2 false true false false 34535000 34535 false false false xbrli:sharesItemType shares Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Excludes common shares repurchased by the entity and held as Treasury shares. Shares outstanding equals shares issued minus shares held in treasury. Does not include common shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 29 Multi-Vote common stock 0 na true na na No definition available. false true false false false false false false false false false http://www.magellanhealth.com/role/balancesheetparenthetical false 1 false false false false 0 0 false false false 2 false false false false 0 0 false false false false 5 USD true false false false Multi-Vote common stock us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_MultiVoteCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ false 6 USD true false false false Multi-Vote common stock us-gaap_StatementClassOfStockAxis xbrldi http://xbrl.org/2006/xbrldi mgln_MultiVoteCommonStockMember us-gaap_StatementClassOfStockAxis explicitMember USDPerShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 $ na No definition available. No authoritative reference available. false 38 Common stock, par value (in dollars per share) 2 us-gaap_CommonStockParOrStatedValuePerShare us-gaap true na instant No definition available. false false false false false false false false false false false terselabel true 1 true true false false 0.01 0.01 false false false 2 true true false false 0.01 0.01 false false false us-types:perShareItemType decimal Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 39 Common stock, Authorized shares 2 us-gaap_CommonStockSharesAuthorized us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 40000000 40000 false false false 2 false true false false 40000000 40000 false false false xbrli:sharesItemType shares The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 40 Common stock, Issued shares 2 us-gaap_CommonStockSharesIssued us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:sharesItemType shares Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 41 Common stock, outstanding shares 2 us-gaap_CommonStockSharesOutstanding us-gaap true na instant No definition available. false false false false false false false false false false false terselabel false 1 false true false false 0 0 false false false 2 false true false false 0 0 false false false xbrli:sharesItemType shares Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Excludes common shares repurchased by the entity and held as Treasury shares. Shares outstanding equals shares issued minus shares held in treasury. Does not include common shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false 2 19 false Thousands Thousands NoRounding false true XML 24 FilingSummary.xml IDEA: XBRL DOCUMENT 2.2.0.7 true Sheet 0010 - Statement - CONSOLIDATED BALANCE SHEETS CONSOLIDATED BALANCE SHEETS http://www.magellanhealth.com/role/BalanceSheet false R1.xml false Sheet 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) CONSOLIDATED BALANCE SHEETS (Parenthetical) http://www.magellanhealth.com/role/BalanceSheetParenthetical false R2.xml false Sheet 0020 - Statement - CONSOLIDATED STATEMENTS OF INCOME CONSOLIDATED STATEMENTS OF INCOME http://www.magellanhealth.com/role/StatementOfIncome false R3.xml false Sheet 0025 - Statement - CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) http://www.magellanhealth.com/role/StatementOfIncomeParenthetical false R4.xml false Sheet 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS http://www.magellanhealth.com/role/CashFlows false R5.xml false Sheet 1010 - Disclosure - General General http://www.magellanhealth.com/role/DisclosureGeneral false R6.xml false Sheet 1020 - Disclosure - Net Income per Common Share Net Income per Common Share http://www.magellanhealth.com/role/DisclosureNetIncomePerCommonShare false R7.xml false Sheet 1030 - Disclosure - Business Segment Information Business Segment Information http://www.magellanhealth.com/role/DisclosureBusinessSegmentInformation false R8.xml false Sheet 1040 - Disclosure - Commitments and Contingencies Commitments and Contingencies http://www.magellanhealth.com/role/DisclosureCommitmentsAndContingencies false R9.xml false Sheet 1050 - Disclosure - Subsequent Event Subsequent Event http://www.magellanhealth.com/role/DisclosureSubsequentEvent false R10.xml false Sheet 9999 - Document - Document and Entity Information Document and Entity Information http://www.magellanhealth.com/role/DocumentAndEntityInformation false R11.xml false Book All Reports All Reports false 1 12 2 0 3 99 true false D2010Q2YTD 52 I2010Q2_OrdinaryCommonStockMember 5 I2009_MultiVoteCommonStockMember 5 I2009_OrdinaryCommonStockMember 5 I2010Q2 42 I2010Q2_MultiVoteCommonStockMember 5 D2009Q2YTD 37 I2009Q2 1 I2009 39 I2008 1 D2010Q2 18 D2009Q2 18 true true EXCEL 25 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A.3AF8F4P9%]A.#`X7S1C,S1?8F-C8U\S9#`S M96)D8S(Y-S0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D)U#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G0\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I7;W)K#I3='EL M97-H965T($A2968],T0B5V]R:W-H965T3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.3AF8F4P9%]A.#`X7S1C M,S1?8F-C8U\S9#`S96)D8S(Y-S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO83DX9F)E,&1?83@P.%\T8S,T7V)C8V-?,V0P,V5B9&,R.3'0O:'1M M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2D\+W1D/@T*("`@("`@ M("`\=&0@8VQA2!A;F0@ M97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@ M8VQA"!#;VYT:6YG96YC:65S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C$L-S8R/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D+3$P+#`P,"!S:&%R M97,M27-S=65D(&%N9"!O=71S=&%N9&EN9RUN;VYE/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3H\+W-T2P@870@8V]S="P@-BPU,#D@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!C;VUM;VX@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!C;VUM;VX@F5D('-H87)E M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A.3AF8F4P9%]A.#`X7S1C,S1?8F-C M8U\S9#`S96)D8S(Y-S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M83DX9F)E,&1?83@P.%\T8S,T7V)C8V-?,V0P,V5B9&,R.3'0O:'1M;#L@8VAA M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PS-#@\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!O<&5R871I;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&%N9"!W87)R86YT M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4],T0R/CQB/DY/5$4@028C,34Q.T=E;F5R86P@ M/"]B/CPO9F]N=#X\+W`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`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`L($%352`R,#$P+3`V(')E<75I2!F;W(@9&5T97)M:6YI;F<@=VAE;B!T2!R97%U:7)E9"!A9&1I=&EO;F%L(&1IF4],T0R/CQI M/E5S92!O9B!%F4],T0R/B9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.U1H92!P M2!A8V-E M<'1E9"!I;B!T:&4@56YI=&5D(%-T871E'!E;G-E2!I;F-L=61E+"!A M;6]N9R!O=&AE"!C;VYT:6YG96YC:65S(&%N9"!L96=A;"!L:6%B:6QI=&EE2!E2!F965S('!A:60@<')I;W(@ M=&\@=&AE(&UO;G1H(&]F('-E"!M;VYT:',@ M96YD960@2G5N929N8G-P.S,P+"`R,#`Y+"!R97-P96-T:79E;'DL(&%N9"`F M;F)S<#LD-3DQ+C(F;F)S<#MM:6QL:6]N(&%N9"`F;F)S<#LD,2PQ-S0N-B9N M8G-P.VUI;&QI;VX@9F]R('1H92!T:')E92!A;F0@2X@/"]F;VYT/CPO M<#X-"CQP('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE2!R96-O9VYI>F5S(')E=F5N=64@87,@2X@1D93(')E=F5N=64@9F]R(#(P,3`@:6YC;'5D97,@=&AE(&%C=&EV:71Y M(&9R;VT@=&AE($UE9&EC86ED($%D;6EN:7-TF4],T0R/CQI/D)L;V-K($=R86YT(%)E=F5N=65S/"]I/CPO9F]N M=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,G/CQF;VYT M('-I>F4],T0R/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.U1H92!-87)I8V]P82!#;VYT2!R96-O9VYI>F5S(')E=F5N=64@9G)O;2!B M;&]C:R!G2!R871A8FQY(&]V97(@=&AE('!E2P@86YD("9N8G-P.R0S,"XW)FYB"!M;VYT:',@96YD960@2G5N929N8G-P.S,P+"`R,#$P M+"!R97-P96-T:79E;'DN(#PO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=&3TY4 M+49!34E,63H@=&EM97,G/CQF;VYT('-I>F4],T0R/CQI/D1I6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UE2!S97)V97,L('=H96X@=&AE('-P96-I M86QT>2!P:&%R;6%C975T:6-A;"!D2=S(&-U2!F;W(@=&AE('-P96-I86QT>2!P:&%R;6%C975T:6-A;"!D M"!M;VYT:',@96YD M960@2G5N929N8G-P.S,P+"`R,#$P+"!R97-P96-T:79E;'DN(#PO9F]N=#X\ M+W`^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,G/CQF;VYT('-I M>F4],T0R/CQI/E!E6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF5D(&]N M(&%N(&EN=&5R:6T@8F%S:7,@<'5R2!U<&]N('1E"!M;VYT:',@96YD960@ M2G5N929N8G-P.S,P+"`R,#`Y+"!R97-P96-T:79E;'DL(&%N9"`F;F)S<#LD M-"XX)FYB2X@/"]F;VYT/CPO<#X-"CQP('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/D-O;G-O;&ED871E9"!# M;VUP86YY(#PO9F]N=#X\+W`^/"]L:3X\+W5L/@T*/'`@2!F;W(@=&AE('-I M>"!M;VYT:',@96YD960@2G5N929N8G-P.S,P+"`R,#`Y(&%N9"`R,#$P+B!4 M:&4@0V]M<&%N>2!A;'-O(&AA6QV86YI82!-961I8V%I9"!P&EM871E;'D@-S(W+#`P,"!M96UB97)S(&EN($UA2P@07)I>F]N82X@56YD97(@=&AE($UA2!I2!!8W0L(&YO;BU4:71L92!825@@86YD M(&YO;BU4:71L92!825@@96QI9VEB;&4@8VAI;&1R96X@86YD(&%D=6QT2X@/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE"!M;VYT:',@96YD M960@2G5N929N8G-P.S,P+"`R,#`Y(&%N9"`R,#$P+"!R97-P96-T:79E;'DL M(&EN8VQU9&EN9R!R861I;VQO9WD@8F5N969I=',@;6%N86=E;65N="!R979E M;G5E(&]F("9N8G-P.R0X,2XV)FYBF4],T0R M/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.TEN($IU;'D@,C`P-RP@5V5L;%!O:6YT(&%C<75I2P@86YD(&5X<')E2!B96YE9FET'!I M6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QV86YI82!#;W5N M=&EE"!M;VYT:',@96YD960@2G5N929N8G-P.S,P+"`R,#`Y(&%N9"`R M,#$P+"!R97-P96-T:79E;'DN(#PO9F]N=#X\+W`^#0H\=6P^#0H\;&D@F4],T0R/D)Y(%-E9VUE;G0@/"]F;VYT M/CPO<#X\+VQI/CPO=6P^#0H\<"!S='EL93TS1"=&3TY4+49!34E,63H@=&EM M97,G/CQF;VYT('-I>F4],T0R/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.U1W;R!C=7-T;VUE"!M;VYT:',@96YD960@2G5N929N8G-P.S,P M+"`R,#`Y(&%N9"`R,#$P+B!4:&4@9FER2X@5&AE('-E8V]N9"!C=7-T;VUE7,G(&YO=&EC92!A9G1E2X@/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE2X@/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE"!M;VYT:',@96YD960@2G5N929N8G-P.S,P+"`R,#`Y(&%N M9"!T:')E92!C=7-T;VUE"!M;VYT M:',@96YD960@2G5N929N8G-P.S,P+"`R,#$P+B!4:&4@9FER"!M;VYT M:',@96YD960@2G5N929N8G-P.S,P+"`R,#$P+"!T:&4@&-E961E9"!T96X@<&5R8V5N M="!O9B!T:&4@;F5T(')E=F5N=65S(&9O6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE2!H87,@=&AE(&%B M:6QI='D@=&\@86-C97-S(&%T('1H92!M96%S=7)E;65N="!D871E+B`\+V9O M;G0^/"]P/@T*/'`@2`H:2YE+BPF;F)S<#MI;G1E6EE;&0@8W5R=F5S+"!E=&,N*2P@86YD(&EN<'5T6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.TEN(&%C8V]R9&%N8V4@=VET M:"!T:&4@9F%I6QE/3-$)U!!1$1)3DF4],T0R/CPA+2T@0T]-34%.1#U!1$1?5$%"3$57 M24142"PB,3`P)2(@+2T^/"]F;VYT/CPO<#X-"CPA+2T@57-E6QE/3-$)T9/ M3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1H M/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O M;&ED.R!&3TY4+49!34E,63H@=&EM97,G(&%L:6=N/3-$8V5N=&5R(&-O;'-P M86X],T0Q,3X\9F]N="!S:7IE/3-$,3X\8CY&86ER(%9A;'5E($UE87-UF4] M,T0Q/B9N8G-P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,G M(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0R/CQF;VYT('-I>F4],T0Q/CQB M/DQE=F5L)FYB6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UEF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`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`Z(#$R<'0[($U! M4D=)3BU,1494.B`Q,'!T.R!415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UEF4],T0R M/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UEF4],T0R/B9N8G-P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE MF4],T0R/B9N8G-P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D M/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!T:6UEF4] M,T0R/B9N8G-P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@=F%L:6=N/3-$=&]P M(&)G8V]L;W(],T1W:&ET93X-"CQT9"!S='EL93TS1"=&3TY4+49!34E,63H@ M=&EM97,G('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)TU!4D=)3BU, M1494.B`Q,'!T.R!415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T M:6UEF4],T0R/C(L,3@U/"]F;VYT/CPO=&0^#0H\=&0@F4],T0R/B8C M,34Q.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UEF4],T0R/B9N8G-P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TU!4D=)3BU,1494.B`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`Q,'!T.R!415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9 M.B!T:6UEF4],T0R/CDL-S4P/"]F M;VYT/CPO=&0^#0H\=&0@F4],T0R/CDL-S4P/"]F;VYT/CPO=&0^ M#0H\=&0@6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B8C,34Q.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!T:6UEF4] M,T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UEF4],T0R/B9N M8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UEF4],T0R M/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UEF4],T0R/B9N8G-P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE MF4],T0R/B9N8G-P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V9O;G0M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T M('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,G('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT(&-O;'-P86X],T0R/B9N8G-P.SPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,G('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT(&-O;'-P86X],T0R/B9N8G-P.SPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3BU, M1494.B`Q,'!T.R!415A4+4E.1$5.5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T M:6UEF4Z M(#$N-7!T.R<@=F%L:6=N/3-$=&]P/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,BXR-7!T(&1O=6)L93L@1D].5"U&04U)3%DZ('1I;65S M)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,CXF M;F)S<#L\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T-/3$]2.B`C,#`P,#`P)R!A;&EG;CTS1&QE9G0@=VED M=&@],T0R-B4@;F]S:&%D93TS1&YOF4],T0R/D5X8VQU9&5S("9N8G-P.R0Q-C,N."9N8G-P M.VUI;&QI;VX@;V8@8V%S:"!H96QD(&EN(&)A;FL@86-C;W5N=',@8GD@=&AE M($-O;7!A;GDN(#QB2!T:&4@0V]M<&%N>2X@/&)R("\^ M#0H\8G(@+SX\+V9O;G0^/"]D9#X-"CQD="!S='EL93TS1"=-05)'24XM0D]4 M5$]-.B`M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S)SX\9F]N="!S:7IE/3-$ M,CXH,RD\+V9O;G0^/"]D=#X-"CQD9"!S='EL93TS1"=&3TY4+49!34E,63H@ M=&EM97,G/CQF;VYT('-I>F4],T0R/DEN8VQU9&5S(&EN=F5S=&UE;G1S(&EN M(&YO=&5S(&ES2!T:&4@1F5D97)A;"!(;VUE($QO86X@36]R=&=A M9V4@0V]R<&]R871I;VXL(&%N9"!T:&4@1F5D97)A;"!(;VUE($QO86X@0F%N M:RX\+V9O;G0^/"]D9#X\+V1L/CPO9&EV/@T*/'`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`P)2(@+2T^/"]F;VYT/CPO<#X-"CPA+2T@57-E6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0Q/B9N8G-P.SPO9F]N M=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`P,#`@,7!T('-O M;&ED.R!&3TY4+49!34E,63H@=&EM97,G(&%L:6=N/3-$8V5N=&5R(&-O;'-P M86X],T0R/CQF;VYT('-I>F4],T0Q/CQB/D=R;W-S/&)R("\^#0I5;G)E86QI M>F5D/&)R("\^#0I'86ENF4] M,T0Q/B9N8G-P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,G M(&%L:6=N/3-$8V5N=&5R(&-O;'-P86X],T0R/CQF;VYT('-I>F4],T0Q/CQB M/D5S=&EM871E9#QB6QE/3-$)TU!4D=) M3BU,1494.B`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`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`P,#`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`P,#`@,BXR M-7!T(&1O=6)L93L@1D].5"U&04U)3%DZ('1I;65S)R!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,CXF;F)S<#L\+W1D/@T*/'1D M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4] M,T0R/B9N8G-P.SQB6QE/3-$)U!! M1$1)3DF4],T0R/CPA+2T@ M0T]-34%.1#U!1$1?5$%"3$5724142"PB,3`P)2(@+2T^/"]F;VYT/CPO<#X- M"CPA+2T@57-E6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE MF4],T0Q M/B9N8G-P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,G(&%L M:6=N/3-$8V5N=&5R(&-O;'-P86X],T0Q,3X\9F]N="!S:7IE/3-$,3X\8CY* M=6YE)FYB6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UEF4],T0Q M/B9N8G-P.SPO9F]N=#X\+W1H/@T*/'1H('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`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`Q,'!T.R!415A4+4E.1$5. M5#H@+3$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!T:6UEF4] M,T0R/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE MF4],T0R/B9N8G-P.SPO9F]N M=#X\+W1D/CPO='(^#0H\='(@6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!T('-O;&ED.R!&3TY4+49!34E,63H@=&EM97,G('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT(&-O;'-P86X],T0R/B9N8G-P.SPO=&0^#0H\=&0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)TU!4D=)3BU,1494 M.B`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`P,#`@,BXR-7!T(&1O=6)L93L@1D].5"U&04U)3%DZ M('1I;65S)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H="!C;VQS<&%N M/3-$,CXF;F)S<#L\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3DF4],T0Q("\^#0H\9&P@8V]M M<&%C=#TS1&-O;7!A8W0^#0H\9'0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3DF4],T0R/CPA+2T@0T]-34%.1#U! M1$1?5$%"3$5724142"PB,3`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`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`Q,'!T.R!415A4+4E.1$5.5#H@+3$P<'0[ M($9/3E0M1D%-24Q9.B!T:6UEF4],T0R/C(L,38T/"]F;VYT M/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W1D/CPO='(^ M#0H\='(@6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED.R!& M3TY4+49!34E,63H@=&EM97,G('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT(&-O;'-P86X],T0R/B9N8G-P.SPO=&0^#0H\=&0@F4],T0R/E1O M=&%L(&EN=F5S=&UE;G1S(&%T($IU;F4F;F)S<#LS,"P@,C`Q,#PO9F]N=#X\ M+W`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`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"=&3TY4+49!34E,63H@=&EM97,G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)V9O;G0M6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,BXR-7!T(&1O=6)L93L@1D].5"U&04U)3%DZ('1I M;65S)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$ M,CXF;F)S<#L\+W1D/@T*/'1D('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE MF4],T0R/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.U1H92!C87)R>6EN9R!V86QU92!F M;W(@=&AE($-O;7!A;GDGF4],T0R/CQI/DEN8V]M92!487AE M6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE"!R871E2!I M;F-O;64@=&%X(')A=&4@<')I;6%R:6QY(&1U92!T;R!S=&%T92!I;F-O;64@ M=&%X97,@86YD('!E